Journals

Call for Papers for Collections on Dove Medical Press

Authors are invited to browse Collections that are currently open for submissions – click on the title of the Collection to learn how you can contribute your own research. These Collections focus on specific topics of interest and importance to the research community.

    Clinical Interventions in Aging

    Empowering Lives: Advances in Cancer Rehabilitation

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Empowering Lives: Advances in Cancer Rehabilitation" in Clinical Interventions in Aging.

    In recent years, the field of cancer rehabilitation has gained prominence as an integral component of comprehensive cancer care. "Empowering Lives: Advances in Cancer Rehabilitation" seeks to explore the latest developments in this field, focusing on innovative approaches that enhance the quality of life for cancer survivors. From physical challenges to emotional well-being, this Collection will delve into a spectrum of interventions designed to address the diverse needs of individuals on their journey to recovery. 

    The importance of advancing cancer rehabilitation lies in the transformative impact it can have on the lives of cancer survivors. Beyond mere survival, the goal is to empower individuals to reclaim their lives post-cancer treatment. Cancer rehabilitation plays a pivotal role in mitigating treatment-related side effects, promoting functional independence, and addressing the psychosocial aspects of survivorship. By highlighting the significance of these interventions, we aim to foster a deeper understanding among healthcare professionals, policymakers, and the broader community, ultimately contributing to a paradigm shift in cancer care that prioritizes not just survival but the holistic well-being of individuals. 

    Within the scope of the journal, this Collection will cover a range of topics, including novel rehabilitation strategies, personalized care plans, and the integration of technology in cancer rehabilitation. Submissions are encouraged to explore the intersection of various disciplines, such as oncology, physiotherapy, psychology, and technology, to provide a comprehensive view of the advancements in cancer rehabilitation. Preferred article types include original research studies and systematic reviews. By presenting a diverse array of evidence-based practices, this Collection aims to inspire further research, encourage interdisciplinary collaboration, and ultimately contribute to the evolution of cancer rehabilitation practices in the context of the journal's mission. Please note that submissions to Clinical Interventions in Aging should have a clear aging research focus, with a particular focus on older persons (> 65 years).

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 May 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Please submit your manuscript on our website, quoting the promo code WCVZL to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    De-Chao Feng, Department of Urology, Institute of Urology, West China Hospital, Sichuan University; Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University

    [email protected]

    Dr. Dechao Feng primarily focuses on urological tumors and stones, with a current emphasis on identifying prognostic biomarkers, big data multi-omics analysis, aging, immunology, circadian rhythms, nanomaterials, and drug-related aspects of cancer rehabilitation.

    Chi Zhang, Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University

    [email protected]

    Prof. Chi Zhang is a member of the following organizations: Shock Wave Committee of Sichuan Rehabilitation Medicine Association; Pain Intervention Group of Interventionalist Branch of Chinese Physicians Association; deputy director of the First Tumour Rehabilitation Committee of Sichuan Acupuncture and Moxibustion Society; Occupational Therapy Committee of Sichuan Rehabilitation Medicine Association; Sichuan Rehabilitation Therapist Association; Professional Committee of Physical Medicine and Rehabilitation of Sichuan Provincial Medical Association.

    View all papers in this article collection

    Nutrition in Aging

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Nutrition in Aging" in Clinical Interventions in Aging.

    A diet rich in nutrients and antioxidants is linked to the prevention of cardiovascular and cardiometabolic diseases, osteoporosis, and diabetes. Early vascular aging is linked to an increased risk of premature mortality related to cardiovascular, metabolic, and renal diseases. Malnutrition is associated with accelerated aging. Furthermore, insufficient intake of nutrients may lead to frailty, anemia, and impaired cognition. With advanced age and concomitant comorbidities, proper nutrition is even more important for supporting healthy aging, and nutrition is a part of secondary and tertiary prevention of different diseases that accompany aging. 

    A healthy lifestyle, which includes physical activity, the maintenance of an optimal weight, smoking cessation, and a healthy diet reduces the risk of subsequent cardiovascular events and mortality. There is more evidence that cardiovascular diseases are marked by vascular aging. Endothelial senescence represents one of the earliest features of arterial aging and contributes to many age-related diseases. Comprehending the pathophysiology of vascular aging, along with its repercussions and potential therapeutic opportunities, presents an advantageous prospect that may translate into effective prevention and the attainment of a cardiovascular disease-free survival over time. Studies demonstrate that the intake of antioxidants and food with anti-inflammatory properties may improve vascular function. Thus, research on the mechanism of nutrition’s impact on overall health, and particularly vascular health, has its significance in healthy aging. 

    This Article Collection invites original research articles and reviews of genetic, metabolic, clinical, and epidemiological studies related to nutrition in aging. Particularly, we are interested in studies presenting mechanisms affected or altered by nutrition and emphasized with aging or influencing aging. Nutritional supplements, functional food, different nutrients and their impact on (cardio)vascular and metabolic health is of interest for the present Collection. However, the Collection is open to other influences of nutrition (e.g., in oncologic disases, malnutrition, etc.) in aging. 

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 September 2024. For questions about this Article Collection, including inquiries regarding discounts of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Please submit your manuscript on our website, quoting the promo code TIUYO to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Ines Drenjančević, Institute and Department of Physiology and Immunology, Faculty of Medicine Osijek University of Osijek, Osijek, Croatia

    [email protected]

    Prof. Ines Drenjančević, MD, PhD is a professor of physiology and immunology at the Faculty of Medicine Osijek, Croatia. She obtained her PhD degree at the Medical College of Wisconsin, Milwaukee, WI, USA. She is a head of the national Scientific Centre of Excellence for Personalized Health Care. Her research interests are: microcirculation, mechanisms of vascular reactivity, impact of diet (such as high salt diet and enriched foodstuff), n-3 PUFAs, renin-angiotensin system, and hyperbaric oxygenation.

    View all papers in this article collection

    Promoting Physical Activity Participation as a Strategy for Protecting the Health of Older Adults in a Changing Climate

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Promoting Physical Activity Participation as a Strategy for Protecting the Health of Older Adults in a Changing Climate" in Clinical Interventions in Aging.

    Climate change is impacting the health of individuals worldwide. According to the World Health Organization, between the years 2030 and 2050, approximately 250,000 additional deaths per year are expected to occur due to climate change. A higher frequency of extreme weather events, such as heat waves and floods, causing disrupted food systems and climate migration, are just a few examples of current and impending global conditions. Older adults are consistently reported as a population most susceptible to the health consequences of a changing climate. An increase in chronological age is associated with a higher prevalence of chronic conditions, limited mobility, dependence, an inability to efficiently respond to environmental challenges, and compromised immune systems – all contributing to an increased vulnerability during extreme weather events. By the year 2050, the world’s population of individuals aged 60 years or older is expected to reach two billion. Between 2020 and 2050, the number of individuals aged 80 years or older is expected to triple, reaching 426 million. Population aging – an increase in the proportion of older individuals causing a shift in the age composition of a population – has serious concerns such as health care costs that are amplified when considered in the context of climate change. 

    Physical activity has consistently shown to provide important benefits that promote healthspan and longevity. Specifically, physical activity participation has been associated with an improvement in the health of older individuals with chronic disease, increased mobility, independence, cardiac autonomic function, and enhanced immune function, just to name a few. Research supports that physical activity participation can enhance our ability to deal with illness or physiological stress. For example, a higher cardiorespiratory fitness level has been associated with a greater tolerance for heat stress resulting in a lower risk for heat-related illness. This Article Collection aims to broadly explore the potential for physical activity participation to provide protection for older adults against the health consequences of climate change. Original research, systematic, and narrative reviews, expert opinions, and commentaries are welcome. 

    Topics within the scope of interest include, but are not limited to:

    • Physical activity participation outcomes that may translate into protection for older adults against the health consequences of climate change.

    • Cardiorespiratory fitness
    • Cardiac autonomic function
    • Mobility
    • Independence
    • Immune system function

    • Investigation of physical activity in association with specific environmental conditions.

    • Mobility concerns associated with extreme weather events such as floods.
    • Thermoregulatory responsiveness during heat exposure.
    • Respiratory function in response to outdoor air pollutants such as wildfire smoke.
    • Insect related conditions such as West Nile virus or Lyme disease.
    • Mental health concerns in response to extreme weather events.

    • Physical activity intervention strategies in preparation for anticipated extreme events (e.g., heat waves during summer)

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 29 March 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Please submit your manuscript on our website, quoting the promo code BNLXH to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Andres E. Carrillo, Associate Professor, Chatham University

    [email protected]

    Andres E. Carrillo, PhD, is Associate Professor of Exercise Science at Chatham University in Pittsburgh, PA, USA. His current research interests include the investigation of cardiac autonomic function in older adults during physiological challenges such as exercise and heat exposure. Dr. Carrillo is actively collaborating with the Gerald P. Murphy Cancer Foundation in West Lafayette, IN, USA to advance the Exceptional Aging in Rottweilers Study (EARS), a study that seeks to understand the biology of aging and disease resistance by investigating the genetic and environmental factors that influence morbidity compression and longevity through the detailed study of the oldest-living Rottweilers in North America.

    View all papers in this article collection

    The Art of Aging Well: The Role of Creative Arts in Modulating Cognitive Functioning and Well-Being in Aging

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Art of Aging Well: The Role of Creative Arts in Modulating Cognitive Functioning and Well-Being in Aging" in Clinical Interventions in Aging.

    Global aging has highlighted the critical role of cognitive functioning as a central factor in determining well-being and quality of life as adults age. Cognitive declines associated with typical and pathological aging significantly impact the individual’s health as well as challenge economic, social, and health systems. Hence, it is fundamentally important to identify therapeutic approaches that preserve and promote cognitive functioning among older adults. Non-pharmacological interventions such as creative art therapy have the potential to nurture constructive and productive lifestyles that positively influence older adults’ lives. 

    Engagement in creative arts enhances cognitive performance, mental health, and psychosocial well-being in healthy older adults as well as those with dementia. However, there is limited literature on the effectiveness of art therapy in the aging population and the quality of the existing evidence is low, raising many critical questions that need to be answered. The goal of this Article Collection is to shed light on the benefits, challenges, and progress made in implementing creative art therapy for older adults. 

    Original research, epidemiological studies, reviews, expert opinions, and commentaries related to any form of creative or expressive arts (e.g., drawing, painting, sculpting, calligraphy, creative writing, storytelling, music, and dance) are welcome. The topics of interest include, but are not limited to:

    • Therapeutic outcomes of art therapy in healthy older adults as well as those with cognitive deficits
    • Therapeutic mechanisms of art therapy
    • Barriers to implementation of community-based arts interventions
    • Comparison of various art forms for success factors related to cognitive functioning and psychosocial well-being
    • Participant characteristics (race and ethnicity, gender, prior experience with arts, etc.) that influence response to arts interventions

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 19 April 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Please submit your manuscript on our website, quoting the promo code ZSWAE to indicate that your submission is for consideration in this Article Collection. 

    Guest Advisor

    Ranjini Mohan, Associate Professor, Department of Communication Disorders, Texas State University

    [email protected]

    Dr. Ranjini Mohan’s research interests include identifying age- and disease-related changes in cognitive-communication across the lifespan. She currently studies the role of creative art therapy in improving communication and quality of life among persons with dementia and aphasia. As a speech language pathologist by training, Dr. Mohan has worked with adults with neurogenic disorders in acute, sub-acute, and outpatient settings in India and the U.S.

    View all papers in this article collection

    Clinical Ophthalmology

    OCT Biomarkers of Macular Disorders: From Theory to Practice

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "OCT Biomarkers of Macular Disorders: From Theory to Practice" in Clinical Ophthalmology.

    The advancement in optical coherence tomography (OCT) technology in recent years has allowed the identification of novel biomarkers for various macular disorders; such biomarkers serve diagnostic and predictive roles. The availability of higher resolution OCT scans and routine OCT acquisition have aided both the characterization and quantification of OCT signs. In that regard, multiple descriptive terminologies for novel OCT signs emerge in the literature on a regular basis, changing the face of medical retina practice every so often.

    While exponential growth in the number of research articles could be appreciated in the literature over the past decade, most articles deal with the description and incidence of these biomarkers. Limited data exist on their utilization in clinical practice, their predictive role, or their implications for patient education and therapeutic choices.

    This Article Collection aims to provide a platform for authors who conduct research on the practical application of novel OCT signs and their utilization in clinical practice. Disorders of interest include but are not limited to: age-related macular degeneration, diabetic retinopathy, retinal vascular disorders, uveitic macular disorders, macular dystrophies, vitreomacular interface anomalies, degenerative retinal conditions, traumatic maculopathy, and preoperative patient evaluation.

    Guest Advisor
    Yousef Ahmed Fouad
    Ophthalmology Specialist, Faculty of Medicine
    Ain Shams University, Cairo, Egypt

    Submission Instructions
    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code MUKBN to indicate that your article should be considered for this Collection.

    The manuscript submission deadline is 31 May 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    Recent Advances in Refractive Surgery

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Recent Advances in Refractive Surgery" in Clinical Ophthalmology.

    Refractive surgery has revolutionized the landscape of ophthalmic care and vision correction over the past few decades. This dynamic field has consistently evolved, bringing forth innovative techniques, tools, and procedures aimed at correcting a range of refractive errors including myopia, hyperopia, astigmatism, and presbyopia. As the thirst for spectacle and contact lens independence grows, so too does the impetus for developing safer, more efficient, and highly precise surgical interventions. 

    The significance of these advances cannot be overstated. Clear, unaided vision is not just a matter of convenience; it deeply impacts an individual’s quality of life, self-confidence, professional opportunities, and day-to-day functionality. Moreover, as the global population ages, the prevalence of refractive errors is set to increase, making the need for effective solutions even more pressing. Additionally, with the integration of technology and interdisciplinary sciences, the potential for more ground-breaking discoveries in refractive surgery promises not just sight restoration, but potentially, enhancements beyond natural capabilities. 

    This Collection seeks to encapsulate the strides made in recent refractive surgical techniques and technologies. Topics of interest include, but are not limited to: 

    • Advancements in laser-assisted surgeries
    • Innovative intraocular lens designs and applications
    • Developments in corneal cross-linking
    • The implications of artificial intelligence and machine learning in predictive surgery outcomes 

    We welcome submissions of original research articles, comprehensive reviews, clinical trial reports, commentaries, and study protocols. 

    By amalgamating the current state-of-the-art knowledge in this domain, we aim to provide a platform for professionals to gain insights, stimulate further research, and improve patient outcomes in the realm of refractive surgery.

    Guest Advisors

    Dr. Bharat Gurnani, Consultant - Cataract, Cornea, and Refractive Surgery, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Chitrakoot, India 

    Dr. Kirandeep Kaur, Consultant - Cataract, Pediatrics Ophthalmology, and Strabismus, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Chitrakoot, Ind 

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission. 

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code GWYIL to indicate that your article should be considered for this Collection. 

    The manuscript submission deadline is 1 April 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    Clinical, Cosmetic and Investigational Dermatology

    Artificial Intelligence in Dermatology

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Artificial Intelligence in Dermatology” in Clinical, Cosmetic and Investigational Dermatology.

    Artificial Intelligence (AI) is revolutionizing dermatology by offering advanced tools for diagnosis and treatment. By leveraging machine learning algorithms, AI analyzes vast amounts of dermatological data to detect patterns, classify skin conditions, and even predict disease progression. These AI-powered systems can assist dermatologists in making accurate diagnoses, especially in complex cases where human interpretation may fall short. Moreover, AI applications enable personalized treatment plans by considering individual patient characteristics and historical data. With the capability to sift through images, medical records, and research findings rapidly, AI expedites diagnosis timelines, leading to timely interventions and improved patient outcomes. Additionally, AI-driven telemedicine platforms extend dermatological expertise to remote areas, enhancing accessibility to quality care. As AI continues to evolve, its integration into dermatology promises not only enhanced efficiency but also opens avenues for groundbreaking research and innovation in skincare.

    The integration of Artificial Intelligence (AI) in dermatology holds paramount importance for several reasons. Firstly, it enhances diagnostic accuracy and efficiency, reducing the likelihood of misdiagnoses and ensuring appropriate treatment plans. This not only improves patient outcomes but also minimizes unnecessary procedures and treatments, thereby reducing healthcare costs. Secondly, AI facilitates quicker and more widespread access to dermatological expertise, particularly in underserved or remote areas where dermatologists may be scarce. Additionally, AI-driven technologies have the potential to streamline workflows in dermatological practices, freeing up healthcare professionals' time to focus on patient care and complex cases. Furthermore, AI enables the analysis of vast amounts of data, leading to the discovery of new insights, treatments, and predictive models for skin diseases. Ultimately, the incorporation of AI in dermatology represents a significant step towards more efficient, accessible, and personalized healthcare in the field of dermatology.

    Subtopics include but are not limited to:

    • AI-Based Diagnostic Tools
    • Personalized treatment approach
    • Telemedicine and Remote Care
    • Data Analysis and Research Insights

    Preferred Article Types

    • Original Research. Presenting novel findings on AI applications in dermatology.
    • Review. Providing comprehensive overviews of specific AI technologies or applications.
    • Case Study. Offering in-depth analyses of individual cases or clinical experiences with AI in dermatology.
    • This collection aims to contribute to the growing body of literature on AI in dermatology, fostering dialogue among researchers, clinicians, and industry professionals to propel the field forward.

    Keywords

    • Dermatology
    • Artificial Intelligence
    • Teledermatology
    • Personalized treatment
    • Personalized medicine

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 September 2024. Please submit your manuscript on our website, quoting the promo code HTKCX to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Luca Potestio, University of Naples Federico II, Italy

    [email protected]

    Matteo Megna, University of Naples Federico II, Italy

    [email protected]

    Fabrizio Martora, University of Naples Federico II, Italy

    [email protected]

    View all papers in this article collection

    Chronic inflammatory skin diseases: From pathogenesis to treatment

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Chronic inflammatory skin diseases: From pathogenesis to treatment” in Clinical, Cosmetic and Investigational Dermatology.

    Significant progress has been achieved in the last few decades in dermatology, especially regarding chronic inflammatory skin diseases. In recent years, great progress has also been made in understanding the pathogenesis of the most common inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa that has led to the development of selective and targeted innovative therapies. In particular, biological drugs (chimeric, humanized, and fully human monoclonal antibodies), biosimilars, and small molecules have completely revolutionized the treatment of chronic inflammatory skin diseases by opening new avenues for clinicians.

    However, significant research efforts are still needed. New studies are needed to identify biomarkers for each disease, so that clinicians may be able to diagnose and treat chronic inflammatory diseases early and predict responses to treatments so that we can choose the best treatment for each type of patient.

    All article types, including case reports, case series, original research articles, and review articles, are in line with the scope of this Article Collection.

    This Collection welcomes submissions covering a range of related areas of chronic inflammatory skin diseases, including psoriasis, atopic dermatitis, hidradenitis suppurativa, alopecia areata and others.

    Keywords

    • Psoriasis
    • Hidradenitis Suppurativa
    • Atopic dermatitis
    • Alopecia areata
    • Skin inflammatory disease

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 15 July 2024. Please submit your manuscript on our website, quoting the promo code TSMRY to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Fabrizio Martora, University of Naples Federico II, Italy

    [email protected]

    Matteo Megna, University of Naples Federico II, Italy

    [email protected]

    Teresa Battista, University of Naples Federico II, Italy

    [email protected]

    View all papers in this article collection

    Hidradenitis Suppurativa: Insights from pathogenesis to treatment

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Hidradenitis Suppurativa: Insights from pathogenesis to treatment” in Clinical, Cosmetic and Investigational Dermatology.

    Hidradenitis suppurativa (HS) is an inflammatory disorder that is characterized by chronic deep-seated nodules, abscesses, fistulae, sinus tracts, and scars in the axilla, inguinal area, submammary folds, and perianal area. This disfiguring condition is accompanied by pain, embarrassment, and a significantly decreased quality of life. Although the mechanism of HS has not been entirely elucidated, lesion formation is believed to center around follicular hyperkeratosis within the pilosebaceous-apocrine unit. Recent research has provided new insight into the role of cytokines in the pathogenesis of HS, helping close some existing knowledge gaps in the development of this condition. Immune cells and keratinocyte-mediated products are widely accepted as key players in HS pathogenesis. Indeed, both pro-inflammatory (e.g., IL-1β, TNF-α, IL-23, and IL-17) and anti-inflammatory cytokines (e.g., IL-10) are found to be increased in HS lesional and perilesional skin.

    The identification of predictive biomarkers of therapeutic response is one of the greatest challenges of modern medicine, particularly in a pathology as HS with a high percentage of therapeutic failures. Although several studies have shown that anti-TNF-α agents clinically reduce the disease activity in HS, the efficacy of these agents is inconstant in some cases. Identifying predictive markers of response is, thus, of strong interest. Several small molecules and biologics are under investigation, for moderate-to-severe HS therapy. With phase III trials ongoing, the anti-IL-17 agents bimekizumab (which blocks IL-17 A and F) and secukinumab (which blocks IL17A) are in the most advanced stage of clinical development showing promising results, based on the extensive evidence of the activation and upregulation of the IL-17 pathway in HS inflammation. Other molecules and biologics are under investigation such as jak inhibitors and IL-23 drugs. New studies are needed to identify biomarkers.

    The Article Collection entitled: “Hidradenitis Suppurativa: Insights from pathogenesis to treatment” aims to bring together the most important recent findings on pathogenesis and treatments for this disease.

    The deadline for submissions is 24 May 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code HWNEN to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Fabrizio Martora, University of Naples

    [email protected]

    Matteo Megna, University of Naples

    [email protected]

    Luca Potestio, University of Naples

    [email protected]

    View all papers in this article collection

    Hyaluronic acid fillers: superficial injections vs tridimensional injections, what changes?

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection: “Hyaluronic acid fillers: superficial injections Vs tridimensional injections, what changes?” organized by Guest Advisors Professor Raffaele Rauso and Professor Nicola Zerbinati in Clinical, Cosmetic and Investigational Dermatology.

    Since the beginning of the 21st century, hyaluronic acid (HA) fillers have become a mainstay in aesthetic medicine; these fillers have been quickly appreciated by both physicians and patients due to HA safety and their temporary effect. HA fillers were born as “dermal filler” in order to be injected in the dermal layer to treat fine lines, but over time physicians understood how to inject them tridimensionally, not only into the skin layer but also in superficial and deep facial fat compartments or over the periosteum in order not only to treat lines but to achieve deep facial feature changes.

    Although HA is an absorbable substance when injected into the dermal layer due to the action of endogenous hyaluronidase, when injected deeply it has a different pattern of resorption, sometimes lasting also several years. Not all physicians are aware of this and continuing to inject HA fillers every 6 to 8 months causes, over the years, accumulation of the filler into the face, achieving unpleasant results of “puffy face”. Also the use of hyaluronidase, in order to dissolve HA fillers previously injected, has increased during recent years as shown in the recent medical literature.

    Nowadays, most aesthetic patients have the stigmata of previous HA injections and a good physician should be aware of it in order to avoid areas where HA is still present, moreover it is mandatory to have a good knowledge of hyaluronidase uses, especially when an unpleasant result is long-lasting and HA needs to be dissolved in order to repeat the treatment in the right way.

    The aim of this collection is to provide scientifically based papers that can give readers a guide on how to approach patients previously injected with HA fillers over the years, potential complications in injecting deep areas already injected, and when and how to use hyaluronidase before to repeat a filler treatment.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 1 March 2024

    Please submit your manuscript on our website, quoting the promo code MWJLR to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Teledermatology, Inflammatory Skin Disorders and COVID-19: What the Experience Has Taught Us

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Teledermatology, Inflammatory Skin Disorders and COVID-19: What the Experience Has Taught Us” in Clinical, Cosmetic and Investigational Dermatology.

    The COVID-19 pandemic has drastically transformed healthcare delivery, forcing medical professionals to seek innovative ways to provide patient care while minimizing face-to-face interactions. Teledermatology, the remote diagnosis and treatment of skin conditions using telecommunication technologies, has emerged as a valuable tool in dermatology practice during this challenging time. This Article Collection explores the application of teledermatology in the context of inflammatory skin disorders and the lessons learned from the COVID-19 experience.

    Inflammatory skin disorders encompass a wide range of conditions. These diseases often require long-term management and frequent follow-ups, making teledermatology a suitable alternative to traditional in-person visits. With the aid of secure digital platforms, dermatologists can remotely assess skin lesions, evaluate disease severity, and provide treatment recommendations. Patients can upload images of their skin lesions or participate in real-time video consultations, allowing dermatologists to make accurate diagnoses and initiate appropriate therapies. The COVID-19 pandemic has highlighted several key benefits of teledermatology for inflammatory skin disorders. Firstly, it reduces the risk of virus transmission by minimizing physical contact between patients and healthcare providers. This is particularly crucial for patients with chronic skin conditions who are at a higher risk of severe illness from COVID-19. Secondly, teledermatology enhances accessibility to specialized care, especially for individuals residing in remote areas or facing transportation barriers. It enables patients to receive expert advice without the need for long-distance travel, thereby improving healthcare equity.

    However, the use of teledermatology in inflammatory skin disorders also comes with certain limitations. To address these limitations, dermatologists have adapted their practices and developed strategies for optimizing teledermatology services. Globally, the experience gained during the COVID-19 pandemic has emphasized the importance of incorporating teledermatology into routine dermatology practice beyond the crisis. Teledermatology has demonstrated its value in triaging patients, improving access to care, and facilitating timely interventions. It has the potential to reduce healthcare costs, decrease patient waiting times, and enhance overall patient satisfaction. Moving forward, efforts should be made to establish guidelines and policies to ensure the ethical practice of teledermatology while maintaining patient privacy and data security. In conclusion, the COVID-19 pandemic has accelerated the adoption of teledermatology in managing inflammatory skin disorders.

    While there are certain limitations associated with remote consultations, the experience gained during the pandemic has taught us that teledermatology is a valuable tool for providing accessible and efficient care.

    The deadline for submissions is 12 June 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code ZOMSS to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Luca Potestio, University of Naples

    [email protected]

    Matteo Megna, University of Naples 

    [email protected]

    Angelo Ruggiero, University of Naples 

    [email protected]

    Fabrizio Martora, University of Naples 

    [email protected]

    View all papers in this article collection

    ClinicoEconomics and Outcomes Research

    Demographic Changes and Health Inequality in Developing Countries

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Demographic Changes and Health Inequality in Developing Countries", organized by Guest Advisor Prof. Qihui Chen in ClinicoEconomics and Outcomes Research

    At least since World War II, structural changes in the population, including those in age structures, fertility rates, sex ratio, marital status, and migration patterns, have been undergoing in many developing countries, which have had profound impacts on the formation of human capital and the development of education, food, health, and welfare systems. Since these changes affect how resources may be allocated to different segments of the population, they will ultimately impact the distribution of individual well-being, health-related outcomes included. Uncertainties introduced by recurring natural disasters, geo-political conflicts, disease outbreaks, and related policies add another layer of complexity to the relationship between demographic changes and health inequality. 

    Understanding the demographic change-health inequality relationship is undoubtedly of policy relevance. Take population aging, for example. With proper inventions, aging tends to create health disparities between older and younger adults. Compared with younger adults, older adults face declines in somatic function and cognitive ability and are more vulnerable to chronic diseases; they need more healthcare but usually lack a stable income to finance this need. The recent COVID-19 pandemic brings about new challenges to older adults. Problems such as reduced access to healthcare, limited food supply, and separation from family members due to safety concerns and travel restrictions are likely to impact older adults more seriously than younger adults, widening existing health gaps between the two groups. Similarly, health disparities may exist between other population segments and along other dimensions. As such, advancements in knowledge about the health challenges faced by different subpopulations introduced by demographic changes, the strategies adopted by different entities to cope with these challenges, as well as the roles of families, private organizations, and public policy, are necessary for informing healthcare policy. 

    This call for a collection of articles provides a forum for scholarly discussions on how demographic changes affect health behavior and outcomes for different subpopulations in developing countries, the roles of and interactions between different entities, and the effectiveness of related policies. Research articles and in-depth reviews examining these issues, especially those combining rigorous empirical analysis and clear policy implications, are welcome for this article collection. 

    Keywords

    1. Demographic changes

    2. Population policy

    3. Health behavior and outcomes

    4. Health inequality

    5. Health policy

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    Please submit your manuscript on our website, quoting the promo code EDKUO to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 31 August 2024.

    Guest Advisor

    Professor Qihui Chen, College of Economics and Management, China Agricultural University, China 

    [email protected]

    Dr. Qihui Chen is a professor in the Center for Food and Health Economic Research at China Agricultural University. He received his Ph.D. degree in Applied Economics from the University of Minnesota in 2012. Dr. Chen’s research focuses on applying causal inference methods to study education and health issues in developing countries, such as how population policies affect child education and health, how retirement policy affects older adults’ nutrition intake and health, and how health information (e.g., disease diagnoses) affect patients’ health behavior. He has served as a consultant for the World Bank Groups for many years since 2011.

    View all papers in this article collection

    Improving Data Collection and Analysis of Costs and Quality-of-Life Measures to Address Health Disparities

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Improving Data Collection and Analysis of Costs and Quality-of-Life Measures to Address Health Disparities” in ClinicoEconomics and Outcomes Research.

    Value assessment is intended as a tool for evaluating treatments to gauge value and inform decisions. Value assessments typically incorporate a cost-effectiveness analysis (CEA), focusing on costs and health outcomes important to payers, but missing important information to optimize resource allocation at a societal level. Despite frequent calls for more explicit consideration of health equity impacts in value assessment, health economists continue to develop models informed by traditional cost and quality-of-life (QoL) data that do not capture differences experienced by health disparity populations. 

    When researchers estimate the cost-effectiveness of a treatment using population-level averages without thoughtful considerations of the heterogeneity of costs and QoL across disadvantaged subgroups, coverage policies based on these estimates may ultimately lead to decisions applied to everyone equally, despite some subgroups having more to gain or lose with access to the treatment. 

    This Article Collection aims to identify original research, systematic reviews, and commentaries that explore costs and QoL data collection and dissemination in a way that incorporates more subgrouping and other methods that can support evaluation of cost-effectiveness in disadvantaged groups compared to advantaged groups. We welcome papers focused on:

    • CEA
    • QoL
    • Policy (e.g., intended and/or unintended policy consequences resulting from CEA and QoL research; policy topics that encourage or discourage more explicit considerations of health disparities in economics research)
    • Community level factors relevant for disadvantaged subgroups in CEA and QoL research

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. 

    Please submit your manuscript on our website, quoting the promo code FRETD to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 1 April 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected]

    Guest Advisors

    Joey Mattingly, Professor, University of Utah

    [email protected] 

    Joe Vandigo, Principal Scientist and Director of Value, Applied Patient Experience

    [email protected]

     

    View all papers in this article collection

    Risk Management Challenges to Ensure Sustainability and Wellbeing

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Risk Management Challenges to Ensure Sustainability and Wellbeing", organized by Guest Advisors Prof. Simon Grima and Prof. Inna Romanova in ClinicoEconomics and Outcomes Research

    Risk management for sustainability and wellbeing involves identifying, assessing, and mitigating potential risks that can impact the long-term viability of organizations, communities, nations and individuals while considering the well-being of people and the environment. In this context integrating risk management with sustainability and well-being involves: 

    1. Identifying risks that can threaten sustainability and well-being. These risks can include environmental hazards, social issues, economic instability, policy changes, technological disruptions, pandemics, nutrition, innovations, information, communication and more. A comprehensive proactive approach to identify both internal and external risks.
    2. Once the risks are identified, to assess their potential impact on sustainability and well-being. This involves evaluating the likelihood of occurrence and the severity of their consequences.
    3. Incorporating and rebalancing environmental, social, and governance (ESG) factors into risk assessment and decision-making processes. Considering the long-term implications of risks on ecological systems, climate change, resource depletion, and social equity etc.
    4. Engaging stakeholders to gain diverse perspectives and insights into risks and their potential consequences. Involving employees, customers, local communities, NGOs, and other relevant stakeholders to understand their concerns and incorporate their feedback into risk management strategies. Stakeholder engagement fosters transparency, accountability, buy-ins and trust.
    5. Developing risk mitigation strategies that align with sustainability and well-being goals. This may involve implementing measures to prevent or minimize risks, such as adopting sustainable practices, diversifying supply chains, developing alternative energy sources, enhancing community resilience, and promoting social inclusion.
    6. Regular monitoring of the effectiveness of risk mitigation measures to be prepared to adapt strategies as new risks emerge or existing risks evolve.
    7. Communicating risk management efforts and progress to stakeholders through transparent reporting. Demonstrating the integration of sustainability and well-being considerations into risk management practices, and providing information on how risks are being identified, assessed, and mitigated. Transparency builds trust and encourages accountability.
    8. Embracing a culture of continuous improvement by learning from both successes and failures. Encouraging innovation and experimentation to discover new ways of managing risks while advancing sustainability and well-being. Regularly reviewing and updating risk management strategies to address emerging challenges and capitalizing on opportunities.

    The creation of a sustainable and desirable future that accomplishes the Sustainable Development Goals (SDGs) is one of the greatest challenges of our time. Human impacts on ecological life support systems are becoming more complicated and widespread in today's "Anthropocene" globe. At the same time, there are greater demands placed on the planet's life support systems to preserve developed-nation living standards and combat global poverty. Poverty in terms of better life standards, adequate nutrition, information on products consumed; health literacy; affordability, longevity and health. In this "full" world, the focus of research, education, and policy must change from focusing on isolating issues to examining complete, intricate, and linked systems as well as the dynamic interactions among its constituent elements.

    Many academics have concentrated on how vulnerability and resilience can be utilized to analyze and ensure long-term sustainability and well-being. Different strategies have been put out in relation to various application areas, ranging from environmental to social and financial contexts. While the majority of the previous research on vulnerability and resilience focuses on particular industries or nations, in this collection we propose a more all-encompassing strategy that enables the sustainability of human well-being to be examined proactively as a whole. According to our understanding, sustainability, where several domains are interconnected, implies well-being and risk management helps to ensure this by proactively rebalancing when a variable is out of line. The focus of this collection is on the interrelated aspect of well-being, taking into account the exposure to risk and the capacity to manage it proactively, whereas the majority of studies consider vulnerability and resilience as aspects of the sustainability of a "system," such as a society, a country, an organization, an individual or even the entire planet. In case studies, theory, and practice, we aim to use both objective and subjective well-being indices. 

    Areas and topic of interest can relate to but not limited to:

    • Environmental issues
    • Nutrition issues
    • Food Supply
    • Legal, Policy and Standards issues
    • Health and Safety Issues
    • Economic Issues
    • Innovation
    • Digitalization
    • Reputational Issues
    • Supply Chain Issues

    Keywords

    1. Sustainability

    2. Wellbeing

    3. Risk management

    4. Long-term viability

    5. Healthy longevity

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    Please submit your manuscript on our website, quoting the promo code YHOFX to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 30 April 2024

    Guest Advisors

    Professor Simon Grima, Department of Insurance and Risk Management, Faculty of Economics, Management and Accountancy, University of Malta

    [email protected]

    Professor Inna Romanova, Faculty of Business, Management and Economics, University of Latvia

    [email protected]

    View all papers in this article collection

    Diabetes, Metabolic Syndrome and Obesity

    Managing obesity with pharmacotherapy

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Managing obesity with pharmacotherapy" in Diabetes, Metabolic Syndrome and Obesity.

    Obesity is a chronic, relapsing, progressive disease causing or negatively impacting numerous medical conditions, including diabetes mellitus, cardiovascular disease, and some types of cancer. The foundation of its treatment is lifestyle modification. However, for many people with obesity, these changes are difficult to achieve and to maintain long-term. For this reason, great efforts have been made to develop effective drugs weight-reducing drugs.

    In the past, pharmacotherapy for obesity produced discouragingly modest weight loss on the whole, and several drugs had to be withdrawn from the market due to unacceptably severe side effects. However, the future of obesity pharmacotherapy looks promising. Glucagon-like peptide-1 (GLP-1) receptor agonists have shown promise in promoting sustained and healthy weight loss in patients with obesity with or without type 2 diabetes. Furthermore, drug combinations that target multiple complementary pathways influencing food intake have the potential to promote more significant weight loss.

    However, several questions need to be addressed. The long-term effectiveness and tolerability of new weight loss drugs have not been fully determined, and many more data are needed on their clinical efficacy on cardiovascular disease and type 2 diabetes prevention, as well as real-word effectiveness. More research is also needed to understand better their mechanisms of action, which patients can benefit most from their use, and when and how these drugs should be combined with lifestyle modifications. It is also crucial to know their long-term effect on the specific subpopulations of obesity patients, such as adolescents, those with binge-eating disorder and their effectiveness before and after bariatric surgery.

    The goal of this Article Collection is to solicit the contribution and submission of any article in the area of pharmacological treatment of obesity, including preclinical studies, clinical trials, and reviews.

    Potential topics include but are not limited to the following:
    • Combination of pharmacotherapy with lifestyle modification for the management of obesity
    • Pharmacotherapy for obesity and bariatric surgery
    • Pharmacotherapy for obesity in binge-eating disorders
    • Pharmacotherapy for obesity in adolescents
    • Pharmacotherapy for obesity and cardiovascular diseases
    • Pharmacotherapy of obesity and type 2 diabetes magament
    • Mechanisms of action of medications for obesity
    • Safety of pharmacotherapy for obesity

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 April 2024.

    Please submit your manuscript on our website, quoting the promo code JTCZR to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Riccardo Dalle Grave, Villa Garda Hospital, Italy

    [email protected]

    Dr. Riccardo Dalle Grave is director of the Department of Eating and Weight Disorders at Villa Garda Hospital (Garda, VR, Italy). In this department, he developed an intensive rehabilitative treatment for severe and disabling obesity and eating disorders both for adults and adolescents based on cognitive behavior therapy. He is the author of 178 peer review articles (Scopus h-index, 40), several book chapters, and books, on the treatment of obesity and eating disorders.

    Giulio Marchesini, “Alma Mater” University, Italy

    [email protected]

    Prof. Giulio Marchesini is former Professor of Clinical Dietetics, “Alma Mater” University. After retirement from clinical duties, he maintained a research contract and chairs several research programs inside the IRCCS Azienda Ospedaliera di Bologna. Specifically involved in studies in the area of obesity, diabetes and non-alcoholic fatty liver disease, he wrote over 500 peer-reviewed papers (Scopus h-index, 87), with over 50k citations.

    Conflict of Interest: In accordance with Taylor & Francis policy and my ethical obligation as a researcher, I am reporting that I received funding from Eli Lilly for a lecture, a company that may be affected by the research reported in the enclosed paper. I have disclosed those interests fully to Taylor & Francis, and I have in place an approved plan for managing any potential conflicts arising from that involvement. I will not handle the paper and I will not be involved in the peer-review process.

    View all papers in this article collection

    Understanding the Impact of Gender and Sex on Diabetes Incidence, Complications, and Treatment

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Understanding the Impact of Gender and Sex on Diabetes Incidence, Complications, and Treatment" in Diabetes, Metabolic Syndrome and Obesity.

    Over 10% of the world’s population has diabetes, a major contributor to coronary heart disease, stroke peripheral vascular disease, end-stage renal disease, retinopathy, neuropathy, and lower-extremity amputations. While diabetes prevalence is similar in male and female populations, there are critical differences in how and when diabetes presents by sex and gender. For example, adult women tend to be diagnosed with type 2 diabetes later in life and have a higher BMI at diagnosis than men, resulting in the condition having often progressed further prior to diagnosis. In addition, complications from diabetes, such as cardiovascular disease, are more common in women with diabetes than in men with diabetes, and women are more likely than men to die from these complications.

    Given the strong evidence of sex- and gender-based disparities in diabetes diagnosis, development of complications, and outcomes, including death, increasing our understanding of how sex and gender impact metabolic risk is critical to slowing the diabetes epidemic. The reasons for these differences are not well understood, but possible contributing factors include genetic differences, sex hormones, cultural or social constructs, and a differential effect of lifestyle factors. Growing evidence also suggests that female sex hormones, reproductive stage, and gender-specific psychosocial health issues can impact how an individual responds to diabetes treatment. Identifying the root causes of gender disparities can help identify ways to improve the prevention and treatment of diabetes among women and gender minorities.

    In this article collection, we will examine how female sex and gender identity impact both (1) the development of type 1 and type 2 diabetes, and (2) the risk of diabetes-related complications such as cardiovascular disease, kidney disease, and depression. Additionally, we will examine how female sex hormonal fluctuations, such as across puberty, pregnancy, and the menopause transition, impact metabolic risk. Finally, we will examine how current treatments for preventing and treating diabetes are impacted by female sex and gender, including how treatment outcomes vary during periods of female sex hormone fluctuations, as well as how prevention, treatment, and outcomes vary comparatively based on gender and sex.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 20 March 2024.

    Please submit your manuscript on our website, quoting the promo code MOCUS to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Erin LeBlanc, Kaiser Permanente Center for Health Research

    [email protected]

    Erin LeBlanc, MD, MPH, is an epidemiologist and board-certified adult endocrinologist. Her research focuses on conditions that affect women, including diabetes, menopause, obesity, osteoporosis, and vitamin D deficiency.

    View all papers in this article collection

    Drug Design, Development and Therapy

    Advances in design and development of ophthalmic drugs

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in design and development of ophthalmic drugs", organized by Guest Advisors Dr. Georgios D. Panos in Drug Design, Development and Therapy.

    This Article Collection will focus on the latest advances in drug design and development for the treatment of various ophthalmic diseases and conditions.

    Ophthalmic diseases, including glaucoma, age-related macular degeneration, diabetic retinopathy, and dry eye disease, are a significant public health concern, affecting millions of people worldwide. Despite the increasing availability of some effective treatments, there is still an unmet need for safe and even more effective drugs that can treat these conditions.

    This Article Collection will bring together leading researchers and clinicians in the field to present their latest research on the design and development of ophthalmic drugs. Topics that will be covered in this special issue include but are not limited to:

    - New drug delivery systems for ophthalmic drugs
    - Advances in small molecule drug design and development for ophthalmic conditions
    - Nanotechnology-based approaches for ocular drug delivery
    - Pharmacokinetics and pharmacodynamics of ophthalmic drugs
    - Design and development of sustained-release ophthalmic drug delivery systems
    - Gene Therapy and novel biological therapies for the treatment of ocular diseases

    We welcome submissions of original research articles and review articles that address any aspect of drug design and development for ophthalmic diseases. All submitted manuscripts will undergo a rigorous peer-review process to ensure the highest quality of the published papers.

    This Article Collection will provide a valuable resource for researchers, clinicians, and pharmaceutical companies working in the field of ophthalmic drug design and development and will further advance the understanding of the current state of the art in ophthalmic drug research and help pave the way for the development of safe and effective treatments for ophthalmic diseases.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 July 2024.

    Please submit your manuscript on our website, quoting the promo code HMYJF to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Beyond Brain Boundaries: Overcoming the Blood-Brain Barrier to Reach the Central Nervous System

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Beyond Brain Boundaries: Overcoming the Blood-Brain Barrier to Reach the Central Nervous System" in Drug Design, Development and Therapy.

    The central nervous system (CNS) is the final frontier in drug delivery due to its intricate network of neurons and complex functions. Despite the increasing prevalence of CNS disorders worldwide, developing effective treatments remains challenging due to exorbitant costs, prolonged clinical pathways, and discouraging failure rates. The formidable barriers guarding the CNS, such as the blood-brain barrier and the blood-cerebrospinal fluid barrier, pose significant challenges, impeding the access of most drugs to their intended targets.

    This Article Collection delves into the realm of drug design and explores innovative strategies and breakthrough materials designed to surmount these barriers, facilitating precise and controlled drug delivery to the CNS. The collection aims to unravel the enigma of the CNS by paving the way for transformative therapies that can revolutionize the treatment of neurological and neuropsychiatric disorders.

    In addition to exploring innovative strategies and breakthrough materials for drug delivery to the CNS, this article collection also aims to investigate the interplay between neural substrates and non-invasive stimulation techniques. By understanding how different neural substrates interact and respond to non-invasive stimulation (i.e., transcranial magnetic stimulation), researchers aim to develop more targeted and effective therapeutic interventions. This interdisciplinary approach holds the potential to reinvent and rethink the treatment of neurological and neuropsychiatric disorders, offering new possibilities for improved patient outcomes.

    Join us as we embark on a journey to uncover the secrets of the central nervous system and pave the way for transformative therapies that can bring about a paradigm shift in the management of neurological and neuropsychiatric conditions. We cordially invite authors to contribute original research and comprehensive review articles.

    The deadline for submissions is 8 April 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code ZDTPN to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Masaru Tanaka, ELKH-SZTE Neuroscience Research Group, University of Szeged (ELKH-SZTE)

    [email protected]

    Dr. Tanaka's scientific interests include depression, anxiety, dementia, pain, and their comorbidities nature, and translational research in neurological diseases and psychiatric disorders. He is ranked in D1 in Biological Sciences (98%) among Hungarian researchers. His articles have been ranked in the top 99.9 percentile in various fields. He is an editorial board member of Frontiers in Neuroscience, Frontiers in Psychiatry, Anesthesia Research, the Journal of Integrative Neuroscience, Advances in Clinical and Experimental Medicine, and Biomedicines.

    Simone Battaglia, University of Bologna

    [email protected]

    Dr. Battaglia's research experience focuses on the functional interplay of different brain areas involved in emotional learning, action control, brain plasticity, decision-making, and a variety of cognitive tasks. To achieve this aim, his research activity mainly includes the use of non-invasive brain stimulation (i.e., TMS and tDCS), and the recording of different physiological measures using different neuroscientific techniques such as EEG, SCR, HRV, and EMG. He has conducted his research in both healthy individuals, studying intra- and inter-individual differences, and in patients with acquired brain injury. His approach integrates various techniques such as behavioral analysis, electrophysiology, and neurostimulation, aiming to develop groundbreaking therapeutic protocols through cortico-cortical paired associative stimulation (ccPAS). He is an active Editor of several peer-reviewed journals with impact factors.

    Francesco Di Gregorio, University of Bologna

    [email protected]

    Dr Di Gregorio's scientific interests include psychophysiological correlates of consciousness and disorders of consciousness after severe acquired brain injury. Additionally, his work focused on how cognitive processes are implemented in the human brain, and on translational research in neurological diseases. He is an editorial board member of Advances in Clinical and Experimental Medicine.

    View all papers in this article collection

    Beyond Monoclonal Antibodies: Cutting-Edge Approaches to Targeted Therapy

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Beyond Monoclonal Antibodies: Cutting-Edge Approaches to Targeted Therapy" in Drug Design, Development and Therapy.

    Monoclonal antibodies have revolutionized the development of targeted therapies, enabling the precise and selective targeting of disease biomarkers, leading to the development of more effective therapies. While over 100 monoclonal antibodies have been approved by the FDA, recent advancements in molecular engineering have greatly expanded the array of engineered proteins that have been approved by regulatory bodies or are currently being evaluated in clinical trials. As a result, the development of targeted therapies has become more versatile and sophisticated, offering new hope for patients with previously untreatable diseases.

    This Article Collection aims to highlight the latest advancements in antibody and protein engineering, including design strategies, preclinical screening methods and their translation into clinical practice. Specifically, this Collection will cover:
    1. Design and selection of synthetic binders, including but not limited to antibodies, affibodies, monobodies, nanobodies, adhirons, ubiquitin variants, DARPin, peptidomimetics, and cytokines.
    2. Antibody engineering, such as the development of bispecific antibodies, antibody-drug conjugates, alternative modalities, and engineered Fc regions.
    3. Genetically encoded protein degraders and their impact on targeted protein degradation.
    4. From the bench to the bedside: showcasing therapeutic applications of novel biologics for the treatment of cancer, autoimmune diseases, and viral infections.
    By highlighting the latest advancements in antibody and protein engineering, we hope to provide insights into how these innovations are changing the landscape of drug development and therapy.
    This article collection in Drug Design, Development and Therapy invites various types of articles, such as:
    • Research articles
    • Review articles
    • Systematic Reviews
    • Mini reviews
    • Clinical Studies
    • Perspectives

    The deadline for submissions is 16 April 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code ZLRGC to indicate that your submission is for consideration in this Article Collection.

    Guest advisor

    Gianluca Veggiani, Louisiana State University

    [email protected]

    Dr. Gianluca Veggiani is a Research Assistant Professor in nano-immunoengineering at the Department of Pathobiological Sciences of Louisiana State University. He joined the university in 2022 and his current work focuses on developing high-throughput methods for synthetic biology, vaccines, and novel cancer diagnostics and therapeutics. During his postdoctoral work at the University of Toronto, Dr. Veggiani developed molecular probes for detection and modulation of post-translational modifications and efficient gene editing. He also pioneered the development of molecular superglues for protein polymerization, enhanced T-cell activation, and sensitive circulating tumor cell isolation during his doctoral work at the University of Oxford.

    View all papers in this article collection

    Is CADD ready to take a leap in the light of AI? Where are we?

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Is CADD ready to take a leap in the light of AI? Where are we?" in Drug Design, Development and Therapy.

    Artificial intelligence (AI) in a research domain represents the theory and the computer technology development that helps to model the physical reality of the phenomenon under study. AI is capable of solving complex problems with higher accuracy and efficiency, such as robust language models like GPT, 3D protein model prediction tools like AlphaFold, and defeating champions in a board game like AlphaGo etc. The success of AI is well appreciated in our day-to-day life as well as in corporate businesses. However, its impact on computer aided drug design (CADD) is still awaited.

    The field of AI in CADD is in its initial stage, where the development of a smart machine is difficult with the amount of data available. Numerous machine learning (ML) models have been built by implementing neural networks (NN), deep neural network (DNN), convolutional NN etc. to predict drug properties, active inhibitors and pharmacophore, and protein-inhibitor affinity - but the accuracy and specificity remains limited due to insufficient data. Recently, AlphaFold2 has been very successful in CASP14 for the prediction of single domain protein structure with experimental resolution (~2Å), which will be of great assistance to structure-based drug design. However, improvement in feature design and novel machine learning approaches will be required for the advancement of ligand-based design and CADD in general.

    There has been significant effort in deploying AI for drug prediction and its target recognition of diseases. AI-based methods such as machine learning and deep learning have revolutionized the field of drug discovery with new algorithms such as back propagation for update of weights, context capture by the use of attention layer, and transformer’s encoder-decoder architecture for input reconstruction. Combined bioinformatics and machine learning have shown great potential in drug target prediction and computer drug design by enabling the analysis of the available amount of biological data and predicting the potential interactions between drugs and their targets, such as cancer, Alzheimer's disease, and other neurological disorders. The endeavour to improve our understanding of the drugs, their targets, and the disease phenotype, is still on and we have yet to build the right tools to solve one of the most complicated question of the biological science.

    The aim of this article collection is to publish articles related to AI assisted structure-based and ligand-based drug design under the subtopics mentioned below.
    1. Current state and future development of novel small molecule design with desired physico-chemical properties/activities by implementing state of the art technique, AI assisted de novo design, synthesis, pharmacophore modelling, and toxicity prediction.
    2. Current and future developments in novel drug target prediction and small molecule drug development through combined machine learning, bioinformatics and CADD technologies.
    3. Current state and future development of novel feature/descriptor engineering and deep learning model building for protein inhibitor binding energy prediction.

    Please note that any submissions based on in-silico research require to be validated using appropriate in vitro or in vivo methods as per the journal Aims and Scope requirements of Drug Design, Development and Therapy.

    The deadline for submissions is 22 April 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code XRMJW to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Zunnan Huang, Guangdong Medical University

    [email protected]

    Neshatul Haque, Medical College of Wisconsin

    [email protected]

    Ling Wang, South China University of Technology

    [email protected]

    Tejaswi Koduru Naidu, Rensselaer Polytechnic Institute 

    [email protected]

    View all papers in this article collection

    Therapeutic advances in adipose tissue dysfunction and bone health in obesity and insulin resistance

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Therapeutic advances in adipose tissue dysfunction and bone health in obesity and insulin resistance", organized by Guest Advisors Prof. Antonio Brunetti, Dr. Maria Mirabelli and Assoc. Prof. Kok-Yong Chin in Drug Design, Development and Therapy.

    The adipose tissue is a large and varied endocrine organ, consisting of different types of fat cells and other cell types (i.e., endothelial cells, fibroblasts, and immune cells) with unique secretory properties. It can influence almost every aspect of body function. In mammals, the adipose tissue grows and develops in utero in relation to maternal blood glucose levels, and if challenged after birth with overnutrition, it may continue to expand almost indefinitely, causing obesity and its attendant metabolic consequences, such as insulin resistance.

    Although there are many hypothesized contributing factors to the development of insulin resistance in obesity (i.e., lipotoxicity, oxidative stress, inflammation, mitochondrial dysfunction, hypoxia), there is still no consensus about its aetiology. This is a significant problem because insulin resistance can have a major impact on the quality and expectancy of life for obese individuals. Insulin resistance plays a key role in the development of prevalent conditions such as type 2 diabetes, cardiovascular and reproductive disorders, metabolic syndrome, non-alcoholic fatty liver and cancer. Additionally, it can negatively impact bone health. Indeed, the hormones released by the adipose tissue, which are collectively called “adipokines”, participate to the complex regulation of bone physiology and integrity, and can interfere, either positively or negatively, with the insulin receptor signalling. Obesity and insulin resistance are associated with changes in the secretion of adipokines. The use of incretin-based (i.e., single, dual, or triple agonist) drugs to lose weight can improve the function of adipose tissue and the secretion of adipokines, potentially reducing the burden of obesity and insulin resistance on the healthcare system. However, it is unclear how and whether these drugs would change the way adipose tissue communicates with bone and other tissues that are sensitive to insulin, and whether this would revert insulin resistance.

    Original research articles (i.e., clinical, preclinical and/or translational studies) and review articles focusing on the latest pharmacological advances for treating obesity, insulin resistance, and their related metabolic/health consequences are welcome for submission to this special issue. Particular emphasis will be placed on articles exploring the connection between adipose tissue dysfunction and bone health, as well as the modulation of weight-lowering drugs on this aspect.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 April 2024.

    Please submit your manuscript on our website, quoting the promo code IQLPK to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs" in Drug Design, Development and Therapy.

    Failure of the conventional delivery of poorly water-soluble drugs could be attributed to their low solubility and hence their limited bioavailability that hinder their pharmacological applications.

    The improvement of drug solubility is of a critical concern in boosting the dissolution rate and bioavailability. Recently, different techniques have been used to increase the solubility and bioavailability of poorly water-soluble drugs.

    Using novel drug delivery systems and nano-based drug delivery systems can improve their solubility. Moreover, many of these systems act as drug reservoirs that also improve the drug permeability and stability. Accordingly, these delivery systems are important in improving the efficacy and applicability of poorly water-soluble drugs.

    Topics that will be covered in this Article Collection include but are not limited to:

    • Novel drug delivery systems such as microemulsions, inclusion complexes, solid dispersions, cocrystals.
    • Nano-based drug delivery systems like nanosuspensions, liposomes, niosomes, proniosomes, transfersomes, etc.
    • Techniques to increase the solubility and bioavailability of poorly water-soluble drugs.

    We welcome submissions of original research articles and review articles that address any aspect of design and development of innovative drug delivery systems to improve the efficacy and applicability of poorly water-soluble drugs. All submitted manuscripts will undergo a rigorous peer-review process to ensure the highest quality of the published papers.

    The deadline for submissions is 13 May 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code KBOSG to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Eman A. Mazyed, Department of pharmaceutical technology, Faculty of pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

    [email protected]

    Kariman M. AbouElhassan, Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt

    [email protected]

    View all papers in this article collection

    Eye and Brain

    Neurodegenerative diseases: link between eye and brain

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on "Neurodegenerative diseases: link between eye and brain” in our journal Eye and Brain. This Thematic Series is Guest Edited by Aroucha Vickers, D.O. Founder & Chair, Neuro-Ophthalmology Department, Las Vegas Neurology Center, USA and Andrew G. Lee, MD, Herb and Jean Lyman Centennial Chair in Ophthalmology, Professor of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, USA.

    Upon submission, please use the promo code PQYDF for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of " Neurodegenerative diseases: Link between eye and brain”. The deadline for manuscripts is 31 May 2024.

    For any enquiries, please email Vicky Ship, Commissioning Editor at [email protected]

    About the Thematic Series

    Neurodegenerative diseases affect millions of individuals worldwide. These conditions can lead to progressive degeneration of the central and peripheral nervous system, and a link between the eye and the brain has long been postulated. The eye in particular has been implicated in neurodegenerative disease in a variety of ways. Here we aim to characterize the effect of neurodegenerative disease on the eye, investigate potential biomarkers that may help predict early detection, and assist with the management and prognosis of neurodegenerative disorders.

    Dr Vickers and Professor Lee are seeking original research, and review article submissions on the following topics:

    • Alzheimer dementia and the eye
    • Parkinson disease and the eye
    • Lewy body dementia and the eye
    • Progressive supranuclear palsy and the eye
    • Multiple system atrophy and the eye
    • Chronic traumatic encephalopathy and the eye
    • Amyloid angiopathy and the eye

    Submit your manuscript

    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Transcription Factors in Eye Development and Disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Transcription Factors in Eye Development and Disease" in Eye and Brain.

    In the human and mouse genomes there are more than 1800 DNA-binding transcription factors. At least 1000 genes are required for the normal development of the eye. It is now established that several transcription factors are of crucial importance for the normal development of specific retinal cells and functions. 

    However, less is known about the role of these transcription factors in eye diseases affecting the retina, the cornea, and other parts of the eye. There is an increasing literature on the consequences of mutations in transcription factors involved in eye development in both mouse models and in human eye diseases. Still, there are many issues concerning the clinical and biological implications of these mutations that are unresolved. 

    This Article Collection is intended to be a platform for experts in transcription factors involved in eye development to address the role of these genes in both the normal function of the eye and in eye diseases using the available methods. 

    We welcome original research articles, reviews, expert opinions, and commentaries.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code AZQOC to indicate that your submission is for consideration in this Article Collection. 

    The deadline for submitting a manuscript is 1 June 2024. If you have questions, please contact Krista Thom at [email protected].

    Guest Advisors

    Thor Eysteinsson, Full Professor of Physiology, University of Iceland 

    Andrea Garcia-Llorca, Postdoctoral Fellow, University of Iceland

    View all papers in this article collection

    HIV/AIDS - Research and Palliative Care

    HIV: treatments and prevention for longevity

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “HIV: treatments and prevention for longevity”, edited by Editor-in-Chief Prof. Dr. Olubunmi Ogunrin in HIV/AIDS - Research and Palliative Care.

    Upon submission, please use the promo code JBJFT for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of “HIV: treatments and prevention for longevity”. The deadline for manuscripts is the 31 May 2024.

    For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

    About the Thematic Series

    For many researchers and clinicians, effective prevention and treatment of HIV can prove a halfway point for its eradication. Since its first outbreak, the developments made highlight a wealth of progress, but how much further does medical science have to go? This Thematic Series will explore current methods to prevent the spread of HIV, alongside those currently in development. This can include the varying types of HIV vaccine in development (e.g., mRNA, T-Cell), our understanding of selective immunity in certain individuals, the efficacy of pre-exposure prophylaxis and more.

    Prevention is one part of reducing the spread of HIV, but the treatments available to patients once diagnosed are equally as important. Recent developments and discoveries in HIV treatment push the field further to improve the quality of life of individuals living with HIV, including progress into injectable treatments. Additionally, pre-existing treatments including antiretroviral drugs receive necessary updates to enhance their efficacy, safety and adherence levels.

    Importantly, how clinicians and society approach HIV and its treatment is crucial for progress. This includes highlighting the accessibility of HIV healthcare across countries, gender, socioeconomic status and age groups. With this information it is hoped that everyone has a chance of receiving high-quality HIV healthcare globally. Attitudes can form a significant part of this, as the benefits of having an external support network will also be explored in this Thematic Series. However, the mental health of the patient can be equally as important as external support, with insight into psychological comorbidities and treatments available to individuals living with HIV.

    The journal is seeking original submissions and review articles on the following topics related to the prevention, treatment and attitudes towards HIV:

    • Latest developments in HIV treatment, including long-acting injectable treatments
    • Knowledge about current antiretroviral drugs and microbicides
    • Impact of genetics on variability in HIV transmission and treatment
    • Cases of cured HIV and how they can inform treatment
    • Selective immunity against HIV in special populations
    • Progress and challenges in various types of HIV vaccine development
    • Variables in the efficacy of pre-exposure prophylaxis (PrEP)
    • Environmental and societal methods for HIV prevention
    • Accessibility of HIV treatment worldwide and across sociodemographic groups
    • Attitudes towards HIV and their impacts on treatment uptake and adherence
    • The power of social support networks
    • Mental health of individuals living with HIV throughout different stages of treatment
    • Psychological comorbidities and psychiatric treatments in HIV care

    Submit your manuscript

    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    ImmunoTargets and Therapy

    Oral Vaccines for Infectious and or Non-Infectious Diseases

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Oral Vaccines for Infectious and or Non-Infectious Diseases" in ImmunoTargets and Therapy.

    Vaccines are biological formulations of antigenic material(s) and excipients capable of inducing protection against one or more infectious or malignant diseases of interest. Next to safe drinking water, vaccines have remained the cornerstone of public health interest as they remain the most cost-effective way to prevent infectious and malignant diseases. Vaccines are most commonly administered by needle injections and only a few are administered through the oral or the nasal routes. Oral vaccines are more advantageous than injection-based vaccines for a number of reasons: including increased safety, ease of administration and compliance, and simpler manufacture and delivery. Additionally, the oral route allows for the development of cellular and humoral immune responses at mucosal and systemic locations to provide a more extensive and long-lasting immunity. Convenient for all ages, oral vaccines can offer immunity against varieties of infectious diseases. 

    Edible vaccines, also referred to as food vaccines, plant-based vaccines, or green vaccines, are a group of newly emerging oral vaccines and may later become possible alternatives to cold-chain vaccines, especially for developing countries. The concept of using edible tissues of genetically engineered crops as a manufacturing and delivery system for biologics was first introduced in the early 1990s by Dr. Charles Arntzen and his associates. This plant-based vaccine can be developed against both communicable and non-communicable diseases and can be taken either by eating the edible part of the transgenic crop or by oral administration of the refined protein extract. 

    It is essential to invest more research efforts into developing stable oral vaccines as a delivery route. Furthermore, oral vaccines which are grown in antigen-producing plants will eliminate the need for transportation and cold chains, and will overcome the challenges of inaccessibility to vaccines in many rural communities of developing countries. More scientific studies are needed in various aspects of oral vaccine to tackle myriads of human and veterinary diseases. 

    We welcome papers covering In silico studies relating to any aspects of epitope identification and oral vaccine design: Immunology and immunological aspects of oral vaccines; Animal models of diseases (communicable and non-communicable) being experimented upon with any form of oral vaccine; Oral and edible vaccines; Implementation Science and management; Oral vaccines for animal and human diseases; and other aspects of oral vaccines. Original research, Commentaries, Letters to the Editor, and Reviews are welcome.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. 

    Please submit your manuscript on our website, quoting the promo code XYTAJ to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 1 July 2024.

    Guest Advisors

    Angus Nnamdi Oli, Nnamdi Azikiwe University

    [email protected]

    Dr. Oli, a trained Pharmacist, is a Reader at Nnamdi Azikiwe University, Awka, Nigeria with expertise in Vaccinology, Immunology, Pharmaceutical Microbiology Quality Assurance and Infectious Disease Researches. He is listed among the first 500 scholars in Nigeria by Scopus for the years 2022 and 2023. He has undergone several trainings including Massive Open Online Courses (MOOC) on Implementation Research (IR) with a focus on Infectious Diseases of Poverty (IDP) organised by African Regional Training Centre, University of Ghana School of Public Health and the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).

    Adekunle Rowaiye, National Biotechnology Development Agency

    [email protected]

    Dr. Rowaiye is a Veterinarian and Pharmaceutical Biotechnologist. His research interest is in the discovery, design, and evaluation of drug candidates which include small molecules, natural products, peptides, and proteins. Dr Rowaiye has several publications in international journals and he is presently working on the discovery of drug candidates that will retard the aging process and prevent neurodegenerative diseases.

    View all papers in this article collection

    The Role of Natural Killer Cells in Disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Role of Natural Killer Cells in Disease" in ImmunoTargets and Therapy.

    Natural killer (NK) cells were first identified by Dr. Ronald B. Herberman, who unfortunately passed away several years ago. Since their first identification, it was clear that these cells expressed anti-tumor activity and were initially named natural cytotoxicity (NC) cells, and later as NK cells. Although they respond to danger whilst circulating in the peripheral blood, they can rapidly migrate into sites of immune reactions in peripheral tissues. It is also apparent that whilst responsible for killing tumor cells, they additionally display an immunoregulatory function. Consequently, they react to microbes, particularly virally-infected cells, as well as protecting the immune system by depleting unwanted antigen-presenting cells - which can sometimes be detrimental due to provoking autoimmunity.

    Although the therapeutic potentials of NK cells in cancer and to some extent in autoimmune diseases are well established, these cells also play important roles in other diseases which will constitute an important aspect of this Article Collection. This Article Collection aims to explore the involvement and/or therapeutic potentials of NK cells in various diseases. Reviews and original articles from worldwide experts dealing with the role of NK cells in any of the below mentioned fields are highly encouraged to submit their valuable work.

    1. Cancers
    2. Autoimmune diseases
    3. Neurodegenerative diseases
    4. Stroke and heart diseases
    5. Virus infection, including COVID
    6. Other microbial infections
    7. Pulmonary diseases
    8. Gastrointestinal diseases
    9. Musculoskeletal diseases
    10. Hematological disorders
    11. Skin diseases

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code HUAAS to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 15 July 2024.

    Guest advisors

    Dr. Azzam A. Maghazachi, Research Department, ImmunoProfiling and Boosting, Oslo, Norway

    [email protected]

    Dr. Azzam A Maghazachi received a masters degree from New York University Medical School (USA), and a PhD degree in Immunology from the University of Manitoba Medical School (Canada). He completed post-doctoral fellowships at NYU Medical School (USA) and then worked under the supervision of the late Dr. Ronald B. Herberman at the Pittsburgh Cancer Institute. Between 1988-2007, he held several senior positions in various institutes and universities in the USA, Canada and Norway. He was a Professor of Physiology in the faculty of Medicine at the University of Oslo, Norway, and later a professor of Immunology in the college of Medicine, University of Sharjah. Dr. Maghazachi research interests include cancer immunology, autoimmune diseases, chemokines, and drug mechanisms of action. Dr. Maghazachi is an editor or editor-in-chief for more than 10 scientific journals in the fields of Immunology, Oncology and Neuroscience. He has published more than 120 scientific papers as well as book chapters and ebooks.

    View all papers in this article collection

    Infection and Drug Resistance

    Antimicrobial Stewardship and Infection Control: A Global Perspective

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Antimicrobial Stewardship and Infection Control: A Global Perspective", organized by Guest Advisor Dr. Anucha Apisarnthanarak in Infection and Drug Resistance.

    Antimicrobial resistance occurs commonly in public and in patient settings and is a major concern in a global scale. Inappropriate use and poor infection prevention are undeniable causes of antimicrobial resistance. Strategies to reduce antimicrobial resistance and effective control measures are needed. This article collection will address the epidemiology of, and innovative strategies to control for, antimicrobial resistance in a global perspective.

    All articles pertaining to antimicrobial stewardship and/or infection control to limit transmission of antimicrobial resistance will be considered for publication. The scope of this article collection will also include laboratory stewardship, antimicrobial stewardship, interventions using Infection Control (IC) together with antimicrobial stewardship to curb multi-drug resistant (MDR) pathogens, novel stewardship strategy, novel IC strategies to reduce MDR, antimicrobial stewardship in resource-limited settings, etc. Articles pertaining to antimicrobial stewardship and control strategies in the community and public, antibiotic prescribing behaviors, as well as epidemiology of multi-drug resistant organisms are also welcome.

    Guest advisor:

    Dr. Anucha Apisarnthanarak is current the Professor and Chief of Infectious Diseases Division at Thammasat University Hospital. He also serves as an Adjunct Visiting Professor at Division of Infectious Diseases, Washington University School of Medicine, USA. Dr. Apisarnthanarak’s research focus included infection prevention in resource-limited setting, infection control to prevent multi-drug resistant microorganisms as well as outbreak investigations. He published more than 250 peer-review articles and more than 20 peer-review book chapters. He has been a key committee member of many national and international societies including Thai National Nosocomial Infection Group, Society of Healthcare Epidemiology of America, and Asia Pacific Society of Infection Control.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 1 May 2024.

    Please submit your manuscript on our website, quoting the promo code MKIRN to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Integrated Pharmacy Research and Practice

    AI's Influence on Enhancing Pharmacy Services

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "AI's Influence on Enhancing Pharmacy Services" in Integrated Pharmacy Research and Practice.

    Over recent years, there has been a remarkable rise in the integration of artificial intelligence (AI) into the healthcare sectors, and the pharmacy sector is at the forefront of this transformation. This Article Collection aims to explore the impact of AI technologies on pharmacy services, including a comprehensive examination of innovative solutions, challenges, and advancements in this dynamic field. 

    The importance of this Article Collection lies in its potential to revolutionize patient care and the operational aspects of pharmacies. AI holds the promise of optimizing the management of medications, reducing errors, and enhancing patient involvement. This Collection seeks to shed light on the transformative possibilities of AI, not only in improving the accuracy and efficiency of medication-related tasks but also in advancing the overall quality of healthcare provision. 

    We invite contributions in research areas including, but not limited to, the following:

    1. AI-powered medication dispensing and supply
    2. Machine learning for personalized medication recommendations
    3. Robotics in pharmacy settings
    4. AI-enhanced patient counselling and education
    5. Ethical and regulatory considerations in AI adoption within pharmacy services

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is April 30th, 2024.

    Please submit your manuscript on our website, quoting the promo code BJPQW to indicate that your submission is for consideration in this Article Collection. 

    Guest Advisor

    Name: Walid Al-Qerem, Associate Professor, Al-Zaytoonah University of Jordan

    [email protected] 

    Dr. Walid Al-Qerem obtained a PhD of Clinical Pharmacy from the University of Sunderland, UK. He is an associate professor at Al-Zaytoonah University of Jordan. Dr. Al-Qerem's research area covers improving the diagnosis and management of different diseases. This includes validation and formulation of spirometic equations to improve the diagnosis and management of many respiratory diseases including asthma and COPD, developing population specific growth charts to improve the tracking of children's growth, and to identify undiagnosed conditions and validate different instruments used to evaluate health-related quality of life and adherence to medication. Dr. Al-Qerem's research also covers the study of different variables that influence the outcomes of different diseases.

    View all papers in this article collection

    Telepharmacy Innovations: The Great Opportunity for Advancing Healthcare in the Digital Age

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Telepharmacy Innovations: The Great Opportunity for Advancing Healthcare in the Digital Age" in Integrated Pharmacy Research and Practice.

    Telepharmacy, an innovative branch of pharmacy that uses technology to provide services remotely, has emerged as a crucial response to changing healthcare needs in the digital age. Its importance lies in its ability to overcome geographic barriers and increase patient access to quality pharmaceutical services. As the world faces challenges such as the COVID-19 pandemic, telepharmacy has become a valuable resource for ensuring continuity of care and reducing the risk of exposure to the virus in healthcare settings. 

    However, despite its growth and acceptance, telepharmacy remains an evolving field that requires continued research. Research is critical to better understand how to maximize its effectiveness, ensure patient safety, and address ethical and legal issues. In the future, potential lines of research could focus on improving communication technologies, integrating effectively with other healthcare professionals, identifying appropriate reimbursement models, and exploring how telepharmacy can be used in primary and specialty care settings. 

    The new concept and model of pharmaceutical care presents telepharmacy as a great opportunity for permanent and real-time contact with the patient. 

    Potential subtopics:

    • Clinical Effectiveness Evaluation: Investigate the efficacy and safety of telepharmacy services compared to traditional pharmaceutical care in a variety of medical conditions. This could include collecting data on clinical outcomes, compliance rates, and patient satisfaction.
    • Technology Integration: Study how the incorporation of emerging technologies, such as artificial intelligence and machine learning, can improve pharmaceutical decision making, drug-drug interaction identification, and treatment personalization.
    • Data Security and Patient Privacy: Investigate advanced data security methods to protect patient privacy and ensure the integrity of health information transmitted through telepharmacy platforms.
    • Reimbursement Models and Economic Sustainability: Explore sustainable reimbursement models for telepharmacy that incentivize the delivery of high-quality services and encourage pharmacist involvement in healthcare.
    • Pharmacist Education and Training: Investigate how effective training can be provided to pharmacists to acquire the skills needed in the telepharmacy environment and keep up with technological advances.
    • Access and Equity: Examine how telepharmacy can address disparities in access to pharmaceutical care, especially in rural and underserved areas.
    • Multidisciplinary Integration: Investigate how more effective collaboration between pharmacists and other healthcare professionals can be achieved through telepharmacy for comprehensive patient care.
    • Patient Experience: Study patient satisfaction and preferences in the use of telepharmacy and how to improve the overall patient experience.
    • Regulation and Standards: Investigate how regulations and standards are evolving in response to the growth of telepharmacy and how they can be adapted to ensure patient safety and quality of care.
    • Cost and Societal Benefit Assessment: Conduct cost-benefit analyses to determine the financial and societal impact of telepharmacy on the healthcare system as a whole.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is August 31st 2024.

    Please submit your manuscript on our website, quoting the promo code KAIKS to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Ramón Alejandro Morillo Verdugo, Associate Professor, Hospital Pharmacy, University of Seville, AGS Sevilla Sur, Hospital de Valme

    [email protected]

    Dr. Ramón Alejandro Morillo Verdugo has worked at Hospital Pharmacy Seville since 2006. He has been an Associate Professor at University of Seville since 2011. He is also the Spanish national coordinator of the “MAPEX Project” from SEFH since 2014.

    View all papers in this article collection

    International Journal of Chronic Obstructive Pulmonary Disease

    Current insights and future trends for inhalation therapy in chronic obstructive respiratory disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current insights and future trends for inhalation therapy in chronic obstructive respiratory disease" in the International Journal of Chronic Obstructive Pulmonary Disease.

    Current respiratory inhalers used by individuals with chronic obstructive pulmonary disease (COPD) and/or asthma have been in use since the 1950s, though the practice of using an inhaler device to deliver therapeutic aerosols as a treatment has existed for a thousand years or longer. Having an aerosol formulation as opposed to an oral tablet that requires a device introduces complexity into the treatment regimen. That many patients have difficulty using inhalers in a manner that optimizes treatment is well-documented. Recent literature has begun to differentiate between critical and non-critical errors and how these errors may be associated with suboptimal outcomes, but gaps remain. Methods for improving inhaler technique have been studied and better outcomes are usually associated with interventions, however identifying scalable and reproducible methods is still challenging. For future inhaler development, there is both a desire for low-cost generic inhalers (with healthcare costs increasing globally), alongside an interest in more “high-tech” inhalers capable of interfacing with smart devices.

    The connection between suboptimal inhaler technique and worse health outcomes has been demonstrated. The societal burden associated with suboptimal delivery of aerosolized medication is substantive. Insight into how best to address this problem and the extent to which other factors such as patient characteristics (e.g., pediatric, existing visual/physical impairments), setting (inpatient, institutional care, outpatient), frequency of use, intent of use (e.g., rescue vs maintenance), may impact inhaler use is also needed. Finally, identifying a roadmap forward – perhaps “thinking outside the box” may be needed in developing future inhalation devices.

    This Article Collection welcomes submissions of original research and systematic review papers as well as opinion articles on current/future technology. Research may include prospective and retrospective studies, clinical trials and observational studies, surveys. Specific areas of interest include:

    • Critical vs non-critical inhalation errors and association with outcomes
    • Inhaler use among individuals with health limitations (physical and cognitive impairment)
    • Pediatric inhaler use
    • Scalable interventions to improve inhaler technique/use
    • New inhaler technologies in development

    Keywords

    • Chronic Obstructive Pulmonary Disease
    • Inhaler technique
    • Healthcare technology
    • Patient engagement

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 18 August 2024.

    Please submit your manuscript on our website, quoting the promo code JHRDC to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Melissa H. Roberts, University of New Mexico College of Pharmacy, USA

    [email protected]

    The preponderance of Dr. Roberts’ research is on outcomes associated with chronic disease, particularly with COPD. Her research focuses not only on treatment effectiveness but also on burden associated with having chronic disease and assessing quality-of-life and barriers to improving patient outcomes.

    Douglas Mapel, Northern Arizona Pulmonary Associates PLLC, University of New Mexico College of Pharmacy, USA

    [email protected]

    Dr. Mapel is a founding partner of Northern Arizona Pulmonary Associates of Flagstaff Arizona, and a research affiliate of the University of New Mexico College of Pharmacy. His primary interests are in epidemiology and health outcomes research in chronic pulmonary diseases including COPD, asthma, and interstitial lung diseases. Specific outcomes of interest have included frailty and other multi-dimensional clinical measures as predictors of outcomes, comparative effectiveness of respiratory treatments, and healthcare cost and utilization in COPD.

    View all papers in this article collection

    Precision Medicine in COPD

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Precision Medicine in COPD" in the International Journal of Chronic Obstructive Pulmonary Disease.

    Precision Medicine in cancer patients refers to a method of analyzing the genes of cancer cells using a next-generation sequencer, finding the gene mutation that caused the cancer, and using a molecularly targeted drug designed to be effective against that gene mutation. This is also called tailormade or personalized medicine. Is this possible in a real clinical setting in people with chronic obstructive pulmonary disease (COPD)? Although studies on the etiology and pathogenesis of COPD have yielded many insights at the genetic level, unfortunately there are no insights that can be directly translated into the content of treatment for individual patients, and it is not unreasonable to suggest that the application of precision medicine in cancer treatment to COPD may still be a fairy tale.

    In general, most medical treatments are designed for the average patient, but this approach may not be effective for everyone. Rather, we would like to think of precision medicine in COPD as: novel strategies for personalizing disease management that take into account variations in the environment, lifestyle, symptoms, and characteristics of individuals. The goal of precision medicine, as many have noted, is to get the right treatments to the right patients at the right time. In the field of medicine for COPD, this policy has been emphasized with increasing importance in recent years and various terms have come into use. A surrogate term for this is "Treatable Traits". Treatable traits have been proposed as an innovative approach to the management of COPD. Many advanced studies and review articles have already been published in the literature on treatable traits, giving an idea of the approaches that have been taken.

    The Global Initiative for Chronic Obstructive Lung Disease (GOLD) document emphasizes the ABCD assessment tool since 2011, or the recently revised ABE assessment tool, which classifies using symptoms (or dyspnoea) on the horizontal axis and exacerbations on the vertical axis. Dyspnoea and exacerbations may be one of the treatable traits there, which also relates to the basis for determining which drug to administer.

    Additionally, COPD patients with a blood eosinophil count (BEC) of 300 cells/mm3 or higher are currently recommended to receive inhaled medications, including inhaled corticosteroids (ICS), because ICS are expected to reduce the frequency of acute exacerbations. In this case, BEC of 300 cells/mm3 or more is considered one of the treatable features and peripheral blood eosinophil count can be positioned as a biomarker.

    A definition of Precise Medicine in COPD does not yet exist. This attempt is rather a first step towards a definition. In this sense, we are trying to cover as broad an area of COPD as possible. We hope that different researchers from around the world will submit their ideas without preconceived notions. If you are involved in real clinical practice, the term Precision Medicine may be difficult to grasp as a familiar term because it is an esoteric term and is associated with advanced medicine related to gene therapy. We have no intention of playing with words. We hope to see the development of steady research that directly contributes to the treatment of individual COPD patients in a familiar patient care setting. A slight change in perspective should lead to new insights that are still being overlooked. We hope that everyone from young researchers to experienced clinicians will take a second look at this field of practice and contribute their findings.

    It is our great pleasure to invite you to submit articles on the topic of COPD. This article collection, entitled "Precision medicine in COPD", will cover all aspects of clinical investigations regarding COPD. I believe this is the best opportunity to publish your excellent work. Both original articles and reviews are welcome. In light of scientific originality this Article Collection is not currently accepting case reports, case series, meeting reports, photo essays, poster extracts, or study protocols.

    Topics include but are not limited to:

    • Early COPD or late COPD
    • Blood eosinophil count as biomarker
    • Asthma and COPD overlap
    • Frequent exacerbators
    • Patient-reported outcomes
    • Health status or health-related quality of life
    • Dyspnoea measurement
    • Definition of COPD exacerbation

    Keywords

    • COPD
    • precision medicine
    • treatable traits
    • biomarker
    • inhaled corticosteroids

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code MXSKB to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Dr. Koichi Nishimura, Visiting Researcher at National Center for Geriatrics and Gerontology, and Director of Clinic Nishimura, Japan

    [email protected]

    Dr. Nishimura has more than 30 years of experience in the practice of COPD and asthma in Japan since the early 1990s. He spent six months at St. George's University of London in 2012 supervised by Professor Paul Jones to research this. Dr. Nishimura retired from the National Center for Geriatrics and Gerontology (NCGG) of Japan in March 2023 and currently serves as a visiting researcher at NCGG while contributing to community health care in his own clinic.

    Dr. Toru Oga, Kawasaki Medical School, Japan

    [email protected]

    Dr. Toru Oga has been a respiratory physician for about 25 years. His major includes clinical and basic research in asthma, COPD, pulmonary fibrosis, sleep-disordered breathing, and respiratory failure. Dr. Toru Oga has led the Department of Respiratory Medicine, Kawasaki Medical School, as a professor, since 2018.

    Dr. Susumu Sato, Kyoto University, Japan

    [email protected]

    Dr. Susumu Sato is an associate professor at Kyoto University Graduate School of Medicine. His experiences are more than 20 years in practicing respiratory medicine, particularly in COPD and pulmonary rehabilitation. He spent two years as a research associate at Boston University and worked with Professor Bela Suki, a distinguished physicist.

    View all papers in this article collection

    Promoting Optimized Health Care for Individuals with COPD in the Era of Telehealth

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Promoting Optimized Health Care for Individuals with COPD in the Era of Telehealth", organized by Guest Advisors Dr. Yumin Zhou (The First Affiliated Hospital of Guangzhou Medical University, China, [email protected]), Dr. Juan Chen (General Hospital of Ningxia Medical University, China, [email protected]), and Dr. Ning Deng (Zhejiang University, China, [email protected]) in the International Journal of Chronic Obstructive Pulmonary Disease.

    This subject highlights the telehealth of COPD for better management and care of COPD patients. As we all know, COPD is a leading cause of morbidity and mortality worldwide, with an economic and social burden that is both substantial and increasing. Patients with COPD typically complain of dyspnea, activity limitation and/or cough and may experience exacerbations that require specific preventive and therapeutic measures. However, many challenges are encountered in delivering preventive and therapeutic measures, including the COVID-19 pandemic and people living far from their healthcare providers and having limited access to services. Now, as a means to mitigate the risk of viral transmission for both patients and clinicians during the COVID-19 pandemic, many health systems have rapidly converted ≥70% of their outpatient visits to telehealth via phone or video delivery. Due to this, telehealth system has become a hotbed of research in recent years.

    Telehealth may offer a bridge to care and now offers a chance to consider virtual and hybrid virtual/in-person care models, with a goal of improved healthcare access, outcomes, and affordability. There are many critical potential benefits of telehealth, as follows:
    • Telehealth systems may improve COPD medication adherence. Self-management education by telehealth system can help a person understand their disease and the benefits of proper use of medication.
    • Telehealth technologies could improve the delivery of healthcare for people with COPD, reduce exacerbations, improve quality of life, anxiety and depression, and lower rates of hospitalization and emergency department visits.
    • Tele-rehabilitation has been proposed as an alternative to the traditional approach.

    Despite the hope of telehealth as a means of COPD patient care, the evidence base is still evolving, and best practices are not established at this time for COPD. We therefore need much more exploration.

    This Article Collection provides a high-quality forum for interdisciplinary researchers to propose novel informatics methods for telehealth to improve patients' mode of visit and health conditions for patients with COPD. We welcome submissions across the evidence spectrum, ranging from studies of component technologies (e.g., sensors, algorithms, and software) to research articles, database articles, software articles, study protocols, reviews, matters arising, comments, etc.

    This Collection welcomes submissions covering a range of related areas of telehealth, including but not limited to:
    • Remote monitoring plus usual care versus usual care alone.
    • Remote consultation plus usual care versus usual care alone (e.g., Face to face visit for a check-up in a health service with a health professional, or as reported by trialists).
    • Remote monitoring or remote consultation versus usual care (e.g., where telehealthcare has replaced an element of usual face-to-face care).
    • Telehealth interventions' long-term effects.
    • Self-education/follow-up/behavioral intervention and compliance monitoring based on the telehealth system.
    • The field of telerehabilitation: i) standardization of delivery platform; ii) tests performed remotely allowing for accurate exercise prescription; iii) post-exacerbation rehabilitation, etc.

    Keywords:
    • Chronic Obstructive Pulmonary Disease
    • mHealth, Telehealth or Digital Health
    • Internet based pulmonary rehabilitation
    • Intelligent/personalized healthcare
    • Remote monitoring and Interventions

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 April 2024.

    Please submit your manuscript on our website, quoting the promo code KFSQK to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Sarcopenia and frailty in COPD: Mechanisms, Biomarkers, and Potential Interventions

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Sarcopenia and frailty in COPD: Mechanisms, Biomarkers, and Potential Interventions" in the International Journal of Chronic Obstructive Pulmonary Disease.

    Chronic obstructive pulmonary disease (COPD) is primarily a respiratory disease with several extra-pulmonary manifestations. For example, many COPD patients present with an advanced form of age-related muscle impairment, called sarcopenia. In addition, these patients may also exhibit reduced physiological reserves and an increased susceptibility to adverse health outcomes, termed frailty. It is generally well recognized that the presence of sarcopenia and/or frailty in COPD patients increases functional dependency, disease exacerbation, and mortality.

    Timely recognition and intervention of sarcopenia and frailty are critical for treating COPD. Both these conditions have multifactorial etiologies, necessitating a rigorous characterization of the associated molecular mechanisms and biomarkers before optimal therapeutic interventions are applied. However, the driving molecular mechanisms, biomarkers for identification, and effective therapeutic strategies for sarcopenia and frailty in COPD remain elusive.

    This Article Collection aims to unravel the molecular and cellular alterations governing pathogenesis of sarcopenia and frailty in COPD. These may include but are not limited to cellular proteostasis, apoptosis and autophagy, bioenergetics, the roles of satellite cells, muscle vasculature, and myonuclear transcription. We also invite studies investigating the diagnostic potential of novel biomarkers of these conditions in COPD. Here, we aim to primarily unravel the blood biomarkers of muscle or non-muscle origin, that reflect the changes in muscle mass, strength, and frailty phenotype in COPD patients. Lastly, we will reflect on therapeutic interventions, including exercise modalities, novel molecules, nutritional supplements, and other modalities of sarcopenia and frailty in COPD patients.

    We invite basic and clinical research for expanding our understanding of disease mechanisms, biomarkers, and therapeutics of sarcopenia and frailty in COPD patients. Original articles, reviews, case reports, and clinical trials are encouraged for submission.

    Keywords

    • Chronic obstructive pulmonary disease
    • Sarcopenia
    • Frailty
    • Biomarkers
    • Muscle wasting

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 May 2024.

    Please submit your manuscript on our website, quoting the promo code GKTXA to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Rizwan Qaisar, University of Sharjah, UAE

    [email protected]

    Dr. Qaisar investigates the mechanisms and biomarkers of muscle impairment associated with physical inactivity, aging, and age-related diseases. His work includes evaluating the regulation of muscle contraction at the motor protein, single fibers, and whole muscle levels using in-vitro, in-situ, and in-vivo methods in experimental animal models and clinical settings. Additionally, he investigates the therapeutic interventions to prevent and/or reduce accelerated muscle loss in older adults with age-associated comorbidities.

    Johan Lindqvist, University of Arizona, USA

    [email protected]

    Dr. Lindqvist is interested in how giant sarcomeric proteins influence skeletal muscle function in both healthy and disease states using molecular to whole animal techniques. His disease interests range from inherited to acquired diseases with a focus on the diaphragm, the main respiratory muscle, related pathologies. He has special focus on structural adaptations to diseases.

    View all papers in this article collection

    International Journal of General Medicine

    Artificial Intelligence (AI) and the future of General Medicine 

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Artificial Intelligence (AI) and the future of General Medicine ", organized by Guest Advisors Prof. Antonio Coronato and Dr. Muddasar Naeem in the International Journal of General Medicine.

    Artificial Intelligence (AI) is a wide-ranging branch of computer science concerned with building smart machines capable of performing tasks that typically require human intelligence. AI in varying forms and degrees has been used to develop and advance a wide spectrum of fields including medicine and healthcare. AI can identify meaningful relationships in raw data, it can support diagnostic, treatment, and prediction outcomes in many medical situations. AI can automate a substantial portion of the manual work and speed up the process. AI based techniques help in identifying targets for intervention, discovering drug candidates, speeding up clinical trials, finding Biomarkers for diagnosing the disease. 

    This Article Collection is intended to report on applications in the healthcare and medicine domain that benefit from the AI technologies including Machine learning, Reinforcement learning and deep learning. In this context, we are envisaging contributions covering one or more of the following topics: 

    • Medical knowledge engineering.
    • Knowledge-based and agent-based systems.
    • AI-based clinical decision making.
    • Natural language processing in medicine.
    • New computational platforms and models for biomedicine.
    • Intelligent devices and instruments.
    • Automated reasoning and meta-reasoning in medicine.
    • AI and data science in medicine, medically oriented human biology, and healthcare.
    • AI-based modelling and management of healthcare pathways and clinical guidelines.
    • Models and systems for AI-based population health.
    • Data analytics and mining for biomedical decision support.
    • Machine learning in medicine, medically oriented human biology, and healthcare.
    • AI in medical and healthcare education.
    • Methodological, ethical, and social issues of AI in medicine.

    Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 May 2024.

    Please submit your manuscript on our website, quoting the promo code JBZJM to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Impact of Dietary Choice on Life Expectancy – General Medicine Perspective in the Era of Longevity

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of General Medicine on "Impact of Dietary Choice on Life Expectancy – General Medicine Perspective in the Era of Longevity", organized by the Lead Guest Advisor Prof. Mihajlo (Michael) Jakovljevic from Hosei University, Japan / the University of Kragujevac, Serbia, and co-Guest Advisors Prof. Arcadio Cerda from Talca University, Chile and Prof. Wenqing Wu from Tianjin University, China.

    Nutrition and dietary patterns during most of the previous history of mankind were largely driven by the way of life imposed by survival. This was the case ranging from prehistoric hunter gatherer communities over several millennia of evolving nomadic and agricultural societies. After the Colonial Age, the modern era is particularly characterized by massive scale industrial development and urbanization across low-and-middle-income nations of the Global South. This has created a unique phenomenon in human history – a surplus of food that continues to grow and becomes a matter of foreign trade and struggle for geo-economical influence.

    In the era of ease, to generate self-sustainable agricultural and industrial-scale food manufacturing across many nations worldwide, other epidemiological challenges have arisen. In the earlier past, the primary causes of short longevity were hunger and starvation, communicable infectious diseases, traumatism, and early childhood and maternal morbidity. Yet constant surplus of food supply and consumption for many decades has given rise to prosperity diseases or non-communicable chronic diseases. Many of them such as cardiovascular and metabolic disorders, diabetes, and cancer are largely attributable to dietary patterns. Long shelf-life market foods contain many oncogenic and toxic adjuvants and conservation substances. This particularly refers to fast foods and their high content of salt, sugar, and saturated fats. On the other hand, introduction of large quantities of herbal fibers into diets, cis-fatty acids, fresh fruits and vegetables, cereals, and bold reduction of sugar content have been proven to increase longevity. Thus, among the public health measures that are affordable to lower-and-middle-income citizens in most of LMICs countries for the prevention of NCDs – nutrition cultural change comes at the first place. It is both affordable and cost-effective. The promotion of and education in healthy dietary habits to school children and households bring long-term benefits. This has been documented in terms of extended life expectancy in so-called Blue Zones across the globe where such dietary patterns and healthy lifestyle prevails.

    This collection attempts to attract a variety of submissions in the field of general medicine, public health, and health economics & policy that attempt to tackle the aforementioned issues. This refers to all the aspects of the causal relationship between dietary habits and longevity as well as their public health consequences. Any article consistent with Dove Press's author guidelines is welcomed. Diversity and heterogeneity of submissions across interdisciplinary health sciences is strongly preferred.

    The deadline for submissions is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code QWLLT to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Muscling Up: Strategies for the Prevention and Management of Sarcopenia

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Muscling Up: Strategies for the Prevention and Management of Sarcopenia", organized by Guest Advisors Prof. Yong-Seok Jee (Hanseo University), Prof. Sang-Kyun, Park (Woosong College), and Dr. Seung-Jae Heo (Chungnam National University) in the International Journal of General Medicine.

    Sarcopenia is a condition characterized by the loss of muscle mass, strength, and function, typically associated with aging. It can have serious implications for an individual's overall health and quality of life, leading to a decreased ability to perform activities of daily living and an increased risk of falls and other health problems.

    To prevent or manage sarcopenia, there are several strategies that can be employed. These include resistance training, adequate protein intake, vitamin D supplementation, hormone replacement therapy, and avoiding inactivity. However, there are still many unresolved issues regarding the prevention and treatment of sarcopenia. For example, there is a lack of interdisciplinary studies on the effectiveness of combining various treatment strategies, and there is a need for more in-depth observational studies at the cellular and tissue levels. That is, the management of sarcopenia is achieved through a multidisciplinary approach by doctors, nurses, psychologists, physical therapists, occupational therapists, exercise therapists, fitness providers, and social workers. The purpose of this Article Collection is to share valuable knowledge and the most recent developments regarding the prevention and management of sarcopenia. We hope that experts from diverse fields will participate and work together in advancing this important area of health sciences.

    Any article types related to the prevention and management of sarcopenia and consistent with the International Journal of General Medicine’s author guidelines are welcomed. Relevant subtopics may include but are not limited to the following:

    • The efficacy of different resistance training protocols in preserving muscle mass and improving strength in individuals at risk of or affected by sarcopenia
    • The role of protein supplementation and dietary strategies to promote muscle protein synthesis and combat muscle wasting
    • Impact of vitamin supplementation on muscle health and function in the context of sarcopenia
    • The potential benefits and risks of hormone therapy in preserving muscle mass and function among aging individuals
    • Cellular and tissue-level studies that can advance our understanding of the underlying mechanisms of sarcopenia

    Keywords:
    Aging, Sarcopenia, Strength training, Protein, Vitamin supplementation, Hormone replacement therapy

    Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31st May 2024.

    Please submit your manuscript on our website, quoting the promo code CYLSQ to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Yong-Seok Jee, Hanseo University

    [email protected]

    Sang-Kyun Park, Woosong College

    [email protected]

    Seung-Jae Heo, Chungnam National University

    [email protected]

     

    View all papers in this article collection

    The Continuum of Aging and Age-Related Diseases: Present Hurdles and Future Evidence

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on " The Continuum of Aging and Age-Related Diseases: Present Hurdles and Future Evidence", organized by Guest Advisors Dr. Woon-Man Kung (Taipei Tzu Chi Hospital and Chinese Culture University) and Dr. Lam King Hei Stanley (The Chinese University of Hong Kong) in the International Journal of General Medicine. Dr. Kung now serves as a Consultant Neurosurgeon in the Division of Neurosurgery, Department of Surgery of the Taipei Tzu Chi Hospital, and is an Adjunct Associate Professor in the Department of Exercise and Health Promotion of the Chinese Culture University. Dr. Lam is a Clinical Associate Professor at the Chinese University of Hong Kong and an honorary Clinical Assistant Professor at the University of Hong Kong. He is also a musculoskeletal, sports, and pain physician and serves as a President of the Hong Kong Institute of Musculoskeletal Medicine and the MSKUS Asia-Pacific.

    Population aging is a significant global challenge, making geroscience an important emerging field. The goal of geroscience is to enhance our understanding of the genetic, molecular, and cellular mechanisms that underlie aging, which is a major risk factor or driver of age-related diseases (ARDs), such as sarcopenia, osteoarthritis, osteoporosis, chronic obstructive pulmonary disease, cancer, Parkinson’s disease, or Alzheimer’s disease. Aging is characterized by a progressive decline in biological and physiological resilience, leading to functional deficit accumulation and reduced ability to maintain health. Although there is evidence supporting shared mechanisms between aging and ARDs, there is also interest in the differences between the two. For instance, not all elderly individuals necessarily suffer from ARDs, and some centenarians may exhibit signs of decelerated aging, while others may develop ARDs at a younger age with signs of accelerated aging. Factors such as genetics, lifestyle, diet, physical activity, and living environment all play a role in the aging-ARDs continuum. Geroscience research is therefore crucial in helping geriatrics slow the impact of aging on ARDs, improve function and resilience in the elderly, and reduce multimorbidity. This Collection aims to provide updated evidence on biological markers, cellular mechanisms, lifestyle factors, environmental risk factors, and more to deepen our understanding of the aging-ARDs continuum.

    Any article types related to aging and ARDs continuum and consistent with the International Journal of General Medicine’s author guidelines are welcomed. Relevant subtopics may include but not limited to the following:

    • Diagnosis and nonsurgical treatment of diseases
    • Elucidation of disease processes and management protocols
    • Patient perspectives including satisfaction, quality of life, health literacy, and communication
    • Development of new healthcare programs and optimizing clinical outcomes
    • Monitoring and treatment protocols
    • Multi-system disease processes

    The deadline for submissions is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code XKROF to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    International Journal of Nanomedicine

    Surfactants in Nanomedicine: Enhancing Efficacy and Potential Applications

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Surfactants in Nanomedicine: Enhancing Efficacy and Potential Applications", organized by Guest Advisors Dr. Taiki Miyazawa (Tohoku university, Japan), Dr. Maharshi Bhaswant (Tohoku university, Japan) and Dr. Hiroaki Komuro (Cedars-Sinai Medical Center, United States).

    Surfactants, classified as amphiphilic compounds, have evolved significantly in response to recent technological advancements. These innovations enable precise tuning of their charge, chain length, and physicochemical properties to meet specific needs. These versatile compounds play a pivotal role in a wide array of applications, spanning from adhesives, paints, cosmetics, household and industrial cleaners, oilfield chemicals, pesticides, plastics, textiles, food, and pharmaceuticals. They are indispensable for promoting a healthy and comfortable human lifestyle.

    Notably, there is a growing utilization of surfactants in the burgeoning field of nanomedicine, driven by strides in nanotechnology. Prominent examples include their role as templates for crafting nanoparticles, as key components in niosomes, and as solubilizers for proteins and antibodies. Furthermore, surfactants hold the potential to impart advanced functionalities in nanomedicine, including the ability to regulate capture by the mononuclear phagocyte system (MPS) within the body, mitigate hemolysis, target specific organs, and mitigate adverse drug effects.

    The potential of surfactants in nanomedicine is expansive, and research results have demonstrated significant promise in various medical domains. These include oncology, cardiovascular diseases, neurodegenerative diseases, gastroenterological diseases, dermatological conditions, ocular disorders, and immunotherapy. Particularly noteworthy are the achievements observed when utilizing surfactants series of poloxamer and polysorbate. In essence, surfactants, with their enduring historical legacy spanning ancient civilizations to the modern era, remain indispensable to human existence. They continue to adapt and find relevance in emerging fields of application.

    The primary objective of this collection of articles is to spotlight the forefront of nanomedicine research harnessing the potential of surfactants. This endeavor takes place against the backdrop of an escalating demand for these compounds. Given the wide-reaching versatility of surfactants across a spectrum of research domains, this collection aspires to function as a conduit. It aims to attract not only specialists in nanomedicine but also thought leaders from related disciplines. Through this interdisciplinary exchange, we anticipate the initiation of innovative avenues of scientific exploration.

    This Article Collection comprehensively explores various facets of nanomedicine research leveraging surfactants.

    The potential applications encompass a wide spectrum and include, but are not restricted to, the following areas:

    • Impact of Surfactants on the Biocompatibility of Nanomedicine

    • Enhancing Nanomedicine's Ability to Evade the Mononuclear Phagocyte System (MPS)

    • Augmenting Nanomedicine's Targeting Precision

    • Preserving the Physical and Chemical Stability of Nanomedicine

    • Functional Evaluation of Niosomes Utilizing Surfactants as Building Blocks

    • Influence of Surfactants on the Antimicrobial Activity of Nanomedicine

    • Modulation of Drug Release Rate by Surfactants in Nanomedicine

    • Enhancing Nanomedicine's Dispersibility

    • Surfactant-Mediated Enhancement of Therapeutic Efficacy

    • Future Directions and Challenges in the field of nanomedicine utilizing surfactants

    This comprehensive coverage underscores the pivotal role surfactants play in advancing nanomedicine research across a multitude of dimensions, offering a promising avenue for innovations in healthcare and therapeutic interventions.

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code JWYJL to indicate that your article should be considered for this Collection.

    The manuscript submission deadline is 31 May 2024

    Please contact Haoyang Yi at [email protected] with any queries regarding this Article Collection. 

    Guest advisors

    Dr. Taiki Miyazawa, Tohoku university

    [email protected]

    Taiki Miyazawa has been an associate professor at the Tohoku university, New industry creation hatchery center (Niche). He received Ph.D. from Tohoku university in April 2014. His research focuses on carotenoids, polyphenols, and vitamins with the aim of elucidating the biological activities of these components. He is also working on the application of nanoparticle-based nanomedicine to efficiently utilize these food components and other pharmaceuticals in the body. He also been developing an AI system for explain the physiological functions exhibited by thousands of molecular species in foods. 

    Dr. Maharshi Bhaswant, Tohoku university

    [email protected]

    Maharshi Bhaswant is currently a JSPS research fellow at Tohoku University, based at the New Industry Creation Hatchery Center (Niche). He completed his Ph.D. degree at Victoria University in Melbourne, Australia, in the year 2016. His primary research focus revolves around natural molecules, with the overarching goal of gaining a comprehensive understanding of their cardiometabolic properties and functions. Furthermore, his research extends to the practical application of micronutrients, with the aim of effectively fortifying these vital components within various food constituents, thereby contributing to improved health and overall well-being. Maharshi's research interests also encompass the identification and assessment of novel therapeutic molecules for the treatment of chronic diseases. 

    Dr. Hiroaki Komuro, Cedars-Sinai Medical Center

    [email protected]

    Hiroaki Komuro has been a postdoctoral fellow at the Smidt Heart Institute, Cedars-Sinai Medical Center, US. In march 2021, he received a Ph.D under the guidance of professor Tetsuo Sasano at Department of Cardiovascular Medicine, Tokyo Medical and Dental University in Japan. His research interests include development of therapeutic and diagnostic using biomaterials, especially extracellular vesicles.

    View all papers in this article collection

    Unveiling the Potential of Nanobiomaterials: Pioneering Insights into Biomedical Engineering

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Unveiling the Potential of Nanobiomaterials: Pioneering Insights into Biomedical Engineering", organized by Guest Advisor Dr. Narsimha Mamidi, University of Wisconsin-Madison, United States and Editor-in-Chief Dr. R.D.K. Misra, University of Texas at El Paso, United States.

    Nanobiomaterials (NBMs) are a class of materials that combine the principles of nanotechnology and biomaterials to create innovative solutions for various biomedical applications. They are designed and engineered at the nanoscale level, which typically involves working with materials and structures that range from 1 to 100 nanometers in size. The field of NBMs has gained significant attention in recent years due to its potential to revolutionize medicine and healthcare. NBMs have unique properties and interactions at the nanoscale that make them suitable for a wide range of applications in biology, medicine, and medical devices. Some of the key characteristics and applications of NBMs include:

    High surface area: Due to their nanoscale size, NBMs have a large surface area relative to their volume. This property is advantageous for applications such as drug delivery, where increased surface area allows for better drug loading and release kinetics.

    Enhanced bioactivity: NBMs can be functionalized with specific molecules to improve their interactions with biological systems, such as cells and tissues. This enables better biocompatibility and targeted delivery of therapeutic agents.

    Drug delivery: NBMs can be engineered to encapsulate and deliver drugs, proteins, or genetic material to specific sites in the body. This targeted drug delivery can improve the efficacy of treatments while reducing side effects.

    Tissue engineering: NBMs play a vital role in tissue engineering and regenerative medicine. They can serve as scaffolds to support cell growth and tissue formation, facilitating the repair and regeneration of damaged tissues and organs.

    Diagnostics: NBMs are utilized in diagnostic applications, such as nanosensors for detecting biomarkers, nanoprobes for imaging, and nanoparticle-based assays for disease detection.

    Therapeutics: Some NBMs have inherent therapeutic properties, such as antibacterial nanoparticles that can combat infections or nanoscale materials with photothermal or photodynamic properties for cancer therapy.

    Implants and medical devices: NBMs are used in the development of advanced implants and medical devices with improved mechanical properties, biocompatibility, and reduced risk of adverse reactions.

    Despite their promising potential, the development and application of NBMs also raise concerns about their long-term safety, toxicity, and environmental impact. As research in this field continues to progress, it is essential to balance innovation with a thorough understanding of the potential risks and benefits associated with these novel materials.

    In this Article Collection, we collect research devoted to the interaction between NBMs and tissue/cell, the effect of size, morphology, shape, and surface of NBMs on their toxicity, biocompatibility, immunogenicity, design of novel biodegradable and biocompatible NBMs, instrumentation, and technologies to analyze biocompatibility of NBMs and challenges to overcome the toxicity of NBMs. This exposure could potentially pave the way for exciting and innovative concepts of NBMs and provide game-changing solutions for several research areas, including tissue engineering, drug delivery, medical devices, biosensors, and other biomedical applications.

    This topic covers several successful models of NBMs, including polymer-based NBMs, magnetic and gold nanoparticles, quantum dots, and inorganic-organic-based and carbon nanomaterials (CNMs)-based NBMs, used in biomedical engineering and biosensing applications. We are specifically emphasizing articles narrating the cell and NBMs interaction, toxicity and biocompatibility advancing protocol, structural-property relationship, degradation of NBMs, etc. Topics include but are not limited to: 

    • Biocompatibility Assessment of NBMs:
    • Designing NBMs with multiple functions for medical purposes.
    • Developing drug delivery strategies using NBMs as carriers.
    • Using in vitro/in vivo approaches to understand the biological effects of NBMs.

    Overall, it is hoped that this Article Collection will facilitate the assembling of new collaborations and motivate new generations to engage in the engineering of NBMs for a wide range of applications. 

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code EJJKG to indicate that your article should be considered for this Collection.

    The manuscript submission deadline is 30 September 2024.

    Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection. 

    Guest advisors

    Dr. Narsimha Mamidi, University of Wisconsin-Madison

    [email protected]

    Dr. Narsimha Mamidi is now serving as Scientist-I at WiscNano, University of Wisconsin-Madison, Wisconsin, USA. His primary research focus revolves around pioneering the development of Nanoformulations for the co-delivery of drugs and genes, with a particular emphasis on cancer immunotherapy. His overarching objective is to advance the application of Nanoformulations for clinical use, revolutionizing the landscape of immunotherapy. This endeavor entails the creation of user-friendly drug delivery platforms tailored for a spectrum of cancer types, including but not limited to triple-negative breast cancer, lung cancer, liver cancer, brain cancer, and pancreatic cancer.

    Dr. R.D.K. Misra, University of Texas at El Paso

    [email protected]

    Dr. Misra is a Professor in the Department of Metallurgical, Materials, and Biomedical Engineering at the University of Texas at El Paso, USA. He is also the Editor-in-Chief of the International Journal of Nanomedicine. His inter-/multidisciplinary research interests include advanced manufacturing of biomedical devices, nanoparticle-systems for drug delivery, antimicrobial systems, super-hydrophobic nanocomposites for wound dressing, nanostructured implants, impact of nanostructured surfaces on protein adsorption, quantum dots for bio-imaging, and bio-nano interactions. His research programs involve the use of a broad spectrum of biomaterials characterization techniques such as electron microscopy, confocal microscopy, X-ray diffraction, EBSD, atomic force microscopy, and mechanical testing, to list a few.

    View all papers in this article collection

    International Journal of Women's Health

    PCOS and Fertility Treatments

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "PCOS and Fertility Treatments", organized by Guest Advisor Dr. Giuseppe Gullo, University of Palermo, Italy, in the International Journal of Women's Health.

    Polycystic ovary syndrome (PCOS) affects 6–10% of women in reproductive age and is characterized by hyperandrogenism, insulin resistance, and chronic anovulation. It is a heterogeneous syndrome with not completely understood aetiology that is related to a complex interaction between metabolic, endocrine, genetic, and environmental factors.

    This is an important topic as women diagnosed with PCOS are at higher risk for type 2 diabetes, high blood pressure, obesity, and endometrial cancer. Increasing evidence suggests that insulin resistance and secondary hyperinsulinemia play a key synergistic role with hyperandrogenism in the development and maintenance of metabolic alterations and anovulation or irregular cycles in both obese and lean patients with PCOS.

    This Special Issue will feature short, focused reviews discussing the distinctive features and comorbidities associates with PCOS, the modern evidence-based clinical assessment and management of PCOS, lessons learned from PCOS animal models, and the latest novel ideas in the pathophysiology of PCOS. This Special Issue aims to provide an update on advances and challenges in the field of PCOS. The goal is to provide up-to-date information on new and developing ideas on the origins, diagnosis, and management of PCOS, highlighting the latest concepts in understanding the aetiology of PCOS, while also generating thought-provoking directions for future investigations and management.

    Overall, the manuscripts published in this special issue add significant and novel elements for the understanding of the aetiology, pathophysiology, diagnosis, and treatment of this complex and multifaceted syndrome. We offer these new insights to the readers, hoping that they will stimulate further debate and address new fields of investigation in the next future.

    Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers).

    All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 1st April 2024.

    Please submit your manuscript on our website, quoting the promo code PQCLS to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Strengths-based approaches to optimizing perinatal mental health and wellbeing

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Strengths-based approaches to optimizing perinatal mental health and wellbeing" in the International Journal of Women's Health.

    Positive perinatal mental health is likely to result from a combination of internal and external resources that foster the ability to cope well despite severe and long-lasting stressors. Individuals who are able to acquire and maintain resources are better situated to cope with the demands associated with the transition to motherhood. Internal and external resources often aggregate and interact during the perinatal period to collectively influence prenatal, birth and postpartum outcomes. Several studies have found that internal resources, including optimism and religiosity, may mitigate perinatal mood disorders and enhance maternal mental health. External resources, including informal and formal supports as well as aspects of the neighborhood environment and community connections may further promote positive perinatal well-being.

    Unfortunately, individuals facing low socioeconomic status and minority individuals experience disproportionately high rates of poor perinatal mental health, have fewer material resources and have a decreased ability to replenish resources over time due to social inequities. Multi-level supports may attenuate these associations leading to positive health outcomes. Additionally, much of the research investigating perinatal mental health focuses on risk factors associated with perinatal mood disorders. Resource capacity frameworks emphasize the importance of strengths-based strategies and interventions to prevent poor perinatal mental health outcomes.

    This Article Collection invites exploratory and intervention studies, as well as secondary data analyses, that apply strengths-based approaches to investigate resources associated with well-being during pregnancy and/or through the first year postpartum. Papers that focus on internal and/or external resources and associations with perinatal mental health and well-being, particularly among low-resourced communities, will be considered. Original research and review articles are accepted.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is March 31, 2024.

    Please submit your manuscript on our website, quoting the promo code NTQSL to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Charlotte Farewell, University of Colorado – Anschutz Medical Campus

    [email protected]

    Dr. Charlotte Farewell is an Assistant Professor with the Rocky Mountain Prevention Research Center and director of the Population Mental Health and Well-being program at the Colorado School of Public Health. Dr. Farewell is a Principal Investigator on numerous intervention projects which focus on promoting the mental health and well-being of low-resourced populations (e.g., pregnant and postpartum individuals). Her research is centered around three overarching goals: (1) to build expertise related to the analysis of developmental research questions, with specific focus on mental health (depression, stress, and anxiety) during the prenatal and postpartum periods, (2) to investigate non-pharmacological methods that can be targeted and/or mobilized to optimize population mental health and resilience in multi-ethnic and low-resourced communities, and (3) to advance research in the field of dissemination science to identify core constructs that are most critical to enhance the uptake of evidence-based behavioral interventions.

    Jenn Leiferman, University of Colorado – Anschutz Medical Campus

    [email protected]

    Dr. Jenn Leiferman has spent the last 20 years working in the area of mental health. Her research focuses on developing and testing prevention and treatment strategies for perinatal and child mental health. Recently, her work has also focused on improving access to care for perinatal mood disorders. She is the director of the Rocky Mountain Prevention Research Center, the founding director of the Population Mental Health & Wellbeing Program, and the Chair of the Community and Behavioral Health Department at the Colorado School of Public Health.

    View all papers in this article collection

    Women’s Health Month 2024

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Women’s Health Month 2024" in the International Journal of Women's Health.

    Women’s Health Month, recognized annually in May, is an awareness event aiming to increase knowledge of women’s health and common issues affecting all women at different stages of their lives. It serves as a reminder for all women to prioritize themselves and their health, whether this be by seeking medical attention when necessary or having the knowledge to identify any unusual symptoms and warning signs. It can also be simply taking a break to unwind and enjoy your favorite activities. 

    Despite all the progress in the past few decades, there remains a substantial gap in the research and treatment for conditions that not only affect women, but also those which manifest differently in women than men such as heart disease, osteoporosis and urinary incontinence. This lack of knowledge and focus has only been further highlighted by the recent COVID-19 pandemic which exposed the fragility of healthcare systems towards women’s health issues and its lack of sufficient policies and guidelines. In some lower-middle income countries, the consequences were detrimental. The socio-economic burden of the pandemic resulted in poorer mental health and due to the lack of priority towards routine checkups for expectant parents, there was also a rise in easily preventable still-born deaths. It is evident, now more than ever, that women’s health needs to be a key priority for everyone, and that the health inequalities need to be addressed. 

    • In this regard, the International Journal of Women’s Health would like to invite authors to submit Original Research Articles, Reviews, Clinical Studies, and other manuscript types accepted by the journal on any subject area tailored towards women’s healthcare that could add to the current knowledge. Possible topics include, but are not limited to:
    • Health conditions pertaining to Obstetrics & Gynecology, Orthopedics, Surgery, Cardiology, Hematology, Oncology, and other fields of science and medicine;
    • Early diagnosis, screening, prevention, and treatment of health conditions including chronic conditions such as pain, migraine, headaches, arthritis, osteoporosis;
    • Sexual and reproductive health including fertility patterns and emerging technologies to address infertility;
    • Infectious disease with chronic sequelae including HIV/AIDS, HPV, PID, and other STDs;
    • Psychological and psychosocial conditions - depression across the life span, substance abuse, domestic violence;
    • Physical and emotional wellbeing;
    • Health maintenance among aging females - factors affecting the quality of life including physical, social, and mental issues;
    • Male vs female incidence comparisons for conditions that affect both genders;
    • Avenues for health promotion and disease prevention across the life span.

    Keywords

    Women's Health, Gender Differences, Health Inequalities, Health Promotion

    All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 31st May 2024.

    Please submit your manuscript on our website, quoting the promo code MRFNP to indicate that your submission is for consideration in this Article Collection.

    Please contact Marya Baig at [email protected] with any queries and discount codes regarding this Article Collection.

    View all papers in this article collection

    Journal of Asthma and Allergy

    Atopic Dermatitis and Other Atopic Comorbidities

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Atopic Dermatitis and Other Atopic Comorbidities” in the Journal of Asthma and Allergy.

    Atopic dermatitis (AD) is a chronic inflammatory cutaneous disorder. Currently, AD has been found to be associated with substantial patient burden and numerous atopic comorbidities, including asthma, allergic rhinitis, food allergy, and eosinophilic esophagitis, as well as nonatopic comorbidities, including allergic contact dermatitis, anxiety, depression, suicidality, infections, and cardiovascular disease. All these comorbidities led to the recognition of AD as a systemic disease. Of note, the relationship between AD and comorbidities is likely bidirectional and multifactorial, as well as some comorbidities may be secondary to the effects of the burden of chronic AD.

    This Article Collection aims to explore the association between atopic dermatitis and other atopic comorbidities, shedding light on the shared pathophysiological mechanisms and the implications for clinical management.

    This Article Collection aims to bring together original research articles, review articles, and commentaries exploring the pathogenesis of atopic diseases, also considering primary immune defects presenting as AD, the role of environmental factors, the impact of environmental allergies and infections, novel diagnostic approaches (including biomarkers), and emerging therapeutic approaches (including biologic treatments and JAK inhibitors). Articles regarding all the atopic diseases (asthma, food allergy, allergic rhinitis, eosinophilic esophagitis, and atopic dermatitis) are welcome.

    Potential topics include the following aspects:
    - Epidemiology and burden of atopic comorbidities
    - Pathophysiological mechanisms
    - The role of environmental allergies in atopic diseases
    - Biomarkers in atopic diseases
    - Asthma and allergic rhinitis in atopic dermatitis
    - Atopic dermatitis and food allergies
    - Atopic dermatitis and mental health
    - Novel therapeutic approaches
    - The use of biologics in atopic diseases
    - Clinical management and guidelines

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 19 April 2024.

    Please submit your manuscript on our website, quoting the promo code DFHHN to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors
    Maddalena Napolitano, Professor, MD, Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
    [email protected]

    Luca Potestio, MD, Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
    [email protected]

    Cataldo Patruno, Professor, MD, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro
    [email protected]

    View all papers in this article collection

    From Guts to Lungs: Understanding Microbiome Dynamics in Respiratory Health

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “From Guts to Lungs: Understanding Microbiome Dynamics in Respiratory Health” in the Journal of Asthma and Allergy.

    Globally, chronic respiratory diseases pose a major public health problem. In 2017, chronic respiratory diseases attributed to approximately 3.91 million (7%) of worldwide deaths. Common chronic diseases of the upper and lower respiratory tract include cystic fibrosis (CF), chronic rhinosinusitis (CRS), asthma, and chronic obstructive pulmonary disorder (COPD). These diseases affect individuals differentially across the lifespan. 

    CF is caused by genetic mutations to the CFTR gene. Recent advances in CFTR modulating therapeutics have improved patient’s quality of life and lifespan. More than half of the CF population is age 18 or older. Childhood asthma contributes to significant morbidity worldwide, and incidence is increasing, particularly in industrialized populations. CRS is a major cause of morbidity in the adult population, affecting between 5%-10% of adults. COPD, the third leading cause of death in the United States, is typically diagnosed later in adulthood, though early onset COPD may be more common than previously recognized. 

    Though not an exhaustive list, these chronic diseases present a significant burden to patients and the healthcare system. Risk factors for onset or severity tend to include environment and sociodemographic factors that have an impact on gut and respiratory microbiome composition and function. The host microbiome, or the trillions of microbes that colonize distinct body sites, has a critical role in health status. Studies of the gut microbiome in respiratory disease demonstrate that gut microbiota are critical modulators of inflammatory pathways in the airways, and this can be influenced by environmental factors, such as diet. It is critical to understand 1) how microbiome-host interactions contribute to chronic inflammation in the upper and lower airways, and 2) how age-associated changes in the microbiome, shaped by the host and environment, contribute to development or severity of respiratory diseases. In this Article Collection, we are interested in manuscripts that broadly explore these topics, with emphasis on the following: 

    • Chronic respiratory diseases and the airway microbiome (e.g., sinus microbiome composition, airway microbiome interactions)

    • Chronic respiratory diseases and the gut microbiome (e.g., gut microbiome-lung axis in asthma; dietary habits on gut microbiome or GI morbidities in respiratory disease)

    • Insights into host-microbiome interactions at the airway mucosa and via the gut microbiome-airway axis (e.g., modulation of type 2 immunity in the lungs by respiratory or gut microbiota; microbial metabolites and immune signaling; epigenetic regulation of host-microbiome interaction)

    • Early-life development of the microbiome and asthma risk (e.g., early life microbial exposures and asthma susceptibility; household microbial exposures in early infancy)

    • Health disparities focused on microbiome-targeted interventions or insights (e.g., intersectionality in health disparities and the combined impact of social determinants and microbiome in airway disease; microbiome-mediate effects of access to healthcare and airway disease outcomes)

    • Novel technologies (e.g., single cell sequencing, integrated omics, microfluidics)

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code VTXKB to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 17 May 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Guest Advisor

    Emily Cope, Associate Professor, Northern Arizona University

    [email protected]

    Dr. Emily Cope is an Associate Professor of Biological Sciences at Northern Arizona University (NAU) and Assistant Director of the Pathogen and Microbiome Institute at NAU. Her research program focuses on the role of the microbiome, specifically microbiome-host interactions, in chronic and progressive diseases.

     

    View all papers in this article collection

    New Promising Treatments for Type 2 and Non-Type 2 Asthma

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “New Promising Treatments for Type 2 and Non-Type 2 Asthma” in the Journal of Asthma and Allergy.

    Although the hallmark of asthma pathobiology is airway inflammation, asthma is highly heterogeneous and is thus characterized by a variety of distinct symptoms supported by elaborate endotype networks of cellular and molecular systems. 

    Type 2 (T2) asthma is the most common phenotype/endotype; it may affect both atopic and non-atopic individuals and is primarily maintained by bronchial eosinophilic inflammation. T2-low inflammation, particularly defined by neutrophilic or mixed (eosinophilic-neutrophilic) cellular infiltration of the airways, is present in a significant portion of asthmatic patients. Neutrophil illness is reliant on the cooperative synergy of innate and adaptive immunological responses, much like eosinophilic asthma. 

    Paucigranulocytic (non-T2) asthma is a different phenotype/endotype that is likely characterized by a predominance of involvement of airway structure cells, such as epithelial cells and particularly smooth muscle cells. 

    These physiological and molecular pathways that underlie airway inflammation in asthma define the targets of the current asthma treatments. Inhaled corticosteroids, which have the ability to block the biological activities of a number of immune-inflammatory cells as well as the generation of a large number of cytokines and chemokines, are the cornerstone of the therapy of asthma. However, severe asthma may also be steroid-insensitive to varying degrees. Therefore, monoclonal antibodies that target IgE, pro-inflammatory cytokines, or their receptors are the basis of add-on biological therapy for T2-high severe asthma. Nowadays, omalizumab (anti-IgE), mepolizumab (anti-IL5), reslizumab (anti-IL5), benralizumab (anti-IL5R), dupilumab (anti-IL4/13R) and tezepelumab (anti-TSLP) are available for the treatment of T2-high asthma. Unfortunately, fewer therapeutic opportunities are authorized to treat T2-low severe asthma. 

    The goal of this Article Collection is to summarize recent developments pertaining to the inflammatory pathways underlying the phenotypes and endotypes of asthma. Clarifying the cellular and molecular targets of pharmacological therapies for this pervasive illness depends on ongoing work in this area. 

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code PAGBV to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 19 April 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected]

    Guest Advisors

    Corrado Pelaia, University "Magna Graecia" of Catanzaro

    [email protected]

    My research interests primarily deal with the pathobiology of asthma and the biological therapies of severe asthma. In particular, I am especially interested in the cellular and molecular mechanisms underlying the development of type 2 inflammation in asthma, as well as in the current knowledge and future perspectives regarding add-on biological treatment of uncontrolled asthma. Therefore, my research interests span both clinical activity and basic science. In particular, my work experiences include the diagnostic and therapeutic management of patients with respiratory diseases, and the laboratory techniques applied to the proteomic and peptidomic analysis of induced sputum, blood, and other biological samples. 

    Angelantonio Maglio, University of Salerno

    [email protected]

    My clinical activity is mainly focused on the treatment of patients with both common and rare pulmonary diseases. In the last few years, I worked in a specialized referral centre for the diagnosis and treatment of severe asthma, idiopathic pulmonary fibrosis, and other rare respiratory diseases.

    My research work focused particularly on the fields of obstructive lung diseases, with contributions to the understanding and management of asthma and COPD. My main research topics include the role of inflammation in asthma, anti-inflammatory treatment in asthma and COPD, brand-new biological therapies in severe asthma, and the search for affordable biomarkers of disease activity and severity. My clinical and research time is supplemented and integrated by didactical activity within PhD courses in Translational and Clinical Medicine.

    View all papers in this article collection

    Journal of Healthcare Leadership

    Breaking the Vicious Cycle: Strengthening Leadership Resilience to Overcome Staff Crisis in Healthcare Systems

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Breaking the Vicious Cycle: Strengthening Leadership Resilience to Overcome Staff Crisis in Healthcare Systems" in the Journal of Healthcare Leadership.

    Healthcare systems worldwide are confronted with a formidable challenge that threatens their sustainability. The increasing number of patients, extended life expectancy, rapid changing technological and pharmaceutical complexity, and aspects of planetary health demand more comprehensive care. Paradoxically, healthcare systems are thus becoming victims of their success. The combination of the shortage of specialists with outdated management concepts, toxic management behavior, and a lack of psychological safety among healthcare professionals in the context of a generational conflict exacerbates this predicament.

    In the face of the current staffing crisis in healthcare systems, recent and future leaders at every level must take decisive and competent actions to ameliorate this concerning trajectory. Failing to do so may threaten the hard-won achievements of modern healthcare systems. Contributions addressing effective leadership strategies in the upcoming Article Collection are essential to navigating and overcoming this critical challenge.

    This Article Collection aims to explore effective leadership strategies to address the crisis arising from the insufficient healthcare workforce. We invite submissions of diverse studies that delve into innovative approaches for bolstering the resilience, safety, and longevity of healthcare systems. Contributions may range from conceptual frameworks to empirical research, shedding light on practical solutions.

    Papers submitted for consideration should focus on, but are not limited to, the following areas:

    • Leadership initiatives to attract and retain healthcare professionals.
    • Innovative workforce management strategies to optimize healthcare delivery.
    • Case studies highlighting successful interventions in overcoming staffing challenges.
    • Policies and practices fostering a supportive and sustainable healthcare work environment.
    • Research exploring the impact of leadership interventions on healthcare system effectiveness.
    • Educational research on healthcare leadership

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 15 July 2024.

    Please submit your manuscript on our website, quoting the promo code UEVPT to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Reinhard Strametz, Wiesbaden Institute for Healthcare Economics and Patient Safety (WiHelP), RheinMain UAS, Wiesbaden/Germany

    [email protected]

    Dr. Strametz is a Professor for Patient Safety at RheinMain University of Applied Sciences in Wiesbaden, Germany. He is anesthesiologist specialized in quality management, clinical risk management and emergency medicine and economist. He was Head of Quality at Frankfurt University Hospital now leading Wiesbaden Institute for Healthcare Economics and Patient Safety (WiHelP). He is Vice Chair of EU CoST Actions European Researchers' Network Working von Second Victims ERNST (CA19113) and Supporting emerging care economy, empowering caregivers to provide safe care at home “BetterCare” (CA22152).

    José Joaquin Mira Solves, Fundacion para el foment de la Investigacion Sanitaria y Biomedica de la comunitat Valenciana

    (FISABIO), Alicante/Spain

    [email protected]

    Dr. Mira is a Professor of the University Miguel Hernández, and clinical psychologist conducting clinical assistance at Alicante-Sant Joan Health District. Dr Mira is also an Associate Editor at BMC Health Service Research offering his expertise in health quality, performance, safety and outcomes, and BMC Primary Care, where he is Co-Editor of the Journal of Healthcare Quality Research (Spanish Journal of Quality Assurance). Additionally, he is President of the Scientific Committee at the FISABIO Research Institute in the Valencian Community and Chair of the EU CoST-Actions ERNST (CA19113) and BetterCare (CA22152).

    Stefan Bushuven, Training Center for Emergency Medicine (NOTIS e.V)

    [email protected]

    Dr. Bushuven is an Infection Control Specialist and Intensive Care Physician in the District of Constance, Germany. He is Vice Chair of NOTIS e.V., an NPO Training Center for Emergency Medicine. His research group focuses on Medical Didactics and Medical Education in Emergency and Intensive Care Medicine especially in the fields of Cognitive Error, Learning Motivation and Second Victim Phenomena.

     

    View all papers in this article collection

    Digital Healthcare Leadership in an Era of Value-Based Care, Health Equity, and Patient Consumerism

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Digital Healthcare Leadership in an Era of Value-Based Care, Health Equity, and Patient Consumerism" in the Journal of Healthcare Leadership.

    The proliferation of health information technology to support patient care, which gained accelerated momentum during the COVID-19 pandemic, has continued unabated in the post-pandemic period, with no sign of waning. The pandemic also served to expose and exacerbate disparities in healthcare and health outcomes both in the United States and globally. In the process, the pandemic served to highlight the potential of value-based payment models to reduce health disparities by encouraging organizations to develop partnerships and invest in infrastructure to address people’s clinical and social needs. Since value-based care requires a concurrent focus on improving outcomes and promoting population health, while keeping costs in check, the success of value-based payment models has been inextricably linked to the use of technology. This in turn has fostered growing recognition of the role of health information technology in reducing health disparities and advancing health equity. 

    With the growing emphasis on value in the industry and concurrent push towards health equity by public payers and policymakers, health information technology remains central to enabling the shift towards value-based equitable care. While barriers exist, value-based care is a concept that appeals to all stakeholder groups in the healthcare ecosystem, including providers, payers, and patients, who are all seeking better data, more interoperability across health IT systems, actionable, real-time insights, and more effective engagement. 

    At the same time, health information technology is also recognized to be central to meeting the increasing demands of patient consumerism. Consumerism refers to growing expectations of patients to be actively involved in decisions related to their own care. Healthcare providers and payers will need to work together to deliver on consumer expectations for convenient, functional high-quality services. In other words, achieving the goals of value-based care in an era of consumerism will require effective personalized care that is seamlessly corroborated across industry operators. This systemwide approach in turn will require organizations to bring together disparate sources of information to create an integrated approach to facilitating improved outcomes and consumer engagement. 

    As patients become more engaged consumers of healthcare, providers will need to continue to reevaluate how they interact with patients with the use of engagement and empowerment tools, data ownership and price transparency. Ultimately, as healthcare organizations learn to thrive in the emerging patient-centric, equity-focused, value-based healthcare system, technology that facilitates connectivity across disparate stakeholders, payers, providers, and consumers, will be a foundational cornerstone that enables high-quality, cost-effective care. 

    To successfully adapt to this industry transformation, leaders of healthcare organizations need to be prepared to proactively address a variety of challenges. Accordingly, this Article Collection invites original research papers and informed commentary for a global audience, on a variety of topics relevant to digital healthcare leadership in an era of value-based care, health equity, and consumer-centric technology solutions. 

    Topics of interest:

    • Health IT and value-based payment models
    • Health IT and health equity
    • Health IT and consumerism
    • Value-based consumer-centric technology solutions
    • Use and impact of telemedicine use on health outcomes
    • Use and impact of telemedicine use on health disparities
    • EHR usability and clinician burden
    • Personalized medicine and predictive analytics
    • Population health analytics
    • Data exchange and interoperability
    • Data safety and privacy
    • Adoption of advanced health IT capabilities
    • Use of health IT for learning and continuous improvement
    • Use of health IT to promote consumer, provider, and payer engagement
    • Health IT and healthcare delivery system reform

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 May 2024.

    Please submit your manuscript on our website, quoting the promo code YNFWF to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Pavani Rangachari, University of New Haven

    [email protected]

    Pavani Rangachari, Ph.D., CPH, serves as Professor of Healthcare Administration and Public health and Director of the Master of Healthcare Administration (MHA) program in the School of Health Sciences at the University of New Haven. Her expertise is in health policy and administration, including healthcare organization, delivery, financing, health disparities, and public health. Her special interest lies in the implementation of innovation and change in healthcare organizations. Dr Rangachari holds an M.S. in Health Management & Policy from the School of Public Health at the University at Albany, State University of New York (SUNY), and a Ph.D. in Public Administration & Policy, from the Rockefeller College of Public Affairs & Policy at the University at Albany, SUNY. Dr Rangachari also has extensive work experience in the healthcare industry, through service in leadership roles at both a state hospital association and a community hospital.

    Dr. Rangachari has received independent research grants as Principal Investigator from the U.S. Agency for Healthcare Research and Quality (AHRQ) and has published numerous primary-authored articles in the fields of healthcare management, leadership, health informatics, and public health. Her scholarship has contributed towards the: 1) identification of evidence-based management strategies for successful innovation implementation in healthcare organizations and 2) development of policy implications for consistent implementation of evidence-based and patient-centered care practices to promote population health. Her research projects have also contributed towards improving healthcare practices and outcomes at her study institutions. Dr. Rangachari’s scholarship has been recognized at a national level with the "Best-Theory-to-Practice Paper Award" from the Academy of Management Healthcare Management Division and nomination for the "Distinguished Paper Award" from the American Medical Informatics Association.

    View all papers in this article collection

    Journal of Hepatocellular Carcinoma

    The Dynamic Landscape of Liver Transplantation and Hepatocellular Carcinoma

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Dynamic Landscape of Liver Transplantation and Hepatocellular Carcinoma" in the Journal of Hepatocellular Carcinoma.

    There has been an ongoing evolution of the role of liver transplantation in the treatment of patients who have a diagnosis of hepatocellular carcinoma over the last four decades. From the beginnings of the Milan criteria to the use of liver transplantation as a salvage therapy for patients who have exhausted other medical and surgical interventions, we are living in a field that is rapidly changing. Newer immunotherapies and incorporating a multi-faceted approach to treat this disease subsequently expands the potential pool of patients who may ultimately require and will subsequently benefit from liver transplantation. Unfortunately the ongoing shortage of donor livers (both deceased and living) plays a role in the availability of liver transplantation as a treatment option. The impact of these therapies on liver transplant outcomes are intertwined and with the field rapidly growing it is important to look at the current state from a research and translational perspective. The following subjects fit within this call for papers:

    • Salvage liver transplantation
    • Pre-transplant immunotherapies
    • Post-transplant HCC recurrence and treatment options
    • Role of living donor liver transplant and HCC
    • Portal vein tumor thrombus and liver transplantation

    Please view the journal Aims and Scope and author submission guidelines. The deadline for submissions is 15 September 2024

    Please submit your manuscript on our website, quoting the promo code PMOQM to indicate that your submission is for consideration in this Article Collection. Standard article publishing charges apply.

    Guest advisor

    David Gerber, Christian R. Holmes Memorial Chair of Surgery and Chair of the Department of Surgery, University of Cincinnati College of Medicine

    Dr. Gerber received his medical degree from the University of Pittsburgh and completed general surgery training at Emory University in Atlanta, GA with a post-doctoral fellowship in Transplantation Immunology. He subsequently completed his clinical transplant fellowship at the Starzl Transplantation Institute at the University of Pittsburgh School of Medicine. Clinically he has expertise in solid organ transplantation with a focus on liver cancer including the integration of navigation into minimally invasive surgery procedures.

    Dr. Gerber has received over 25 basic science grants including extramural funding from the National Institutes of Health, the American Liver Foundation, the Roche Organ Transplant Research Foundation, the American Society of Transplant Surgeons, and the American College of Surgeons. He has been principal investigator or co-investigator of more than 40 industry-sponsored clinical trials focusing on advancing patient outcomes in hepatocellular carcinoma and transplantation. He has published over 200 peer reviewed publications, peer-reviewed abstracts and book chapters in the areas of liver cancer, transplantation, stem cell biology, and regenerative medicine. In addition, he has received two patents and has given over 100 national and international presentations in healthcare and biotechnology.

    View all papers in this article collection

    Journal of Inflammation Research

    New Insights into Autoinflammatory Diseases From South America

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "New Insights into Autoinflammatory Diseases From South America", in the Journal of Inflammation Research.

    The concept of autoinflammatory disease was only recognized by the medical field 20 years ago. Now, around 60 genes have been identified that lead to related inborn errors of immunity. 

    Although autoinflammatory diseases have gained relevance in the medical literature data through clinical, basic, and translational research, most published research comes from high-income countries. 

    Research from middle-income countries, such as those in South America, is needed to help us understand the manifestations and prevalence of these conditions in a variety of social, economic, and geographic contexts. 

    This Article Collection will highlight research on autoinflammatory diseases from researchers in South America and in South American populations. We welcome original research, reviews, symposium reports, expert opinions, and commentaries. 

    Topics of interest include: 

    • Genomic findings related to autoinflammatory diseases
    • Genotype/phenotype manifestations of autoinflammatory diseases
    • Pharmacological and non-pharmacological interventions in autoinflammatory diseases
    • Epidemiological data on autoinflammatory diseases
    • Environmental factors contributing to autoinflammatory diseases

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript. Standard Article Publishing Charges apply.

    Please submit your manuscript on our website, quoting the promo code FGRXV to indicate that your submission is for consideration in this Article Collection. Promo codes are used to identify articles that belong to a specific Collection, so it is important to use the correct code.

    The deadline for submitting a manuscript is 1 October 2024. If you have questions, please contact Krista Thom at [email protected].

    Guest Advisor

    Leonardo Oliveira Mendonca, Professor of Clinical Immunology and Allergy, Universidade Santo Amaro, Sao Paolo, Brazil

     

    View all papers in this article collection

    Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes", in the Journal of Inflammation Research.

    Takayasu arteritis (TAK) is a rare large vessel vasculitis (LVV). Although more common in Asia, TAK is diagnosed worldwide. The pathology of TAK is a granulomatous inflammation of the aorta and its major branches. Limited studies available from mostly Europe and North America have revealed an increased mortality risk with TAK relative to the general population. 

    Much remains to be understood about TAK. The assessment of disease activity is challenging. In many instances, TAK sets in insidiously. Patients with TAK might simply be diagnosed incidentally upon the detection of asymmetry of pulses or blood pressure. On the other hand, it can also present with prominent constitutional symptoms without pulse loss at the onset or can present with severe ischemic manifestations such as stroke, myocardial infarction, or vision loss. While the pathology is an inflammatory vasculitis, in many instances, traditional inflammatory markers such as C-reactive protein (CRP) are not elevated. In such instances, 18-F fluorodeoxyglucose PET can identify active TAK even in the absence of CRP elevation. Of late, novel PET ligands such as SST2R and FAPI have been explored as denoting macrophage infiltration or fibroblast activation in the arterial wall. 

    The treatment of TAK is also challenging. Despite the key pathology of vessel wall inflammation, no immunosuppressive agent has been identified to be effective in a clinical trial of TAK. There is a need to explore newer therapies or therapeutic strategies in TAK, which could include the exploration of adjunctive therapies that affect arterial wall fibrosis (which is a prominent histopathological feature of TAK) in addition to the targeting of inflammation. 

    This Article Collection invites original and review articles of translational relevance in TAK, including those related to novel blood and imaging biomarkers of disease activity and arterial wall damage, novel therapeutic strategies, and biomarkers of long-term outcomes in TAK. 

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code AHYGD to indicate that your submission is for consideration in this Article Collection. Promo codes are used to identify articles that belong to a specific Collection, so it is important to use the correct code.

    The deadline for submitting a manuscript is 15 May 2024. If you have questions, please contact Krista Thom at [email protected].

    Guest Advisor

    Prof. Durga Prasanna Misra, Associate Professor, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    View all papers in this article collection

    Journal of Multidisciplinary Healthcare

    Crosstalk in multidisciplinary approaches for evidence-based medicine

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the Journal of Multidisciplinary Healthcare on "Crosstalk in multidisciplinary approaches of evidence-based medicine", organized by co-Guest Advisors Dr. Yao-Chin Wang (Min-Sheng General Hospital and Taipei Medical University, Taiwan), Dr. Sunil Kumar (Nottingham Trent University, England), and Lead Guest Advisor Dr. Woon-Man Kung (Taipei Tzu Chi Hospital and Chinese Culture University, Taiwan).

    Evidence-based medicine (EBM) provides care to patients using the appropriate use of the best available evidence. EBM has increased due to the advancement of clinical measurements, research design, and efficient data analysis techniques. A multidisciplinary approach and the capacity of available evidence have made EBM more reliable than ever. The current development's objective is to achieve high-quality clinical research in the field of clinical decision-making. Now EBM is laced with new clinician skills that provide the edge in collecting vital information about patients' diagnosis, therapy, prognosis, clinical trial studies, and healthcare issues. Therefore, crosstalk in EBM with interdisciplinary consideration has become essential to better understand and serve patients and our society. Certainly, crosstalk on EBM in a multidisciplinary approach will provide options for treatments, medications, harmful side effects, and any potential risks involved.

    Any article types related to healthcare, clinical, and medicines are welcomed. Relevant subtopics may include but are not limited to the following:
    • Diagnosis and nonsurgical treatment of diseases
    • Elucidation of disease processes and management protocols
    • Patient perspectives, including satisfaction, quality of life, health literacy, and communication
    • Development of new healthcare programs and optimizing clinical outcomes
    • Monitoring and treatment protocols
    • Multi-system disease processes

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 December 2024.

    Please submit your manuscript on our website, quoting the promo code GGICE to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Journal of Pain Research

    Dysmenorrhea: Therapy and Mechanism

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Dysmenorrhea: Therapy and Mechanism", organized by Guest Advisor Dr. Jie Yang (Chengdu University of Traditional Chinese Medicine) in the Journal of Pain Research.

    Dysmenorrhea, commonly known as menstrual cramps, is a widespread gynecological disorder that affects a significant number of women worldwide. Despite its high prevalence, effective treatments and a clear understanding of the underlying mechanisms are still lacking. To address this gap in knowledge, we are inviting submissions related to dysmenorrhea for our upcoming Article Collection.

    Specifically, we are interested in papers that cover the following topics:
    1. Pathophysiology of Dysmenorrhea, including the role of prostaglandins, uterine contractions, and central nervous system sensitization. This topic is crucial in providing a comprehensive understanding of the pathogenesis of dysmenorrhea.
    2. Pharmacological Interventions for Dysmenorrhea, such as NSAIDs, hormonal contraceptives, analgesics, and other medications. We are seeking articles that address the evidence, limitations, and side effects supporting the use of these interventions in the management of dysmenorrhea.
    3. Non-Pharmacological Interventions for Dysmenorrhea, including exercise, acupuncture, heat therapy, and other alternative therapies. We welcome papers that discuss the evidence supporting the use of these interventions and their potential role in managing dysmenorrhea.
    4. Potential Mechanisms for Dysmenorrhea, such as central and peripheral factors, uterine and ovarian blood supply, and other related mechanisms. We also encourage submissions that explore the potential mechanisms underlying therapies aimed at improving ovarian or uterine functions.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code LOYEF to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Pain in Space: a Journey of Discovery

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Pain in Space: a Journey of Discovery” organized by Guest Advisors Professor Pablo Ingelmo and Professor Juan Pablo Cata in the Journal of Pain Research

    We invite you to contribute to a special journal collection dedicated to unravelling the mysteries of pain in space. As humanity extends its reach beyond Earth's boundaries, understanding the impact of microgravity on pain perception and its underlying mechanisms becomes paramount. This unique opportunity beckons for ground-breaking research to shed light on an unexplored realm.

    The microgravity environment of space challenges human physiology across multiple systems, including the musculoskeletal, immune, and nervous systems. Recent studies have unveiled the distressing reality of pain experienced by astronauts during and after spaceflight. Back and neck pain afflict a significant majority of astronauts during their time in microgravity, with implications extending beyond their return to Earth. Primordial studies highlight startling parallels between space-induced musculoskeletal changes and terrestrial back pain. However, the interactions between microgravity-induced bone resorption, sensitization to thermal stimuli, and the intricate relationship between pain and cellular senescence pose intriguing challenges. 

    This Article Collection seeks submissions that explore the multifaceted facets of pain in space, including but not limited to:

    1. Nociceptive Responses and Inhibitory Systems: Investigate alterations in astronauts' nociceptive profiles and the functioning of descending inhibitory systems, harnessing quantitative sensory testing and conditioned pain modulation paradigms.

    2. Immune Blood Cells and Pain Pathways: Uncover specific pathophysiological pathways induced by immune cell changes and their potential role in modulating pain perception.

    3. Inflammation and Systemic Response: Examine dynamic changes in systemic inflammatory markers and their implications for pain and tissue deterioration in microgravity environments.

    4. Bone Health and Pain: Explore the interplay between bone resorption dynamics and pain sensitization, elucidating their role in the genesis of pain in space.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 1 March 2024.

    Please submit your manuscript on our website, quoting the promo code KVMIA to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    The Future of Pain Medicine: Emerging Technologies, Treatments, and Education

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “The Future of Pain Medicine: Emerging Technologies, Treatments, and Education” organized by Guest Advisors Dr. Giuliano Lo Bianco, Dr. Christopher Robinson, Dr. Ryan S D'Souza, Dr. Robert Jason Yong, and Dr. Tess Veuthey in the Journal of Pain Research.

    "Emerging Technologies, Treatments, and Education" is an in-depth examination of how cutting-edge technologies are revolutionizing pain medicine and education for chronic pain providers and trainees. This Collection explores the transformative impact of emerging technologies such as artificial intelligence, virtual reality, cloud-based technologies, wearables, and novel roles for neuromodulation. By integrating these technologies, pain management and training can be enhanced and patient outcomes improved. Authors are encouraged to contribute their expertise and research findings to advance our understanding of these technologies' role in shaping the future of pain management and education. Whether you are an established researcher or an emerging scholar, this Collection provides a unique opportunity to contribute to the evolving narrative of pain medicine. Join us in exploring the frontiers of technology-driven advancements that promise to transform how we perceive, diagnose, and alleviate pain.

    Traditional approaches to pain management face challenges in providing personalized and effective interventions. The integration of artificial intelligence allows for data-driven precision medicine, enabling tailored treatment plans based on individual patient characteristics. Virtual reality offers innovative therapeutic interventions, providing patients an immersive environment to alleviate pain and improve well-being. Cloud-based technologies facilitate seamless data sharing, fostering collaboration among healthcare professionals and researchers globally. Wearables provide real-time monitoring and feedback, enhancing the understanding of pain patterns and enabling timely interventions. Neuromodulation continues to expand its applicability, treating even more conditions than previously considered. Furthermore, pain education must continually evolve to meet the growing arsenal of tools that providers can utilize in their practice. This Collection aims to showcase the significance of these advancements, encouraging researchers to contribute to the ongoing dialogue and propel the field toward a future where technology serves as a powerful ally in the fight against pain.

    The Collection invites contributions that span a spectrum of subjects aligned with the scope of our journal.

    Subtopics include, but are not limited to:

    • Application of artificial intelligence, virtual reality, wearables, and cloud-based technologies in collaboration, monitoring, diagnosis, management, and outcomes.
    • Novel applications of neuromodulation such as sensory, motor, or functional restoration.
    • Exploration of psychedelics for the management of chronic pain.
    • Education reform to accommodate a more efficient and comprehensive training process that equips trainees with the necessary skills to start practice.

    Preferred article types for this Collection include original research articles, scoping reviews, systematic reviews and/or meta-analyses, editorials, and perspectives that contribute to the scholarly discourse and foster a deeper understanding of the intersection between emerging technologies and pain management.

    Through this diverse array of contributions, we aim to assemble a Collection that not only informs but also sparks dialogue and innovation in the field.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 1 September 2024.

    Please submit your manuscript on our website, quoting the promo code MYDFN to indicate that your submission is for consideration in this Article Collection.

    Please do not hesitate to contact Commissioning Editor Alice Soteriou at [email protected] should you have any questions with regards to your submission.

    Guest Advisors

    Dr. Giuliano Lo Bianco, MD, PhD, FIPP, EDPM, is a distinguished expert in Anesthesia and Pain Therapy, specializing in percutaneous fluoro/ultrasound-guided interventions. With a commitment to advancing pain therapy, he collaborates with leading experts globally and holds key positions at Fondazione G. Giglio di Cefalù since 2020, serving as the Head of the Operational Unit for Analgesia and Percutaneous Surgery. Dr. Lo Bianco is an esteemed educator, sharing his expertise through lectures at the University of Palermo and the University of Pavia, contributing to the development of pain therapy programs. His dedication to advancing pain medicine and research makes a lasting impact on healthcare and well-being.

    Dr. Christopher Robinson, MD, PhD is a resident physician-scientist at Harvard Medical School-BIDMC and will be doing his chronic pain fellowship at Brigham and Women's Hospital. Dr. Robinson did his MD, PhD in stem cell biology in the lab of Dr. Shuibing Chen at the Weill Cornell Medicine/Rockefeller University/Sloan-Kettering Tri-Institutional MD-PhD Program. His team leadership experience from running a startup during his PhD allowed him and his PhD team including the 2020 Nobel Prize winner in medicine, Dr. Charles Rice, to discover a new anti-viral drug targeting Zika virus during the epidemic. Prior to his MD/PhD, he completed his undergraduate studies at Georgetown University in Washington DC. Now, his chronic pain research team, consisting of members across the globe, work together to accomplish science and medicine in a whole different way utilizing everyone's skillsets across all specialties from machine learners (artificial intelligence developers) to physician-scientists to ethicists to bring education and research to all while keeping the patient at the center.

    Dr. Ryan S D’Souza is an interventional pain physician and anesthesiologist in Mayo Clinic. He was ranked in the top 1% of physicians in the country based on national clinical knowledge testing required to graduate from residency and fellowship. Dr. D'Souza is currently an Associate Professor of Anesthesiology and Perioperative Medicine at Mayo Clinic (Rochester). His clinical and research interests include spinal cord stimulation, peripheral nerve stimulation, fibromyalgia, evidence appraisal, and education. He has lectured both national and internationally and has published extensively in neuromodulation and chronic pain.

    Dr. Robert Jason Yong earned his medical degree and Master of Business Administration at Baylor College of Medicine in Houston. He completed his internship in General Surgery at Beth Israel Deaconess Medical Center in Boston and completed his residency in Anesthesiology at Brigham and Women’s Hospital in Boston, where he was named Chief Resident, an FAER Scholar and a Distinguished Resident. Dr. Young completed his fellowship in Pain Medicine at Brigham and Women’s Hospital in Boston. He completed his Bachelor of Arts in Biology at the University of Texas at Austin.

    Dr. Tess Veuthey MD/PhD is a neurology resident at Stanford interested in neural engineering, chronic pain, psychedelics, and health disparities. Her PhD examined neural representations of behavior in rodents learning motor skills and brain-machine interface tasks. She is looking to bring tools from those fields into the study of chronic pain and its treatment. Dr. Veuthey aims to integrate neuromodulation and psychedelics to collaboratively develop safe, effective treatments for neuropsychiatric conditions both within and outside of formal medical contexts. She has been supported by a Fulbright Fellowship, National Defense Science and Engineering Graduate Fellowship (NDSEG), North American Neuromodulation Society Diversity and Outreach Committee Pipeline Fellowship Grant, and NINDS R25.

    View all papers in this article collection

    Nature and Science of Sleep

    Dreaming of Victory: The Influence of Sleep on Athletic Performance

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Dreaming of Victory: The Influence of Sleep on Athletic Performance" in Nature and Science of Sleep.

    The intricate relationship between sleep and athletic performance is an emerging field of interest within sports science and medicine. This Article Collection seeks to explore and deepen our understanding of how sleep impacts the physical and mental capabilities of athletes. We aim to address the dynamic interplay between sleep patterns and athletic performance, acknowledging the crucial role that rest and recovery play in achieving peak performance levels.

    Recent studies underscore the significance of sleep as a cornerstone of athletic recovery and performance enhancement. Insufficient or disrupted sleep can severely impair cognitive functions, mood, and physiological recovery, leading to decreased performance and increased injury risk. However, there is a pressing need for evidence-based interventions and strategies tailored to the unique lifestyle and stressors of this population. This call for research aims to fill the gap in our current understanding and provide actionable insights for athletes, coaches, and practitioners.

    We invite contributions that shed light on the multifaceted relationship between sleep and athletic performance. Submissions may cover a range of topics, including, but not limited to:

    • The effects of sleep quality and quantity on physical performance.
    • The impact of travel, training schedules, and psychological stress on sleep patterns.
    • The effectiveness of various sleep intervention strategies tailored for athletes.
    • The importance of napping on cognitive performance.

    We welcome original research articles, systematic reviews, and meta-analyses that contribute to our understanding of how to optimize sleep for enhancing athletic performance and recovery.

    By focusing on intervention research, this collection aims to offer new perspectives and evidence-based recommendations to improve sleep health among elite athletes. We encourage submissions from a diverse array of disciplines to foster a holistic understanding of the topic.

    This call for papers represents an exciting opportunity for researchers and practitioners to advance the science of sleep and athletic performance. Join us in contributing to a specialized Collection that promises to inform best practices and foster innovative approaches to athlete health and well-being.

    Guest Advisor

    Matt Driller, Associate Professor in Sport and Exercise Science, La Trobe University, Melbourne, Australia

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code EABZJ to indicate that your article should be considered for this Collection. Standard article publishing charges apply.

    The manuscript submission deadline is 30 September 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    Intersection of AI and Sleep Medicine: Innovations, Challenges, and Ethical Considerations

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Intersection of AI and Sleep Medicine: Innovations, Challenges, and Ethical Considerations" in Nature and Science of Sleep.

    Sleep disorders burden healthcare systems due to laborious diagnostics and limited workforce capacities. However, a wealth of data collected from sleep recordings, patient histories, and electronic medical records remains underutilized in current practices. Additionally, emerging data from wearables, nearables, and apps hold immense potential for understanding the long-term implications of sleep disorders.

    Artificial intelligence (AI) may revolutionize sleep research and medicine by enhancing diagnostic efficiency and accuracy, predicting outcomes, and characterizing patient and disorder traits for optimized and personalized care. However, it is crucial to ensure the ethical design, development, and implementation of these methods while considering data privacy, transparency, validation best practices, and method reliability and generalizability.

    This call for papers explores the latest advancements in AI in sleep medicine and research. It seeks to emphasize the translation of methodologies into clinical practice, focusing on the technical aspects while acknowledging the importance of ethics.

    Topics of interest include:

    • Automatic sleep study scoring
    • Novel methods for sleep disorder detection
    • Utilization of subjective and objective data
    • Integration in electronic medical record systems
    • Minimally invasive data collection for screening and long-term follow-up of the general population
    • Validation and implementation
    • Discussions on best practices, ethical considerations, and practical implementation of AI in sleep research and medicine

    We welcome submissions of original research, reviews, perspectives, and commentaries. Join us in contributing to the conversation on the role of AI in sleep medicine and the considerations surrounding the translation to clinical practice. This collection will serve as a valuable resource for researchers, practitioners, and policymakers interested in the intersection of AI and sleep research.

    Guest Advisors

    Jon Skirnir Agustsson
    VP Artificial Intelligence and Data Science
    Nox Medical ehf, Reykjavik, Iceland

    Anna Sigridur Islind
    Associate Professor
    Department of Computer Science, Reykjavik University, Iceland

    Henri Korkalainen
    Adjunct Professor, Postdoctoral Researcher
    University of Eastern Finland, Kuopio, Finland

    Submission Instructions
    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

    Please submit your manuscript on our website. During submission, enter the promo code AUCFK to indicate that your article should be considered for this Collection.

    The deadline for submitting manuscripts is 31 March 2024. If you have any questions, please contact Krista Thom at [email protected].

    View all papers in this article collection

    Sleep and COVID-19

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Sleep and COVID-19", organized by Guest Advisor Dr. Cecilia Cheng (University of Hong Kong, China), in Nature and Science of Sleep.

    The emergence of the COVID-19 pandemic has brought unprecedented challenges to the world, affecting every aspect of our lives. One of the key areas of concern that has come to light is the impact of the pandemic on sleep. Sleep plays a crucial role in maintaining our physical and mental health, and any disruption to it can have significant consequences. With the outbreak of COVID-19, several factors have come into play that have had a profound impact on sleep, and this has led to an increased interest in the subject.

    The COVID-19 pandemic has brought about a range of changes in our daily lives that have contributed to sleep disruptions. For one, the pandemic has forced many people to work from home, which has led to changes in daily routines and work schedules. These changes have disrupted our circadian rhythms, the internal clock that regulates our sleep-wake cycle. Additionally, the pandemic has caused widespread anxiety and stress, which can lead to insomnia and other sleep disorders. Fear of contracting the virus, financial uncertainty, and social isolation have all contributed to increased levels of stress and anxiety, which can make it difficult to fall asleep and stay asleep. The pandemic has also led to changes in our physical activity levels and exposure to natural light. With many people confined to their homes and limited outdoor activities, there has been a decrease in physical activity and exposure to natural light. These factors can have a negative impact on sleep quality, as exposure to natural light and physical activity are both essential for regulating our circadian rhythms. Furthermore, the COVID-19 pandemic has also led to changes in sleep patterns among healthcare workers who are on the front lines of the pandemic. Healthcare workers are often required to work long hours, which can disrupt their sleep patterns and lead to chronic sleep deprivation. This can have serious consequences on their physical and mental health, and may even compromise their ability to provide quality care to their patients.

    Sleep is an essential aspect of health and well-being, and disruptions to sleep can have significant impacts on physical and mental health. During the COVID-19 pandemic, many people have experienced increased stress and anxiety, which can exacerbate sleep problems. Understanding the relationship between sleep quality and pandemic-related stress and anxiety is critical for developing effective interventions to support individuals' mental and physical health during and beyond the pandemic.

    In conclusion, the COVID-19 pandemic has significantly altered our daily lives, resulting in a profound impact on our sleep patterns. The pandemic has disrupted our circadian rhythms, increased stress and anxiety levels, reduced exposure to natural light and physical activity, and altered the sleep patterns of healthcare workers. As we continue to navigate this unprecedented situation, it is crucial that we pay close attention to the effects of these changes on our sleep and take necessary steps to maintain healthy sleep habits. As such, we organized an Article Collection with the aim of investigating the relationship between sleep quality and psychological distress, including but not limited to pandemic-related stress and anxiety. The collection also seeks to explore potential interventions that could improve sleep patterns during these challenging times.

    Potential subtopics include (but are not limited to):
    • The impact of COVID-19 on sleep quality and duration
    • The relationship between pandemic-related stress and anxiety and sleep
    • Interventions to improve sleep during the COVID-19 pandemic, including cognitive-behavioral therapy for insomnia, mindfulness-based interventions, and sleep hygiene education
    • The impact of sleep disruptions on mental and physical health during the pandemic
    • The role of technology in monitoring and improving sleep during the pandemic
    • The impact of sleep on immune system functioning and susceptibility to infection
    • The effects of social distancing measures on sleep patterns
    • The impact of COVID-19 on sleep in certain occupations, such as healthcare workers and other frontline workers
    • The effectiveness of public health messaging and education campaigns in promoting healthy sleep during the pandemic.
    • Long-term consequences of COVID-19 on sleep disorders.
    • Advantages and challenges of telemedicine in sleep medicine.
    • Telemonitoring and its role in managing sleep-related conditions.
    • Remote sleep studies and their efficacy during pandemics.
    • Benefits and limitations of NIV during pandemics.
    • Analysis of dream patterns and themes during the COVID-19 pandemic.
    • Relationship between stress, anxiety, and pandemic-related dreams.
    • Melatonin supplements and their efficacy in treating sleep disorders.
    • Role of melatonin in managing sleep disturbances during pandemics.
    • Impact of COVID-19 vaccines on sleep patterns and quality.
    • Long-term effects of vaccinations on sleep disorders.

    Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is March 31, 2024.

    Please submit your manuscript on our website, quoting the promo code EJYZN to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Cecilia Cheng, University of Hong Kong

    [email protected]

    Cecilia Cheng is a professor of psychology at the University of Hong Kong, with expertise in various realms of psychology, including social, health, applied, personality, cross-cultural, and cyber-psychology. She has been elected as a Fellow of the Association for Psychological Science, and has received prestigious awards including the Fulbright Senior Scholar Award and the ICP Early Career Research Award. Professor Cheng has also held editorial positions at several flagship journals in the field of psychology, including the Journal of Personality and Social Psychology and Health Psychology Review. At the University of Hong Kong, she has served as the Associate Dean of the Faculty of Social Sciences and currently the Associate Dean of the Graduate School.

    View all papers in this article collection

    The Fundamentals of Sleep-Wake and Consciousness

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Fundamentals of Sleep-Wake and Consciousness" in Nature and Science of Sleep.

    Consciousness remains one of the most elusive and fascinating mysteries of life. Every day and night, human beings and other species naturally transition between consciousness and unconsciousness, i.e., between wakefulness and sleep. A disruption of this process can result in sleep-wake disorders, such as central disorders of hypersomnolence, parasomnia, or insomnia. However, the alteration of consciousness or presence of unconsciousness is not limited to sleep-wake cycles but includes other prominent examples such as anesthesia, disorders of consciousness (e.g. due to brainstem lesions), epilepsy, and neuro-psychiatric disorders (e.g., encephalitis or psychosis).

    The identification of essential brain structures and their associated networks involved in the regulation of sleep-wake functions and other altered states of consciousness is key to the understanding of the formation and modulation of consciousness. This fundamental pillar of neuroscience contributes to the understanding of (patho)physiology and forms the foundation for diagnosis, prognostication, and therapeutic approaches of many disorders.

    We welcome original articles, study protocols, and reviews (narrative and systematic) that highlight new advances and provide insight into the fundamentals of sleep and consciousness. Although submissions should be sleep-wake related, this call emphasizes inter- and transdisciplinary research.

    • Areas of interest include but are not limited to:
    • Theoretical concepts
    • Innovative study protocols
    • Novel methodologies for monitoring sleep and consciousness
    • The impact of circadian rhythms on sleep-wake and consciousness
    • New therapeutic concepts for improving sleep-wake functions and promotion of consciousness
    • Public health implications of disorders affecting sleep-wake and consciousness

    There is no restriction on species.

    Guest Advisor

    Dr. David Schreier, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code VVTXY to indicate that your article should be considered for this Collection. Standard article publishing charges apply.

    The manuscript submission deadline is 15 November 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    The Interplay Between Sleep and Pain

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Interplay Between Sleep and Pain" in Nature and Science of Sleep.

    Among individuals with chronic pain, more than half suffer from sleep problems. Emerging evidence from different settings and methodological approaches suggests that sleep problems can lead to a greater risk and poorer prognosis for chronic pain conditions. This has led to the view that sleep and pain perpetuate and exacerbate each other. 

    To develop more refined therapeutic strategies for individuals suffering from pain and sleep problems, we need a better understanding concerning the long-term trajectories of these conditions, the impact of sleep quality on pain management, and the underlying mechanisms of the sleep-pain relationship. 

    Important questions remain about the role of sleep in the treatment of chronic pain, including what components of the sleep therapy are useful, in what format, and whether targeting sleep problems is effective for all types of patients. 

    Moreover, technological innovations may offer great potential for a better understanding of the impact of different sleep characteristics in the development and clinical course of different types of chronic pain – knowledge that may have great implications for healthcare policy and clinical practice. 

    We seek rigorous and high-quality observational, experimental, or intervention-based studies in the area of sleep and pain to address gaps in knowledge. We will consider reviews/meta-analyses, expert opinions, and commentaries if they make a significant contribution to the field. 

    Topics of interest include: 

    • The impact of sleep quality on pain management, including pharmacological and non-pharmacological approaches for the management of sleep problems
    • Mechanisms contributing to the sleep-pain relationship
    • Longitudinal studies and factors influencing the sleep-pain relationship
    • Causal approaches that address confounding and/or reverse causation
    • Technological innovations and their clinical relevance in individuals with sleep and pain
    • Population-specific considerations (e.g., psychosocial and sociodemographic factors)

    Guest Advisor 

    Dr. Eivind Schjelderup Skarpsno

    Norwegian University of Science and Technology (NTNU), Trondheim, Norway

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code ZATAE to indicate that your article should be considered for this Collection. Standard article publishing charges apply.

    The manuscript submission deadline is 1 October 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    The Role of Sleep in Selectively Consolidating Memories Based on Their Perceived Future Relevance During Encoding

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Role of Sleep in Selectively Consolidating Memories Based on Their Perceived Future Relevance During Encoding" in Nature and Science of Sleep.

    Many studies have found that sleep has a beneficial effect on memory consolidation compared to wake. Beyond that, many have claimed that during sleep, memories with perceived high future relevance are preferentially consolidated. Recently, however, systematic reviews and meta-analyses have found that this selective consolidation effect of sleep is not as large as has been claimed, and might not even exist at all. It has also been suggested that different forms of memories are consolidated during different stages of sleep. However, this idea has also suffered from poor replicability of findings. 

    The proposed role of sleep in selectively consolidating memories is important for basic research on the neurobiological function of sleep, and on the mechanisms through which sleep consolidates memories. For example, is memory consolidation during sleep based on passive protection or active processing? It could also have important implications for learning and memory, as it might allow us to predict how an event will be remembered based on whether it was followed by sleep or wake. 

    Knowing which sleep stages consolidate which types of memory could also be important as technology used to manipulate sleep advances. If such patterns exist, mapping out which sleep stage consolidates which kinds of memories could allow us to select which memories are remembered and which are forgotten. 

    This Article Collection will examine whether sleep (compared to wake) preferentially consolidates memories based on their perceived future relevance. “Future relevance” could be either intrinsic to the stimuli (e.g., using stimuli with varying degrees of emotional tone) or based on instructions during encoding or retrieval (e.g. by manipulating test expectations; telling participants they will be rewarded for good memory performance; or combining sleep with various memory paradigms that induce forgetting such as directed forgetting, retrieval-induced forgetting, or suppression-induced forgetting). 

    We are also interested in studies examining whether particular sleep stages preferentially consolidate different kinds of memories based on their perceived future relevance, including studies that have examined this by manipulating sleep in various ways. Priority will be given to high-powered and pre-registered studies. We warmly welcome null findings, as we believe that the selective publication of significant findings creates exaggerated effect sizes in the literature and limits replicability. We are particularly interested in original research articles, but will also consider reviews, expert opinions, and commentaries that make a significant contribution to the field. 

    Guest Advisor 

    Dr. Per Davidson, 

    Kristianstad University,

    Kristianstad, Sweden 

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code BDQEV to indicate that your article should be considered for this Collection.

    The manuscript submission deadline is 15 May 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    Neuropsychiatric Disease and Treatment

    All about Psychogenic Non-Epileptic Seizures (PNES) and Functional Neurological Disorders (FND)

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "All about Psychogenic Non-Epileptic Seizures (PNES) and Functional Neurological Disorders (FND)", organized by Guest Advisor Dr. Daichi Sone in Neuropsychiatric Disease and Treatment

    Psychogenic non-epileptic seizures (PNES), also known as a form of functional neurological disorders (FND), is a medically unexplained seizure disorder. PNES mimics epileptic seizures, but there is no evidence that they are caused by abnormal electrical activity in the brain like epilepsy, and it is generally supposed that they are caused by psychological factors. 

    Although PNES is a common condition encountered in neuropsychiatric clinical practice, it is often misunderstood and misdiagnosed, leading to inappropriate treatments, such as unnecessary and harmful antiseizure medications for a long time. In addition, the gold standard for diagnosing PNES is video-EEG monitoring to record symptoms and EEG during PNES, but access to video-EEG monitoring varies widely from region to region, which is problematic. In addition, with appropriate treatment, such as rehabilitative and psychotherapeutic approaches, the prognosis for PNES is not necessarily poor, but the lack of a known mechanism of the disorder makes it difficult to develop a fundamental treatment. In recent years, it has attracted attention also in the field of neurology as a form of FND, and the neural mechanisms and the possibility of new treatments have been suggested. 

    This Article Collection solicits papers, original research or review articles, on any aspect of PNES, including but is not limited to, psychosocial, clinical practice, psychiatric, neurological, and neuroscientific aspects; papers on conversion disorders other than PNES or other types of FND may also be considered. It is hoped that the review of the current state and novel discoveries will develop better clinical practice for PNES and FND. 

    Keywords

    • Psychogenic Non-Epileptic Seizures (PNES)
    • Functional Neurological Disorders (FND)
    • Functional Seizures
    • Conversion Disorder
    • Epilepsy

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    The deadline for submissions is 31 August 2024.

    Please submit your manuscript on our website, quoting the promo code DPNSP to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Daichi Sone, Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan

    [email protected]

    After graduating from the University of Tokyo, Faculty of Medicine in 2008, Dr. Daichi Sone began his clinical career as a neuropsychiatrist through basic and specialized training. From 2012, he started working at National Center of Neurology and Psychiatry, Tokyo, Japan, specializing in neuropsychiatry, epileptology, and neuroimaging. He obtained PhD degree at Graduate School of Medicine, the University of Tokyo in 2017, and then, to develop the expertise in neuroimaging for epilepsy, he moved to London and launched the next career in Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology. Since 2021, Dr. Sone has been working at Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan, as a Senior Lecturer.

    View all papers in this article collection

    Autism, the disorder without borders and geopolitical variations

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Autism, the disorder without borders and geopolitical variations", organized by Guest Advisors Dr. Yvette Hus, Prof. Kakia Petinou, and Dr. Osnat Segal in Neuropsychiatric Disease and Treatment.

    Topic: Prevalence of a disease, including new and preexisting cases, is ‘the proportion of individuals in a population who have a particular disease or attribute at a specified period of time’ (according to the CDC). It is exceedingly difficult to determine Autism prevalence as many dynamic conditions influence the calculations including unequal distribution of socio-economic resources, diverse cultures with unique views of disease and treatment, and meagre or non-existent meaningful instruments for identification and intervention in the population’s specific context. Each geopolitical region requires factoring these issues into their calculations, consequently, complex algorithms are employed when establishing prevalence data.

    Value: Prevalence data are of utmost importance, especially in Autism, with mostly a lifetime impact and an evolving developmental trajectory and changing needs. This reality profoundly affects individuals, their families, and their communities. The data permit calculating risk of occurrence or number of new cases in a specified time, guide planning for resources and education for impacted individuals and support services for families, and establish professional training programs to provide essential services to autistic populations of any age.

    Contributing authors and topics: In the following, a virtual tour around the globe, the IALP Autism Committee members highlight specific geopolitical regions with target populations to discuss Autism prevalence, challenges encountered, available resources and practices, and reveal their efficacy. In their review K. Petinou, M. Christopoulou (Cyprus) and I. Vogindroukas (Greece) discuss Autism prevalence in understudied areas: Malta, Cyprus, and Balkan regions including Bulgaria. Y. Hus (Canada) thematic review highlights Canadian indigenous peoples, representing geographically remote and economically vulnerable communities within an industrialized privileged region, with authorities ‘frozen’ in a colonial era in their approach to families with autistic loved ones. S. Adam’s (South Africa) article underscores the challenges of determining Autism prevalence in South Africa and Nigeria. K. Jensen de Lopez and H. Thirup Møller (Denmark) review focus is autism prevalence in 7-9 years old in Scandinavia: Denmark, Sweden, Norway, and related regions: Finland, Iceland, and Greenland. N. Neubauer (USA New Jersey) reviews the Northeast USA Hispanic and Asian communities with a ‘heads-up’ to Speech Language Pathologists to be prepared to meet their dynamic needs. K.L. Johnson and A. Kristofik (USA Texas) tackle the Under-identified and Under-served Autistic Texan indigenous pediatric populations. O. Segal and S. Ferman (Israel) data compilation reviews prevalence, incidence, diagnosis, treatment, and educational opportunities for autistic individuals in the mosaic of the Israeli communities. C. Westby (USA New Mexico) and L. Cheng (USA California) review presents prevalence and services to ASD in Taiwan and Thailand representing a collective cultural perspective. Finally, C. Westby (USA New Mexico) and R. Roman (Bolivia; USA) review highlight two Latin countries, Paraguay where state agencies’ efforts are responsible for establishing services for autistic children, while a Bolivian family’s challenges to secure services for their affected child provides a ‘reality lens’ in these efforts.

    Keywords:
    • Autism
    • Prevalence
    • Geopolitical Variations
    • Under-identified
    • Underserved

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code FQVDO to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors & Conflict of Interest
    1. Dr. Yvette Hus, PhD SLP ([email protected])
    Yvette Hus, a McGill and Concordia universities graduate, is a Canadian Speech Language Pathologist (SLP), Quebec licensed clinician, educator, and researcher focusing on pediatric populations with diverse bio-neurodevelopmental disorders: Autism, DLD (SLI), Specific Learning Disabilities, and ADHD. She is the IALP ASD standing committee deputy chair headed by Prof. Petinou, and a Theralab Research Collaborator (Prof. Kakia Petinou director) of Cyprus University of Technology, Rehabilitation Sciences Department. Her publications are found on ResearchGate.
    *No Conflict of Interest
    2. Prof. Kakia Petinou, PhD ([email protected])
    Kakia Petinou is a Professor and Chair of the Department of Rehabilitation Sciences, School of Health Sciences, Cyprus University of Technology. She is a member of the International Association of Communication Sciences and Disorders (IALP) and the Chair of the Autism Spectrum Committee (ASD) of the IALP. Petinou is the founder and director of the THERALAB research laboratory (http://theralab.cut.ac.cy/), and a registered member of the Cypriot Association of Speech Therapists.
    *No Conflict of Interest
    3. Dr. Osnat Segal, PhD ([email protected])
    Osnat Segal is a senior lecturer and department head at Tel Aviv University Sackler Faculty of Medicine Department of Communication Disorders. Her pediatric research focus is infant speech and language acquisition, autism, hearing loss, and Childhood Apraxia of Speech. Her responsibilities include SLP clinical education in an orthodox program. Dr. Segal is the Israeli Speech Hearing and Language Association chair, and heads the scientific and organizing committees for the upcoming IALP 2025 Congress in Tel-Aviv. She is the founder and member of the IALP Autism standing committee.
    *No Conflict of Interest

    View all papers in this article collection

    Cognitive dysfunction in bipolar disorder: Bio-psycho-social perspective

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Cognitive dysfunction in bipolar disorder: Bio-psycho-social perspective", organized by Guest Advisor Dr. Kuniyoshi Toyoshima in Neuropsychiatric Disease and Treatment.

    Bipolar disorder affects >1% of the global population, and it causes cognitive impairment, functional disability, and death by suicide. Bipolar disorder is also characterized by recurring manic and depressive episodes. In individuals with bipolar disorder, not only mood symptoms but also cognitive impairment affects quality of life, even during euthymic phases and in the case of young people. Cognitive impairment also correlates with illness awareness, social function, suicidal ideation, etc. Therefore, recently, cognitive dysfunction has become considered to be a treatment target.

    However, the pathology of cognitive impairment in bipolar disorder has not been elucidated. Furthermore, an effective treatment for cognitive dysfunction in bipolar disorder has not yet been established. Hence, in clinical settings, biological, psychological, and social interventions are performed in combination according to the patient’s condition.

    This Article Collection seeks papers that study cognitive impairment in bipolar disorder, in terms of the bio-psycho-social perspective. It is hoped that this Article Collection will contribute to well-being and functional recovery in individuals with bipolar disorder.

    Keywords:
    • Cognitive dysfunction
    • Bipolar disorder
    • Functional recovery
    • Well-being
    • Bio-psycho-social perspective

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 31 March 2024.

    Please submit your manuscript on our website, quoting the promo code QGCFU to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Current Insights into the Epidemiology, Risk Factors, Treatment and Management Options of Seizures and Epilepsy After Stroke

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current Insights into the Epidemiology, Risk Factors, Treatment and Management Options of Seizures and Epilepsy After Stroke", organized by Guest Advisor Dr. Beata Sarecka-Hujar in Neuropsychiatric Disease and Treatment

    Stroke is a serious medical problem resulting in several harmful neurological consequences which in both pediatric and adult patients affect everyday functioning and increase the costs of medical care and rehabilitation. Seizures and epilepsy are among the most common consequences of stroke although the incidence differs between the populations. Ischemic stroke is the cause of half of the epileptic seizures that newly occur in the population of patients above 60 years of age. Based on the time of onset of epileptic seizures after stroke, they can be divided into early (occurring up to 7 days after stroke) and late seizures (occurring up to 2 years after stroke), which are characterized by different pathomechanisms. 

    It was reported that the mortality rate of stroke patients who experience poststroke seizures is significantly higher than that of all ischemic stroke patients. Moreover, it has been shown that seizures after stroke increase disability at discharge and also prolong hospital stay. In contrast, data on pediatric stroke patients have not shown increased mortality or disability in relation to early seizures. The available data may seem quite heterogeneous due to the definitions changing in recent years. Since 1.1 million patients suffer a stroke each year in Europe and poststroke survival rates improve, the number of patients with poststroke epilepsy continues to increase. In poststroke epilepsy, antiepileptic drug therapy is overall effective and monotherapy is sufficient in most patients, but there are still some treatment issues that require in-depth evaluation. Also, it remains difficult to assess the risk of poststroke seizures however some first attempts at predicting late seizures were demonstrated with promising results. Therefore, more detailed knowledge about risk factors for poststroke seizures and epilepsy and the ability to predict their occurrence may improve the prevention and treatment of the disease. 

    The present Article Collection will focus on the current opinions on epidemiology, risk factors, classification and treatment as well as prognosis in poststroke seizures and epilepsy both in adults and children. This Collection will cover clinical cohort studies, studies on biomarkers, prospective and retrospective studies concerning epidemiology and treatment options, or neuroimaging studies. 

    Keywords

    • Stroke
    • Poststroke Seizures
    • Epilepsy
    • Poststroke Consequences
    • Antiepileptic Treatment

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    The deadline for submissions is 31 August 2024.

    Please submit your manuscript on our website, quoting the promo code BQGZY to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Beata Sarecka-Hujar, Faculty of Pharmaceutical Sciences, Medical University of Silesia, Katowice, Poland

    [email protected]

    Beata Sarecka-Hujar, Ph.D. at the Medical University of Silesia in Katowice. Dr. Sarecka-Hujar conducts research on epidemiology, risk factors for cardiovascular diseases in adults as well as on risk factors and outcomes of neurological diseases, e.g. arterial ischemic stroke, epilepsy, schizencephaly, cerebral palsy in the paediatric population. Additionally, Dr. Sarecka-Hujar is interested in modern techniques for manufacturing and controlling pharmaceutical preparations. Dr. Sarecka-Hujar is a member of the Editorial Board of several journals, including BMC Pediatrics (Associate Editor), Brain Sciences, Journal of Pediatric Genetics, and Advanced Neurology. Dr. Sarecka-Hujar is an author of over 125 full-text articles, which can be found on ResearchGate or ORCID.

    View all papers in this article collection

    Epileptic disorders: advances in the diagnostic and therapeutic strategies

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Epileptic disorders: advances in the diagnostic and therapeutic strategies", organized by Guest Advisors Dr. Luo Zhou and Dr. Bo Xiao in Neuropsychiatric Disease and Treatment.

    Epilepsy is a neurological disorder that affects a substantial number of individuals worldwide, with more than 70 million individuals suffering from this condition. It is considered to be one of the most common serious diseases of the central nervous system. The incidence of epilepsy shows a bimodal distribution, meaning that the highest risk of developing the disorder is observed in infants and older age groups. The clinical presentation of epilepsy can vary greatly from person to person, resulting in diverse symptoms and manifestations. These variations can have a profound impact on the patients’ quality of life, affecting their daily activities, social interactions, and overall well-being.

    For clinical approaches, investigations such as brain imaging and genetic testing could aid in identifying the underlying etiologies and predicting the prognosis. In recent years, the field of precision medicine has gained significant attention in the context of epilepsy. Through the discovery of genes associated with these disorders, researchers have been able to advance their understanding of the underlying biology and pathogenesis of epilepsy. This newfound knowledge has opened up possibilities for developing targeted therapies that can modify or even cure the condition. The advances in brain imaging techniques have also played a significant role in epilepsy research. These imaging modalities, including structural magnetic resonance imaging (MRI), functional MRI (fMRI), and positron emission tomography (PET) have enabled researchers to identify structural and functional abnormalities in the brain that may be responsible for causing or contributing to epileptic seizures.

    Furthermore, an improved understanding of the gradual development of epilepsy, as well as the role of epigenetic factors and pharmacogenomics, has offered hope for the development of better therapeutic strategies. Researchers are exploring both pharmacological and non-pharmacological approaches to treat epilepsy, with the aim of improving patient outcomes and enhancing their quality of life. This Article Collection will focus on the latest research progress in epilepsy diagnosis and treatment. It will cover topics such as clinical observational study, neuroimaging study, genetic analysis, mechanism research, prospects for further targeted treatment, and rehabilitation interventions. By highlighting these advances, the collection aims to provide valuable insights for clinicians, researchers, and patients alike personalized approaches for managing epilepsy.

    Keywords:
    • Epilepsy
    • Diagnostic and therapeutic strategies
    • Neuroimaging
    • Genetic analysis
    • Targeted treatment

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this Collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code TPAGK to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Investigating the Role of Ketamine and Its Enantiomers in Bipolar Depression

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Investigating the Role of Ketamine and Its Enantiomers in Bipolar Depression", organized by Guest Advisor Dr. Alina Wilkowska in Neuropsychiatric Disease and Treatment

    Bipolar depression (BD), affecting 2-3% of the global population, is a major research priority given the alarming suicide rates (5-10%) and a 30% non-response rate to existing treatments. The urgent need for innovative therapeutic strategies has led to interest in Ketamine and its enantiomers, including esketamine and arketamine, as potential options for BD treatment. However, robust evidence for ketamine's effectiveness in BD remains elusive, underscoring the necessity for thorough randomized studies, particularly those examining maintenance phase and long-term outcomes.

    We invite submissions of original research and review articles exploring:

    • Therapeutic strategies for BD focusing on ketamine, esketamine, and arketamine. Topics could include maintenance treatment, variability of formulations, co-administration with standard treatments such as lithium, and real-world data from patients with comorbidities on various medications.

    • The impact of ketamine, esketamine, and arketamine on BD symptoms, including suicidality, anxiety, sleep disturbances, and anhedonia.

    • The progression of BD as a chronic disease, contributing factors, and the potential roles of ketamine and its enantiomers in slowing this progression.

    • Comprehensive reviews on definitions of treatment-resistant bipolar depression, offering insights into optimal definitions and categorizations.

    • The influence of ketamine and its enantiomers on connectivity disturbances in BD, enhancing our understanding of their effects on brain network interactions.

    • The role of ketamine and its enantiomers in addressing BD-associated immune system dysregulations. 

    We welcome contributions from various disciplines aiming to advance our understanding of BD and the potential benefits of ketamine and its enantiomers. Please submit manuscripts in accordance with the guidelines provided on our journal's submission page. Together, let's strive to expand the therapeutic options for BD patients. 

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 31 March 2024.

    Please submit your manuscript on our website, quoting the promo code YQCPB to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    The effectiveness of non-pharmacological interventions for people with cognitive dysfunction

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The effectiveness of non-pharmacological interventions for people with cognitive dysfunction", organized by Guest Advisors Professor Hsin-Hung Wu, Professor Pei-Fen Wu, and Dr. Kai-Ming Jhang in Neuropsychiatric Disease and Treatment.

    There is no curable treatment for dementia. Strategies about how to prevent cognitive decline from the stages of subjective cognitive dysfunction or mild cognitive impairment into dementia are important. Appropriate care for people living with dementia (PLWD) and their caregivers, such as transferring suitable care facilities or communication skills according to their care needs, is also necessary.

    The journal is seeking original submissions and review articles on the following topics related to the effectiveness of non-pharmacological intervention:
    • Benefits of technological intervention in cognitive impairment: Technological intervention brings personalized, engaging, and innovative approaches to cognitive training, art therapy, reminiscence therapy, and social engagement and support. By leveraging technology, these interventions enhance cognitive functioning, stimulate creative expression, foster emotional well-being, and facilitate social connections, ultimately improve the overall quality of life for individuals.
    • Assistive tools, devices, data analytics, and predictive models.
    • The effectiveness of psychoeducation, behavioral therapy, multisensory therapy, therapeutic activities, individualized or group setting, on the change of cognitive function, behavior and psychological symptoms of dementia (BPSD) or physical function.
    • The effectiveness of care models, such as specialized dementia units, collaborative care models, or case manager leading care coordination, on the change of cognitive function, BPSD or physical function.
    • Benefits of different care facilities or care delivery systems on PLWD or their caregivers.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code CPDTH to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    OncoTargets and Therapy

    Cancer Immunotherapy: Harnessing the Immune System for Cancer Treatments

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Cancer Immunotherapy: Harnessing the Immune System for Cancer Treatments” organized by Guest Advisor Dr. Anna Maria Di Giacomo in OncoTargets and Therapy.

    In the last decade, harnessing the immune system with immune checkpoint blockades has achieved remarkable results in solid tumors of different histotypes, enabling durable responses and long-term survival. Despite these unprecedented results, primary or acquired resistance can limit its efficacy; therefore a deeper understanding of the underlying mechanism of resistance is crucial for the identification of novel therapeutic strategies in several clinical settings (e.g. adjuvant, neo-adjuvant setting, rare tumors, etc.). In this exciting scenario, to untangle the threads of immunotherapy, research needs to answer some key questions, ranging from the mechanistic exploration causing lack of response, to the identification of biomarkers, but also the development of novel immunotherapeutic modalities and their clinical applications.

    In this regard, we are seeking original research, and review article submissions on the following topics:
    • Immune-checkpoint blockade for cancer treatment: from biology to clinical results
    • Therapeutic combinations of immune-modulating antibodies
    • Immunotherapies for brain metastases and brain primary tumors
    • Immunotherapies for ocular melanoma
    • Immunotherapies for rare tumors
    • Immunotherapy in adjuvant and neoadjuvant settings
    • Mechanisms of immune escape and potential strategies to overcome resistance
    • Epigenetic immune remodeling to improve the efficacy of cancer immunotherapies
    • Harnessing T-cell metabolism to improve anti-tumor responses
    • Microbioma and immune-checkpoint blockade therapy
    • Beyond immune-checkpoint(s): new targets for cancer immunotherapy
    • Imaging challenges of immunotherapy
    • Biomarkers of immune response and toxicity in immunotherapy
    • Radiomics and deep learning approach in cancer immunotherapy

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 April 2024.

    Please submit your manuscript on our website, quoting the promo code ZDDYW to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Understand and target the complexity of the tumor milieu

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Understand and target the complexity of the tumor milieu" in OncoTargets and Therapy.

    The process of tumor initiation and progression is influenced by genetic/epigenetic alterations in tumor cells and the rearrangement of the tumor microenvironment (TME) through complex signaling networks. The TME consists of various components, including tumor cells, stromal fibroblasts, endothelial cells, immune cells, and extracellular matrix (ECM) components. Crosstalk between tumor cells and these non-malignant cells in the TME plays a critical role in promoting tumorigenesis, metastasis, and drug resistance.

    Interactions within the TME involve cytokines, chemokines, growth factors, and other mediators, as well as novel mechanisms such as circulating tumor cells (CTCs), exosomes, cell-free DNA (cfDNA), and apoptotic bodies that contribute to horizontal gene transfer between tumor and normal cells. Understanding these interactions is essential to understanding tumor growth and metastasis. Targeting the TME offers potential opportunities for cancer treatment and personalized therapy.

    This Article Collection seeks research and review articles that focus on the molecular interactions between cancer cells and TME components, the link between tumor heterogeneity and metabolic plasticity, and related strategies that can bridge the gap between preclinical and clinical research.

    The deadline for submissions is 31 August 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code SCXVO to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Yong Teng, Emory University and Georgia Tech

    [email protected]

    Dr. Teng is an Associate Professor in the Department of Hematology and Medical Oncology at Emory University and an Adjunct Associate Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. He is the inaugural recipient of the Winship Cancer Institute Wally Award and a member of the BME Program and BDCI at Emory University. Dr. Teng's primary research interests are in tumor microenvironment, tumor metabolism and metastasis, with a focus on molecular determinants and paradigm-shifting treatment regimens.

    Nabil F. Saba, Emory University

    [email protected]

    Dr. Saba is Professor and Vice Chair of the Department of Hematology and Medical Oncology. He holds the Lynne and Howard Halpern Chair in Head and Neck Cancer Research and serves as Co-Director of the Head and Neck Cancer Multidisciplinary Program at the Winship Cancer Institute of Emory University. Dr. Saba is a recognized expert in immunotherapy for head and neck cancer and leads numerous translational research efforts focused on targeting the tumor microenvironment.

     

    View all papers in this article collection

    Open Access Emergency Medicine

    Decision making within the first hour of admission

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “Decision making within the first hour of admission", edited by Editor-in-Chief Dr Amit Agrawal in Open Access Emergency Medicine.

    Upon submission, please use the promo code LQHJW for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series "Decision making within the first hour of admission". The deadline for manuscripts is the 31st May 2024.

    For any enquiries, please email Victoria Ship at [email protected]

    About the Thematic Series

    For a long time, the concept of the importance of decision-making within the first hour of admission has been used to improve the outcomes in trauma and stroke practice. Recently, this concept has been expanded to various other clinical disciplines including neonatal, toxicology, shock, etc. The philosophy of this approach utilizes the advancements in patient care algorithms, multidisciplinary approach, inter-team communication and collaboration protocols. The main aim of this is to shorten the delay between admission and start of definitive management, improving patient outcomes in the process. The present Series is an effort to comprehensively present the elaborative concept of decision-making within the first hour of admission and its expanded applications in one platform.

    Journal Editors are seeking original research, and review article submissions on the following topics; however this list is not exhaustive, and contributors are welcome to modify or add a title of their interest.

    Decision-making within the first hour of admission:
    • scope and opportunities
    • in trauma care
    • in the emergency room
    • and thermoregulation
    • in polytrauma care
    • in neurotrauma interventions
    • and neonatal life
    • and stroke
    • and management of shock
    • and cardiovascular medicine
    • in toxicology practice
    • role of intensive care unit
    • resuscitation and stabilization
    • role of technology
    • quality care opportunities and challenges
    • logistics challenges and solutions
    • a perspective form developed economies
    • gaps and challenges in low- and middle-income countries
    • from onset-to-intervention: how to reduce time delays
    • protocols: how to measure the impact
    • capacity building

    Submit your manuscript
    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Open Access Journal of Contraception

    Complexities in contraception

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “Complexities in contraception”, edited by Editor-in-Chief Professor Igal Wolman in the Open Access Journal of Contraception.

    Upon submission, please use the promo code ZKTCB for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of “Complexities in contraception”. The deadline for manuscripts is the 31st of May 2024.

    For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

    About the Thematic Series

    In the modern world, contraception forms a regular part of life and medical care to cover a range of symptoms, preventative needs and additional concerns. With a wealth of choice in contraceptive care, it seems probable that complexities arise. This Thematic Series will investigate how medication-based contraceptives compare against Long-Acting Reversible Contraceptives, in terms of their efficacy, safety and use to treat multiple aspects of reproductive health. How do contraceptives go beyond their physical effects to affect psychological wellbeing? Moreover, when regular contraception fails, the efficacy of emergency contraception will also require consideration.

    An additional complexity includes access to contraceptive devices, while it is a regular part of life, it is not as easily accessible for all. This series will also investigate the demographics influencing the accessibility of contraception and the consequences to health and wellbeing when inaccessible. Beyond geographical and physical accessibility, the perception and attitudes towards contraception may form a significant part of access. How does knowledge affect outcomes when on the topic of contraception? Does this change when focus shifts to more permanent forms of contraception, or alternative methods of contraception, including male hormonal contraception.

    Even still, complexities can arise when considering the individual and their contraceptive method of choice. Responsiveness can differ by age, or by life cycle, perhaps even the influence of pre-existing comorbidities can add to the complexities of contraception. Additional factors beyond the individual, including policies and attitudes towards delivering contraception, can affect the amount of choice provided. How about the impacts of discontinuing contraception and the effect it has on patients? All of these aspects of contraception combined can prompt the need for best practices within reproductive healthcare, of which this series intends to highlight.

    The journal is seeking original submissions and review articles on the following topics related to contraception and related issues:

    • Comparative effectiveness of contraception methods (e.g., medication, LARCs)
    • Safety and efficacy of contraceptive devices and use in multiple contexts
    • Physical and psychological side effects of contraception, including emergency contraception
    • Developments in contraceptive technologies
    • Global disparities in accessing contraception and treatment of side effects
    • Consequences of lacking accessibility
    • Attitudes towards and knowledge about contraception and reproductive health
    • Permanent contraception and associated attitudes, risk factors and best practices
    • Advances in male hormonal contraception
    • Effects and outcomes of discontinuing contraception
    • Best clinical practices for reproductive health practitioners

    Submit your manuscript

    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Patient Preference and Adherence

    Advancing Medical Problem-Oriented Approaches in Infectious Disease Management

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Advancing Medical Problem-Oriented Approaches in Infectious Disease Management”, organized by Dr. Ahmad Riyad Alsayed, in Patient Preference and Adherence.

    Infectious diseases remain a significant global health challenge, with the emergence of new pathogens, the spread of drug-resistant strains, and the ongoing threat of pandemics. In response to these challenges, infectious disease management has continuously evolved, adopting innovative strategies to combat common and emerging infections. This Collection aims to highlight and disseminate cutting-edge research and developments in the field, particularly on problem-oriented approaches.

    Scope and Objectives

    This Article Collection seeks to provide a comprehensive platform for researchers, clinicians, and public health experts to share their insights and findings related to problem-oriented approaches in infectious disease management. The primary objectives of this Article Collection include:

    1. Illuminating the critical issues surrounding drugs and treatment, using classification systems like drug-related problems (DRPs), treatment-related problems, or recently, the medical problems-oriented plan (MPOP), with the ultimate goal of enhancing patient outcomes and the overall quality of care in patients suffering from infectious diseases.
    2. Exploring Novel Diagnostic Tools: Papers in this Article Collection will delve into the development and application of innovative diagnostic tools, including molecular techniques, point-of-care devices, and artificial intelligence-driven algorithms, to enhance the rapid and accurate detection of infectious pathogens, considering patient acceptance and adherence.
    3. Advancements in Therapeutic Strategies: Researchers are encouraged to present studies on discovering and evaluating new therapeutic agents, vaccines, and treatment modalities for infectious diseases. Emphasis should be placed on personalized and precision medicine approaches.
    4. Surveillance and Epidemiological Studies: Contributions that focus on using epidemiological models, big data analytics, and advanced surveillance systems to predict, prevent, and manage infectious disease outbreaks will be featured.
    5. Antimicrobial Stewardship: Papers discussing the implementation of antimicrobial stewardship programs in healthcare settings and strategies to combat antimicrobial resistance will be considered for inclusion.

    The deadline for submissions is 31 December 2024. Please review the journal’s aims and scope, alongside the author submission instructions prior to completing your submission.

    Please submit your manuscript on our website, quoting the promo code EHHUY to indicate that your submission is for consideration in this Article Collection.

    Guest advisor

    Ahmad Riyad Alsayed, Applied Science Private University

    [email protected]

    The main aims of Dr. Alsayed's practice and research are to promote evidence-based medication use to improve disease outcome and health-related quality of life of patients with internal medicine-related disorders. His current research interests include clinical pharmacy, evidence-based medicine, clinical trials of effectiveness and safety, quality of life, and pharmaceutical care,  with a special interest in infectious, respiratory, diabetes, and cardiovascular diseases.​

    View all papers in this article collection

    “How are you taking your medication?” Communication and information about medicine use

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “‘How are you taking your medication?’ Communication and information about medicine use”, organized by Dr. Liset van Dijk, Dr. Marcia Vervloet, and Dr. Laura Schackmann, in Patient Preference and Adherence

    Worldwide, many people use medication on a daily basis. However, it is not always easy for them to take these medicines properly or to start a conversation with a healthcare professional about their medication use. Furthermore, information about medication is not always easy to find and understand, especially for patients with limited health literacy. Patient leaflets, for example, often are too complex and sometimes contain information that is not relevant to the patient. Also, communication about medication between healthcare professionals and patients is often one-sided and patient-centeredness is lacking. 

    Good communication has been proven to positively affect adherence (Zolnierik 2009). In addition, clear and detailed medication-related information is important to improve proper medication use. Thus, communication and information are cornerstones in supporting patients to manage their medication. Better adherence leads to better health outcomes, better quality of life, lower healthcare use (including fewer hospital admissions), and reduced healthcare costs. 

    There is increasing attention paid to patient-centered communication and information, but still more knowledge could be gathered on how improvements in this area can be achieved, especially to improve medication use/adherence. This Article Collection welcomes articles that contribute to this, including but not limited to:

    • Innovative interventions to improve written/online/printed information about medication, especially for those with limited health literacy
    • Innovative interventions to improve communication skills of health care professionals and patients in the field of medication use/adherence
    • Observational research on patient-centeredness of communication about medication use
    • Experimental studies on information provision about medication

    The deadline for submissions is 30 April 2024. All submissions will undergo a rigorous peer-review process to ensure the quality and relevance of the contributions. We kindly ask all submitting authors to review the Aims and Scope of the journal, alongside the author submission instructions prior to completing your submission. 

    Please submit your manuscript on our website, quoting the promo code MFXTF to indicate that your submission is for consideration in this Article Collection.

    Guest advisers

    Dr. Liset van Dijk, Nivel, Netherlands institute for health services research, the Netherlands

    [email protected]

    Dr. Liset van Dijk is coordinator of the Pharmaceutical Care research program at Nivel and an honorary professor of 'Pharmacy health services research', University of Groningen, the Netherlands. Her main research interests include medication adherence, pharmaceutical patient care, pharmacist-patient communication and implementation. Liset is board member of the International Society for Medication Adherence (ESPACOMP). 

    Dr. Marcia Vervloet, Nivel, Netherlands institute for health services research, the Netherlands

    [email protected]

    Dr. Marcia Vervloet works as senior researcher within Nivel’s Pharmaceutical Care research program. Her research focuses on stimulating proper medication use from the patient’s perspective. Her expertise is on topics as medication adherence, patient-pharmacy staff communication, (understandable) information about medication, digital solutions. 

    Dr. Laura Schackmann, Nivel, Netherlands institute for health services research, the Netherlands

    [email protected]

    Dr. Laura Schackmann is postdoctoral researcher at Nivel in the pharmaceutical care research program. Her work is centered on patient-centered communication, with a special interest in challenging situations at the pharmacy counter. Also, she focuses on how the provision of health/medication-use information accommodates the needs of different patient groups.

    View all papers in this article collection

     Enhancing Medication Safety: Prioritizing Risk Management and Ensuring Safe Dispensing, Prescribing, Pharmacovigilance, and Patient Adherence

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Enhancing Medication Safety: Prioritizing Risk Management and Ensuring Safe Dispensing, Prescribing, Pharmacovigilance, and Patient Adherence", organized by Guest Advisors Dr. Mansour Adam Mahmoud and Dr. Alnada Ibrahim in Patient Preference and Adherence

    Safe medication use is of paramount importance in healthcare systems. The quality of healthcare depends on the safety of medication use, that will ultimately lead to patient safety. Medication safety involves safe medication use during dispensing, prescribing, monitoring and administering medication to the patients. Any disruption occurring in these pivotal stages has the potential for patient harm. At the forefront of these efforts, pharmacovigilance emerges as a proactive process, fostering vigilance among healthcare professionals, patients, and caregivers alike. Through appropriate adverse drug reaction reporting systems, pharmacovigilance ensures the reporting of critical information to relevant regulatory bodies. These bodies subsequently utilize the aggregated data to derive meaningful conclusions and make informed decisions regarding the safety profiles of specific medications. In addition, adherence to prescribed medications assumes paramount significance. Despite their importance, numerous studies underscore the tendency of patients to deviate from their prescribed medication regimens. Effectively measuring adherence mandates the application of validated tools tailored for this purpose. In this domain, an array of methodically validated tools exists, designed to accurately measure and evaluate medication adherence. 

    Adhering to established medication safety protocols and guidelines is of utmost significance to mitigate patient harm and enhance overall patient safety. Prominent organizations including the World Health Organization (WHO), the Institute of Safe Medication Practice (ISM), the International Pharmaceutical Federation (FIP) among others, have issued vital recommendations aimed at strengthening patient safety and enhancing medication safety. Incorporating these guidelines alongside tailored quality assurance systems within hospitals, community healthcare centers, and relevant institutions holds the potential to reduce medication errors, adverse drug events, and reactions. 

    We invite scholars, researchers, and practitioners to contribute to our upcoming Article Collection focused on the critical area of safe medication usage. The Collection aims to explore various facets, including pharmacovigilance, medication safety, safe prescribing including pharmacist prescribing, and dispensing practices, ensuring the well-being of the public. 

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    Keywords

    • Medication Safety
    • Safe dispensing and Prescribing
    • Pharmacovigilance
    • Adherence
    • Patient Safety

    The deadline for submissions is 30 September 2024. Please review the journal’s Aims and Scope, alongside the author submission instructions prior to completing your submission.

    Please submit your manuscript on our website, quoting the promo code BCDLN to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Mansour Adam Mahmoud, Department of Clinical and Hospital Pharmacy, Taibah University

    [email protected]

    Dr. Mansour Adam Mahmoud is currently working as an associate professor at the Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University. He has more than 12 years of experience in teaching, learning and research. His areas of research interest are medication safety and pharmacovigilance, clinical pharmacy practice, pharmacy education and global health. Mansour has authored and co-authored more than 100 scientific articles published in international peer-reviewed journals. He has also authored and co-authored two book chapters and one e-book. His current Google Scholar H-index is 20, i-10 31, citations more than 1500. Mansour has actively participated in the WHO Global Patient Safety Challenge: Medication without Harm which was launched in 2017 aiming to reduce medication-related harm by 50%. Dr. Mansour has taken up roles as an associate editor and spearheaded various research topics in the realm of Medication Safety, Interventions to Mitigate Patient Harm, Vaccines Safety During Emerging Infections, and the Concerns of Special Populations and Minority Groups. Recognizing his accomplishments, international organizations have honored Dr. Mahmoud with travel awards, enabling him to share his research findings in Canada, Taiwan, and the UK.

    Alnada Ibrahim, College of Pharmacy, Princess Nourah bint Abdulrahman University

    [email protected]

    Dr. Alnada Ibrahim, PhD in Pharmacy Practice, graduated from the University of Bath, United Kingdom. She is currently working as Associate Professor at the Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdurrahman University, Saudi Arabia. Her research interests lie in the area of medication safety, pharmaceutical care, assessing pharmacists' roles in a variety of capacities, clinical pharmacokinetics, and pharmacy education. She published around 25 papers in international peer-reviewed journals. She also presented various academic topics as well as research-based papers at several national and international conferences. Currently, she is working with some multidisciplinary research groups that conduct and share research across a range of issues.

     

     

    View all papers in this article collection

    Making An Impact in Diabetes Preference and Adherence Research

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Making An Impact in Diabetes Preference and Adherence Research" in Patient Preference and Adherence.

    Diabetes is a significant clinical and economic burden in the United States and worldwide. According to the Centers for Disease Control and Prevention, 37.3 million Americans have diabetes and 96 million have pre-diabetes. The total costs of diabetes were estimated to be $327 billion in 2017, up from $245 billion in 2012. By 2030, diabetes is estimated to cost $414 billion, or 1.69% of gross domestic product.

    Management of diabetes requires diet, exercise, pharmacological treatment, and self-management. While there is a significant amount of evidence demonstrating the efficacy of these interventions, only about 50% of patients with diabetes achieve glycemic control and continue to have a higher risk of cardiovascular and/or renal disease and mortality.

    While research of methods that address diabetes management adherence exists, actual adherence to clinical recommendations remains poor. To address this problem, it is important to take a holistic approach to examine reasons for non-adherence from all stakeholders, including patients, prescribers, institutions, and others. Furthermore, a focus on interventional research to address adherence and its impact on short- and long-term clinical and economic outcomes in high-risk populations is necessary as well. This Article Collection invites papers that report novel research in this area, including but not limited to innovative interventional studies that address the spectrum of adherence in prediabetes and diabetes management, innovative methods to measure adherence and its impact on clinical and economic outcomes particularly in high-risk groups, and evaluations using real-world data that identify factors of non-adherence including using social determinants of health. Studies in both children and adults are welcome. In this Article Collection we will consider reviews, original research both qualitative or quantitative, and opinion pieces on the subject.

    The deadline for submissions is 30 April 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code AUPDS to indicate that your submission is for consideration in this Article Collection.

    Guest advisor

    Alexandra Perez, Nova Southeastern University College of Pharmacy

    [email protected]

    Dr. Alexandra Perez has published many studies in the area of medication use and outcomes using existing national databases and also in pharmacoeconomic research in diabetes and cardiovascular disease. She hopes to make an impact in populations with diabetes by conducting meaningful research that will improve diabetes management and clinical outcomes.

    View all papers in this article collection

    Treatment non-adherence in psychiatric disorders: conceptual and clinical aspects

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Treatment non-adherence in psychiatric disorders: conceptual and clinical aspects", organized by Guest Advisors Professor Subho Chakrabarti and Professor Saeed Farooq in Patient Preference and Adherence.

    About half or more of the patients with chronic psychiatric illnesses either do not take medications correctly, miss appointments, or drop out from psychotherapy. Rates of non-adherence have remained relatively unchanged over the years despite the introduction of newer treatments. However, there has been a gradual shift from an illness-centered to a patient-centered approach to adherence in psychiatry. This shift has been propelled by the inability of demographic and clinical factors to fully explain non-adherence, the emergence of health-behavior theories, a move away from earlier compliance-based models to those that place greater emphasis on collaborative relationships between patients and clinicians, and the growing use of psychosocial treatments in the management of non-adherence.

    Despite advances in conceptual and clinical aspects, non-adherence continues to be a significant problem and leads to sub-optimal clinical benefit, adverse clinical outcomes, increased health-care costs, and greater burden on the patient, family, and the wider society. Moreover, our understanding of this complex phenomenon and attempts to alleviate the problem have been inadequate. Thus, the subject of non-adherence in psychiatric disorders is still relevant for both clinical practice and research endeavors.

    This collection intends to include articles that focus on concepts, extent, consequences, detection, prediction, and management of non-adherence in various psychiatric disorders. The type of articles could include reviews, original research both quantitative and qualitative, and opinion pieces on the subject. Articles on non-adherence among vulnerable patient groups such as children, adolescents, the elderly, and those from different ethnic or cultural backgrounds could make an important contribution. To align with the current broader perspective of the phenomenon, articles that emphasize patient perspectives and psychosocial management of non-adherence are particularly welcome.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 31 March 2024.

    Please submit your manuscript on our website, quoting the promo code WUHOC to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Pharmacogenomics and Personalized Medicine

    Breaking Down the Intricacies of Catabolic Enzymes

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Breaking Down the Intricacies of Catabolic Enzymes”, organized by Editor-in-Chief Dr. Martin Bluth in Pharmacogenomics and Personalized Medicine.

    Genetic polymorphisms are one way in which people vary from one another. While initial thoughts of "variance" might include a person’s physical features, it is well established that the body’s internal processes are also subject to differ dependent on a multitude of factors. This could include traits that follow them from birth, but also polypharmacy, or even diet.

    In line with the advances in modern medicine and genetic testing, research has started to explore the plethora of information linked to catabolic enzyme polymorphisms. This can involve specifying polymorphisms of interest, such as the Cytochrome P450 (CYP) family such as those including the location on the chromosome, possible allelic variations and the impact of these polymorphisms on their parent compound, metabolites or other molecules.

    Genetic polymorphisms affect many parts of human function, irrespective of specific health status. This stresses the importance of such polymorphisms further, for both promoting wellbeing in times of health, but to also understand how to approach certain illnesses given the variance in each individual case. This Collection aims to explore the role of catabolic enzyme polymorphisms for a wide variety of disease areas, such as oncology, pulmonology, immunology, psychology, cardiology and more.

    The advances in medicine can also leave researchers asking more questions. As more drug compounds reach regulators and medicine agencies, should we be considering how enzyme polymorphisms influence the efficacy and reaction of new medicines? What dangers exist when you inhibit or enhance an enzyme reaction? When considering these possibilities for new medicines, it is also imperative to acknowledge the range of possible reactions and their severity, given that polymorphisms highlight how differences between people should not be underestimated. In turn it is hoped that this Article Collection can promote best practices when prescribing treatments, by placing leading research in this collection.

    It is also hoped that research can investigate catabolic enzyme polymorphisms with a wider lens, to understand global trends in such polymorphisms and our understanding of variance on a larger scale. Thus, exploring upcoming topics of interest in this field, such as genomic testing and the use of bioinformatics in predictive technologies, elucidating the intricacies of such interaction are now within reach. These possibilities may provide more control to the individual, their medical practitioners, drug manufacturers by acknowledging human variance stretches beyond what meets the eye. These investigations, questions and early research outcomes highlight the importance of this topic for sustaining our health as a population.

    The journal is seeking original submissions and review articles from all disease areas on the following topics related to catabolic enzyme polymorphisms:

    • Identifying and understanding polymorphisms (e.g., single-nucleotide polymorphisms)
    o All aspects of enzyme metabolism (e.g., catabolism, anabolism)
    o Associated mutations, location and allelic compositions
    o Functions of interest (e.g., CYPs, steroidogenic enzymes)
    • Incidence and variance of poor metabolizers
    • Biochemical impact of polymorphisms (e.g., on parent compound, metabolites)
    • Impact of polymorphisms on drug reaction symptoms, severity and consequences
    o Variance in pro-drug and active drug reactions
    • Non-drug consumables (i.e. diet, infectious diseases) and polymorphisms
    • How epigenetic and infectious processes affect polymorphism function
    • Treatment efficacy and polymorphisms
    o Role of polypharmacy on reactions
    o Personalized dosages, drug classes and emergency medical care
    • Global trends and variation in polymorphisms
    • Progress in polymorphism genomic testing and associated benefits and costs
    • Use of bioinformatics and modelling systems for predictive testing

    All manuscripts submitted to this Article Collection are subject to desk assessment and peer review processes as part of our standard editorial process. We kindly ask all submitting authors to review the Aims and Scope of the journal, alongside the Author Information prior to completing your submission.

    The deadline for submissions is 31 May 2024.

    Please submit your manuscript on our website, quoting the promo code FEFSM to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Pragmatic and Observational Research

    Application of artificial intelligence to data management processes and predictive analysis

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Application of artificial intelligence to data management processes and predictive analysis” in Pragmatic and Observational Research.

    The rightful use of artificial intelligence (AI) and machine learning (ML) approaches can accelerate our ability to leverage and extend the information contained within original, heterogeneous, and high-volume multi-omics/genomics, phenotypic, longitudinal, and healthcare data management, processing, integration, annotation, interpretation, and sharing. AI/ML have the potential to elevate recovery process with diagnostic and predictive analysis to identify major causes of mortality, modifiable risk factors, and actionable information that supports early detection and prevention of targeted disorders and sequela. Effective application of AI/ML algorithms will lead to identifying treatments that have the most potential and detecting disease development and progression through symptoms and procedures that typically precede a diagnosis to identify patients who are very likely to develop a disease. This Article Collection will focus on studies involving application of AI/ML for data management process, biomarkers discovery, and predictive analysis. 

    This Article Collection features Artificial Intelligence, Machine Learning, Data Management Processes, Biomarkers Discovery, and Predictive Analysis. It invites relevant high-quality articles including reviews, original research, methodologies, analytics, modelling, clinical studies and patient surveys for transparent peer review and publication. 

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code UWZUB to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 31 May 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected]

    Guest Advisor

    Zeeshan Ahmed, Assistant Professor, Rutgers Robert Wood Johnson Medical School, Rutgers Institute for Health, Health Care Policy and Aging Research (IFH), Rutgers, The State University of New Jersey

    [email protected]

    Dr. Zeeshan Ahmed is an academic computational scientist, driven towards the development of artificial intelligence (AI), machine learning (ML), and bioinformatics applications for multi-omics/genomics, phenotypic, longitudinal, and clinical data management, processing, integration, annotation, interpretation, and sharing. His lab is focused on implementing AI/M approaches for discovering significant biomarkers and predicting complex disease with high accuracy for precision medicine.

    View all papers in this article collection

    Optimizing patient outcomes by personalizing therapeutic management for gastrointestinal malignancies

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Optimizing patient outcomes by personalizing therapeutic management for gastrointestinal malignancies” in Pragmatic and Observational Research.

    In this Article Collection, Pragmatic and Observational Research hopes to shed light on the real-world effectiveness and key considerations surrounding personalized medicine initiatives for the diagnosis and management of gastrointestinal cancers. 

    Despite advancements in chemotherapy-based regimens, the clinical efficacy and survival outcomes for patients with advanced gastrointestinal malignancies remain inadequate. Such limited outcomes are due to a variety of factors that promote resistant mutations, compromise the tumor immune microenvironment, re-shape the tumor stroma to aid oncogenesis, and due to increased toxicity associated with conventional standard of care treatment approaches. Effective diagnostic and therapeutic strategies addressing these barriers should significantly optimize clinical outcomes for difficult to treat gastrointestinal cancers and are thus urgently needed. 

    A Collection of reviews, original research, methodologies, analytics, modeling, clinical studies, and patient surveys evaluating the current state of clinical investigations will be organized. Please note that Pragmatic and Observational Research will no longer consider meta-analyses for publication. Studies incorporating real-world evidence via public repositories or electronic medical records originating from multiple institutions, with inclusion of under-represented populations and orphan diseases such as cholangiocarcinoma are particularly encouraged. Potential topics include but are not limited to the following: 

    • Emerging therapeutic targets in gastrointestinal cancer subtypes;

    • Targeted treatment selection strategies tailored towards patients with challenging hepatobiliary cancers;

    • Personalized medicine approaches for the diagnosis and disease monitoring of gastrointestinal malignancies, with an emphasis on the role of ctDNA;

    • Role of clinicopathological predictors of treatment response in gastrointestinal malignancies, especially colorectal cancers. 

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code HLTRH to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 12 April 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected]

    Guest Advisors

    Khurum Khan, Honorary Associate Professor and Consultant Medical Oncologist, University College London Hospital

    [email protected]

    Dr. Khan is an Honorary Associate Professor and Consultant in Gastrointestinal Oncology at UCLH. He is actively involved in translational research and has presented and lectured in international conferences and public forums respectively. Dr. Khan has published several high-impact research papers in peer-reviewed journals such as Science, Cancer Discovery, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Cancer, Cancers, and British Journal of Cancer. He currently serves as an Associate Editor of gastroenterology section of Frontiers in Oncology. He is now a UK Chief Investigator on a phase III study at UCLH, and PI on multiple phase II/III studies. 

    Umair Mahmood, Clinical Research Fellow, University College London Hospital

    [email protected]

    Umair Mahmood is a clinical researcher in the Department of Gastrointestinal Oncology at the University College London Hospital. He pursued additional research training in clinical trials at the Dana-Farber Cancer Institute and in radiation biology at the University of Oxford. His academic interests lie in clinical studies using targeted agents for gastrointestinal malignancies, in exploring the interplay between radiotherapy and the tumor microenvironment, and in clinical bioinformatics.

    View all papers in this article collection

    Pharmacological intervention in atrial and ventricular fibrillation: real world evidence and regulatory considerations

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Pharmacological intervention in atrial and ventricular fibrillation: real world evidence and regulatory considerations” in Pragmatic and Observational Research edited by our journal Editor-in-Chief, Professor David Price.

    In this Article Collection, Pragmatic and Observational Research hopes to shed light on the real-world effectiveness and key considerations that surround clinical interventions for atrial and ventricular fibrillation. An emphasis will be placed on real-world studies that provide significant evidence to complement data from the key phase III randomized controlled trials. Articles on non-interventional studies, administrative and claims database analyses, patient registries, electronic health records and patient surveys will be considered. Diagnostic innovations, heart monitoring approaches, big data capacities and regulatory considerations will be tackled where applicable. This collection seeks to identify drivers of progress, key barriers and real and potential solutions for clinicians and patients. The journal will pursue scholarly leadership on novel approaches within these sub-specialties. The Editors will consider Reviews, Original Research, Editorials and Reports.

    Upon submission, please use the promo code VNXRA to indicate that your manuscript will be considered for this Article Collection. The deadline for manuscripts is August 31st, 2024.

    For any enquiries, please email Jermaine Wilcock, Commissioning Editor at [email protected]

    View all papers in this article collection

    Real world data and AI/machine learning for drug development and drug evaluations

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Real world data and AI/machine learning for drug development and drug evaluations” in Pragmatic and Observational Research.

    This Article Collection will focus on studies that use real world data (RWD) and artificial intelligence (AI) and machine learning (ML) to conduct drug development and drug evaluation research. Our goal is to highlight the integration of RWD with AI/ML to promote pragmatic and observational research. 

    RWD, such as electronic health records (EHRs) and insurance claims, when combined with AI/ML, offer a unique opportunity to develop innovative approaches to conduct drug development and evaluation research. By combining AI/ML and RWD, drug development and evaluation can become more data-driven, efficient, and patient-centric, ultimately leading to faster discovery, development, and delivery of safe and effective drugs. 

    Manuscripts should be written for a broad target audience within the field of pragmatic and observational research. Manuscripts addressing the spectrum of the integration of RWD with AI/ML for drug development and evaluation research will be considered, with the following being of interest: 

    • Illustration of best practices of RWD with use cases demonstrating improved drug development and evaluation and health outcomes
    • The integration of drug development and evaluation with RWD and AI/ML, including EHRs, insurance claims, patient registries, and other data sources with linkage to public health entities
    • The development and applications of novel approaches (e.g., novel AI/ML and causal principled models) to study drug development and evaluation
    • Opportunities and challenges for digital health technologies to transform drug development and evaluation and improve patient care
    • The improvement of clinical research enrollment diversity for drug development and evaluation
    • Use cases of studying drug development and evaluation and enabling learning health systems and learning health communities
    • Infrastructure, including governance, IT support from EHRs, and key implementation best practices to support RWD and AI/ML to conduct research for drug development and evaluation

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code ZNFGI to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 15 March 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected]

    Guest Advisors

    Jiang Bian, Professor & Chief Data Scientist, University of Florida

    [email protected]

    Dr. Bian is currently a Professor and Division Chief of Biomedical Informatics in the Department of Health Outcomes & Biomedical Informatics, College of Medicine, at the University of Florida (UF) and the Chief Data Scientist & Chief Research Information Officer (CRIO) for the UF Health system. He also serves as the Chief Data Scientist for the OneFlorida+ Clinical Research Consortium, Director of Biomedical Informatics program of the Clinical and Translational Science Institute (CTSI) at UF, and the Director of Cancer Informatics Shared Resource at the University of Florida Health Cancer Center (UFHCC). Dr. Bian has a diverse yet strong multi-disciplinary background and extensive expertise in machine learning, natural language processing, network science, ontology development and evaluation, semantic web technology and software engineering. He has extensive experience in developing informatics tools and systems, as well as expertise in data science methods for the analysis and interpretation of biomedical and textural data. Especially, he has a track record of building data infrastructure and using electronic health records (EHRs) for research and natural language processing (NLP) tools. 

    Serena Guo, Assistant Professor, University of Florida

    Dr. Guo is an Assistant Professor in the Department of Pharmaceutical Outcomes and Policy at the University of Florida (UF) College of Pharmacy. She received her MD from Peking University in Beijing, China and her PhD in Epidemiology from the University of Pittsburgh. Dr. Guo conducts research in pharmacoepidemiology and pharmacoinformatics, primarily focused on cardiometabolic diseases and neurodegenerative conditions (e.g., dementia) with the goals of promoting precision health and health equity. Her research draws on large real-world data (e.g., electronic health records and insurance claims data) and advanced analytics (e.g., AI/machine learning, causal-principled modeling, and geospatial analyses). 

    Lixia Yao, CEO, Polygon Health Analytics LLC

    [email protected]

    Dr. Lixia Yao is the founder and CEO of Polygon Health Analytics LLC, which develops high-quality real-world data (RWD) and rigorous real-world evidence (RWE) in disease areas with pressing unmet medical needs. With two decades of experience in this field and by leading a team of data scientists and healthcare professionals and collaborating with world-renowned scholars and clinicians, she has published over 60 peer-reviewed scientific articles, including several high-impact publications in prestigious journals such as Nature Biotechnology, Genome Research, and Drug Discovery Today. Her H-index is 20. She is also the recipient of a Career Development Award in Biomedical Informatics (K01) from the National Library of Medicine for 2016-2019, a Fellow of American Medical Informatics Association (FAMIA), the Chair of the AMIA KDDM working group from 2020-2022, and the Member Engagement Co-Chair for The Professional Society for Health Economics and Outcomes Research (ISPOR) Oncology Special Interest Group for 2023-2024. Additionally, she serves as an adjunct associate professor in Department of Health Services Administration and Policy at Temple University.

    View all papers in this article collection

    Surgical interventions in heart valve replacement: Surgical and patient-reported outcomes

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Surgical interventions in heart valve replacement: Surgical and patient-reported outcomes” in Pragmatic and Observational Research edited by our Editor-in-Chief, Professor David Price.

    In this Article Collection, Pragmatic and Observational Research hopes to shed light on the real-world effectiveness and key consideration surrounding surgical approaches to heart valve replacement, aftercare considerations, and outcomes. An emphasis will be placed on surgical outcomes, trials comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR), morbidity, mortality, bleeding complications and longer-term efficacy. This collection seeks to identify drivers of progress, key barriers and real and potential solutions for clinicians and patients. The journal will pursue scholarly leadership on novel approaches within these sub-specialties. The Editors will consider Reviews, Original Research, Editorials and Reports.

    Upon submission, please use the promo code WOYHX to indicate that your manuscript will be considered for this Article Collection. The deadline for manuscripts is August 31st, 2024.

    For any enquiries, please email Jermaine Wilcock, Commissioning Editor at [email protected]

    View all papers in this article collection

    Psoriasis: Targets and Therapy

    Psoriasis: Life Style Interventions to Improve Outcome with Biologics

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Psoriasis: Life Style Interventions to Improve Outcome with Biologics", organized by Guest Advisors Dr. Fabrizio Martora (University of Naples, Italy), Dr. Teresa Battista (University of Naples, Italy) and Dr. Matteo Megna (University of Naples, Italy) in Psoriasis: Targets and Therapy.

    The management of psoriasis has evolved considerably over the past 100 years. This has occurred in parallel with our understanding of the pathogenesis of this common, complex and enigmatic disease. It should be celebrated as an outstanding example of successful translational research. With precise targeting of immune pathways for the treatment of psoriasis with new biologics and small molecules has come the realization that the most effective approach to patient management is a holistic one which encompasses the biopsychosocial nature of the disease. This involves a stratified medicine approach to identifying the best drug for an individual allied to patient education, screening for comorbidity, and regular review as both the clinical presentation and the patient's needs will change over time.

    Extrinsic environmental factors, including patient lifestyle (alcohol intake, smoking, stress, sleep disturbances, and sedentary habit), diet and single nutrients intake may affect psoriasis clinical presentation, severity, and course.

    Current authoritative knowledge confirms that low‐calories, Mediterranean, and protein restricted/vegetarian diets may be beneficial. Psoriatic patients are also recommended to engage regular physical activity, to avoid alcohol intake and to consume fish rich in omega‐3 polyunsaturated fatty acids, as well as fruit and vegetables. Prebiotics and probiotics may also provide potential benefit, whereas vitamin D supplementation and gluten‐free diet are useful in selected cases only. Changing of dietary and lifestyle habits alone does not replace conventional treatment but must be considered as an adjuvant.

    Lifestyle and nutrition may play an important role in the outcome of psoriasis therefore, the purpose of our Article Collection should be a compilation of the authors' experiences of the interventions carried out to improve the outcome of the biological treatments available to date for psoriasis.

    Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code OSZGU to indicate that your submission is for consideration in this Article Collection.

    Please contact Haoyang Yi at [email protected] with any queries regarding this Article Collection.

    View all papers in this article collection

    Psychology Research and Behavior Management

    Advancing global addiction neuroscience in the genomic era

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Advancing global addiction neuroscience in the genomic era” organized by Guest Advisor and Editorial Board Member Professor Kenneth Blum in Psychology Research and Behavior Management.

    Addiction neuroscience is a multidisciplinary field aimed at unraveling the neural mechanisms underlying addictive behaviors, including eating disorders and behavioral addictions. Numerous neurotransmitters and second messengers contribute to overall well-being and their intricate interactions regulate the controlled release of dopamine at post-neuronal sites, particularly at the nucleus accumbens, commonly referred to as the brain's reward center. In 1995, Kenneth Blum introduced the concept of 'Reward Deficiency Syndrome’ (RDS) to highlight hypofunctionality of the brain reward circuits, clinically manifested as diminution of drives and of capacity to experience pleasure.

    Nowadays, it is widely recognized that hypodopaminergia, either acquired and/or influenced by genetic predisposition, contributes to the development of RDS. Thus, people afflicted with RDS might turn to addictive substances in an ill-fated attempt to alleviate their symptoms due to the drugs offering temporary relief from the reward deficits. Yet the ongoing use of such substances exacerbates the deficits over time, subsequently amplifying reward deficiency and stress levels. Moreover, RDS is exacerbated by negative emotions, triggering epigenetic changes like methylation on chromosomal histones, resulting in substantial disruption of gene expression. One potential solution to such deepening distress is engaging in positive and nurturing behaviors that bring about beneficial effects on gene expression and contribute to a healthier reward circuitry. The present Article Collection aims to curate high-quality manuscripts pertaining to addiction neuroscience including relevant genetic and epigenetic factors.

    Importance:

    In the United States alone, opioid-induced fatal overdoses claim the lives of over 100,000 individuals a year. Globally, around 800 million people exhibit addictive behaviors or RDS, necessitating innovative thinking to address this alarming concern. We firmly believe that early detection of preaddiction traits through tools such as genetic testing is paramount for potential preventive strategies. Shifting the focus from merely prescribing medications e.g., medication assisted therapy for opioid use disorder towards restoring "dopamine homeostasis,” that is to say, “hedonostasis,” may be a complementary approach. While articles aligned with these concepts are of utmost priority, we also encourage the exploration of other pertinent topics within this realm of addiction neuroscience.

    Topics that fit within this scope include, but are not limited to:

    • Clinical outcome studies with interventions
    • Gene-environmental studies related to addictive behaviors
    • Substance Use Disorders
    • Behavioral Addictions
    • Preaddiction
    • Neuroepigenetics
    • Nutrigenomics
    • Preventive strategies
    • Genetic assessment tools
    • Recovery aspects
    • GWAS
    • Candidate gene approaches
    • mRNA profiling studies
    • Micro-RNA and addiction
    • Biomarkers for addiction
    • Gene therapy approaches
    • Genetic edits of reward genes
    • Comorbidity across all psychiatric disorders
    • Neuroplasticity
    • Personalized addiction medicine

    Types of articles

    • Original research
    • Systematic review
    • Expert opinion
    • Editorial
    • Letters to editor
    • Case study

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 1 July 2024.

    Please submit your manuscript on our website, quoting the promo code MEZFB to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Social media and mental health: exploring their complex relationships

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Social media and mental health: exploring their complex relationships” organised by Guest Advisors Professor Tore Bonsaksen and Dr Annette Løvheim Kleppang in Psychology Research and Behavior Management.

    Social media have become a permeating feature of modern life. Billions of individuals use them, to a greater or lesser extent, for a multitude of reasons, in a variety ways, and with a range of foreseen and unforeseen consequences. For example, social media may be experienced as positive and liberating, as when they facilitate connection and shared interests. However, they may also serve as platforms for bullying and harassment, with detrimental effects on the mental health of those affected. Some find it difficult to log off in fear of missing out on something. Others, including healthcare services and -professionals, use social media to attract attention to and provide guidance on mental health-related issues. For many reasons, social media is a relevant factor to assess in relationship to mental health.
    Advancing the research in this field will increase our understanding of – and instigate public debate about – the many and complex relationships between social media use and mental health. The knowledge provided may guide public and healthcare policies and therapeutic approaches, as well as the directions for further research. Ultimately, it may assist individuals in making sound choices concerning their use of social media.

    For this Article Collection, we invite authors to submit articles that will expand the knowledge in this rapidly emerging field. Original research articles and reviews are particularly encouraged, while case reports, expert opinions and commentaries will be considered. We seek contributions that advance the state of knowledge on topics such as, but not limited to:

    • Mental health-related precursors and consequences of social media use
    • Mental health-related outcomes of social media policies and interventions
    • Mediators and moderators of associations between social media use and mental health
    • The role of social media and social media literacy in mental health services
    • Mental health opportunities related to social media
    • Social media in relation to self-efficacy, social support and loneliness
    • Social media use and sleep
    • Motivations for social media use
    • Social media addiction and therapeutic approaches
    • Behavior change related to social media use
    • Self-presentation on social media
    • Bullying and harassment on social media
    • Social media scale development and testing

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 1 March 2024.

    Please submit your manuscript on our website, quoting the promo code COUDI to indicate that your submission is for consideration in this Article Collection.

     

    View all papers in this article collection

    Research and Reports in Tropical Medicine

    Chagas disease: transmission and treatment

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on "Chagas disease: transmission and treatment", edited by Editor-in-Chief Dr Mario Rodriguez-Perez in Research and Reports in Tropical Medicine.

    Upon submission, please use the promo code NGEUC for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the Thematic Series of "Chagas disease: transmission and treatment". The deadline for manuscripts is the 31st of May 2024.

    For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

    About the Thematic Series

    Chagas disease is a neglected tropical disease that continues to sweep across endemic areas, typically unnoticed. The asymptomatic nature of the disease can leave diagnosis rates low globally until individuals affected present with symptoms. As a consequence of this there are 6–7 million infections annually, with 10,000 deaths from the disease.

    How do we tackle the ongoing Trypanosoma cruzi infections and the subsequent symptoms? As part of this, research must determine the susceptibility to Trypanosoma cruzi amastigotes, including the heterogeneity resistance and receptor antagonists that affect the likelihood of infection.

    As researchers convene to develop a vaccine for Chagas disease, we hope to encourage publications that will lessen the "neglected" aspect of this tropical disease. Moreover, improving the understanding of the latent and chronic stages of the infection can pave the way to drug development, including practical molecular and chemotherapy-based techniques. Through this the disease may become treatable and preventable in the regions affected.

    The journal is seeking original submissions and review articles on the following topics related to Chagas disease:
    • Treatment of the chronic phase
    • Efficacy of current drug treatments
    • Molecular and chemotherapy-based techniques
    • Susceptibility to Trypanosoma cruzi amastigotes
    • Metabolic heterogeneity resistance Chagas disease development
    • Receptor antagonists for Chagas disease
    • Chagas disease vaccine development and potential side effects
    • Challenges in understanding immunity correlates
    • Transmission rates through intra-domiciliary, active, transplacental and vectorial transmission
    • Vector control
    • Sentinel animals in the epidemiology of Chagas disease
    • Eco-epidemiology of Chagas disease

    Submit your manuscript
    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Current research and opinion on neglected helminthic infections

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current research and opinion on neglected helminthic infections" in Research and Reports in Tropical Medicine.

    Hundreds of millions of people are infected with helminthic diseases, which occur widely, though not uniformly, throughout the tropical regions of planet Earth. Although simple sanitation and treatment measures have largely eliminated helminthic disease as a serious public health problem in the developed world, helminthic diseases continue to exert a very significant burden in many of the world's most underdeveloped countries and in most of the world's most seriously impoverished regions. Many helminthic diseases are being targeted for control or elimination by national and/or international health organizations; however, most are not treated everywhere they are endemic, and some are not targeted at all. Largely due to historic neglect, research advances in the field of helminthic disease lag behind those of many other infectious diseases and thus there are opportunities to make major and rapid advances in the field helminthic disease research by learning from advances made in more intensively studied areas of infectious disease.

    This Collection aims to encourage and support the publication of research reports and comments on issues surrounding not only the helminthic diseases that are targeted for control but also those, like mansonellosis and loiasis, which presently are not.

    The Collection welcomes all types of academic articles that are published in the journal, including short and full reports from research studies, reviews and opinion pieces that deal with the diagnostics, surveillance, epidemiology, treatment and control of all helminthic diseases. It also encourages the submission of all types of academic articles on the basic biology and taxonomy of helminthic parasites and vectors and all studies concerning interactions between the causative parasites and their host immune systems. We will also consider articles studies that model and infectious disease dynamics and control strategies and that calculate helminthic disease burdens.

    Keywords

    • Neglected Tropical helminthic diseases
    • Filariasis
    • Schistosomiasis
    • Soil transmitted helminths

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code NBOJU to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 31 October 2024.

    Guest Advisors

    James Lee Crainey, Oswaldo Cruz Foundation, Brazil

    [email protected]

    Dr. Crainey has studied filarial parasites and their vectors for more than 20 years. Initially working on the genomics of filarial vectors from Africa and Europe, Dr. Crainey began studying the filarial parasites and vectors of the Amazon after leaving London for Brazil at the end of 2011. Today Dr. Crainey´s research is focused on mansonellosis, the most prevalent filarial disease in the Brazilian Amazon region where he presently lives and works.

    Thuy-Huong Ta Tang, Instituto de Salud Carlos III, Spain

    [email protected]

    Dr. Thuy-Huong Ta Tang is a research scientist based at the Malaria and Neglected Tropical Disease Laboratory of the Instituto de Salud Carlos III, Madrid, Spain. Dr. Tang has worked and published on the subject of filarial disease research and has been involved in studies in both Latin America and Africa. Dr. Tang´s review papers on mansonellosis are among the most cited in the field.

    View all papers in this article collection

    Strategies against Neglected Tropical Viral Disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Strategies against Neglected Tropical Viral Disease" in Research and Reports in Tropical Medicine.

    Many tropical diseases have been historically neglected because of lower prevalence, social stigma and lack of profitability. These neglected tropical diseases are endemic to poor developing countries and often promote poverty through long-lasting impacts on quality of life. Dengue and Chikungunya are categorized by the WHO as neglected tropical virus diseases. Like these, other arboviral diseases including ZIKA and Japanese encephalitis also affect developing countries in tropical and sub-tropical regions. The poor are most affected by these arboviral diseases through long-lasting sequelae with huge impact on their socio-economic status. None of these viral diseases have been prioritized in global health programs. Accordingly, adequate effective therapeutic strategies are not available for their management. Thus, despite the debate about classification, all these viral diseases can be considered neglected tropical diseases, in order to attract attention for research and development to devise effective therapeutic strategies.

    With increased globalization, climatic change and adaptation of vectors, these arboviral diseases are no longer limited to tropical or sub-tropical countries. They have become global pathogens, and with higher adaptability the disease outbreaks have become more unpredictable. This has attracted wide research attention for development of therapeutic strategies. Efforts to develop new vaccines or specific antivirals have not been very successful. While higher mutability of these viruses has been a challenge for vaccine development, inadequate elucidation of virus-host targets has posed hurdles for effective antiviral development. Nonetheless, concepts of mutable vaccines and success of mRNA vaccines against COVID-19 have fueled hopes for effective vaccine development. Further, greater insights into the virus life-cycle and host response aided by computational techniques have revealed attractive drug targets for antiviral development. Also, there have been efforts to repurpose existing drugs and use herbal drugs/alternative systems for management of these diseases. Considering the fact that virus-induced inflammation is the primary cause of morbidity and mortality, approaches have also been investigated to modulate immune and inflammatory pathways to manage these viral diseases.

    Authors are encouraged to submit original research articles and reviews that focus on, but are not limited to, the following areas:

    • Updates in vaccine development against DENV/CHIKV/JEV/ZIKA virus
    • Vaccine design through in silico approach
    • Drug targets for therapeutic intervention against Dengue
    • Updates in drug development strategies against DENV
    • Therapeutic targets for CHIKV infection
    • Drug development strategies against CHIKV
    • Drug development strategies against JEV
    • Drug development strategies against Zika virus
    • Drug repurposing against DENV/CHIKV/JEV /ZIKA virus infection
    • Structure based drug design against DENV/CHIKV/JEV/ZIKA virus
    • Complementary therapy to manage DENV/CHIKV/JEV/ZIKA virus infection
    • Herbal drugs/alternative strategy to manage DENV/CHIKV/JEV/ZIKA virus infection
    • Immune-inflammatory signalling in viral infection
    • Modulation of host factors for management of viral disease


    Keywords

    • Tropical virus
    • Antiviral
    • Vaccine development
    • Neglected disease
    • Therapeutic strategy

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code STQQX to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 30 September 2024.

    Guest Advisors

    Bharat Bhusan Subudhi, Siksha O Anusandhan Deemed to be University, India

    [email protected]

    Dr. Bharat Bhusan Subudhi has been working in the field of drug development for last 19 years. He has expertise in drug design, synthesis, drug product development, analysis and toxicological/pharmacological evaluations. Antiviral development is his major research focus.

    Soma Chattopadhyay, Institute of Life Sciences, India

    [email protected]

    Dr. Soma Chattopadhyay has more than 20 years experience in the field of virology/infectious disease biology involving HSV, CHIKV, JEV and SARS-CoV-2. She has expertise in molecular virology, animal models as well as development of viral antibodies. She has worked on drug repurposing and involved in the process for development of strategy for management of CHIKV, HSV, JEV and SARS-CoV-2.

    View all papers in this article collection

    Research and Reports in Urology

    Therapeutic Advances in Urologic Malignancies

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancing Patient Safety Culture and Managing Healthcare Risks for Sustainable Healthcare", organized by Guest Advisor Werner T.W. de Riese in Research and Reports in Urology.

    In recent years an evident paradigm shift has evolved across both local and systemic treatment choices for urologic malignancies. Regarding prostate cancer management, research has focused on a multitude of treatment options; whereas radical prostatectomy is well established for local disease, the role of pelvic lymph node dissection remains controversial, in particular in the context of metastatic disease on imaging. Adjuvant and early salvage radiotherapy offer distinct approaches, with recent studies indicating comparable outcomes. Systemic therapies continue to evolve as e.g., chemotherapy's role in radiation therapy is still an ongoing subject of clinical studies.

    For locally advanced penile squamous cell carcinoma (PSCC), neoadjuvant chemotherapy and adjuvant therapy are actively explored as research is studying new drug regimens for first-line treatment options. While there are new and promising developments in understanding of cellular pathways and immune system targets for potential therapies, the results of limited trials are restricting their broad clinical application. Though the therapeutic achievements in systemic treatment of renal cell carcinoma currently rely on tyrosine kinase inhibitors with varying success, new certain immune checkpoint inhibitors are revealing very promising clinical results. Adjuvant therapy for urothelial carcinoma, in particular bladder cancer, has remained controversial in the literature, despite the proven effectiveness of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

    Practicing urologists and medical oncologists are often confronted with challenging clinical scenarios of urologic malignancies. Therefore, an update on recent advancements in the therapeutic outcome of difficult disease stages is appreciated as treating clinicians are ultimately driven to improve the chances of reducing disease burden, and thus improving patients’ survival. 

    In this Collection, we are seeking original research articles as well as review papers. This Collection will include novel aspects of treatment options for urologic malignancies within the field of PSCC, prostate cancer, and bladder cancer. Among others, this collection will include primary discoveries as well as summaries of both adjuvant and neoadjuvant therapy, surgical treatment, use of checkpoint inhibitors, and hormonal therapy. The main goal and purpose of this Collection is bringing awareness about recent advancements for the different disease stages of these urologic malignancies.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 3 May 2024.

    Please submit your manuscript on our website, quoting the promo code XNJYG to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Risk Management and Healthcare Policy

    Advancing Patient Safety Culture and Managing Healthcare Risks for Sustainable Healthcare

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancing Patient Safety Culture and Managing Healthcare Risks for Sustainable Healthcare", organized by Guest Advisors Prof. Hsin-Hung Wu, Dr. Chih-Hsuan Huang and Dr. Yii-Ching Lee in Risk Management and Healthcare Policy

    This Article Collection focuses on a critically important aspect of modern healthcare: “Advancing Patient Safety Culture and Managing Healthcare Risks for Sustainable Healthcare.” The evolving area of this proposal bridges the gap between patient safety, risk management, and sustainability in healthcare. As healthcare systems worldwide strive for patient-centered care, it has become crucial to recognize that a culture fostering patient safety and effective risk management strategies contributes significantly to the overall sustainability of healthcare institutions. 

    This topic’s relevance stems from the contemporary need for a safer and more efficient healthcare sector. With the rising complexity in healthcare processes, patient safety and risk management have become paramount. They form the bedrock for the trust patients place in healthcare systems. More so, effective management of these aspects often leads to significant cost savings, thereby promoting the sustainability of healthcare services. In a broader perspective, cultivating a patient safety culture and implementing comprehensive risk management plans contribute to the overall health outcomes and well-being of the society at large. 

    In the Collection within the ambit of the “Risk Management and Healthcare Policy” journal, we invite submissions encompassing our theme. Relevant subtopics include, but are not limited to, methods of enhancing patient safety culture, new and innovative approaches to healthcare risk management, the role of policy and leadership in promoting patient safety, and the influence of digital technology on patient safety and risk management. These themes explore the intersection between patient safety, risk management, and the overall sustainability of healthcare institutions. We welcome submissions of various article types, including original research articles, reviews, case studies, commentaries, and policy analyses. This Collection aims to stimulate informed dialogue, inform policy alterations, and inspire future research in these key areas of healthcare management. 

    Keywords

    • Patient Safety Culture
    • Healthcare Risk Management
    • Enhancing Patient Engagement in Healthcare
    • Healthcare Policy
    • Healthcare Quality Improvement

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    The deadline for submissions is 31 March 2024.

    Please submit your manuscript on our website, quoting the promo code NTEGW to indicate that your submission is for consideration in this Article Collection.

    Guest advisers

    Professor Hsin-Hung Wu, Department of Business Administration, National Changhua University of Education

    [email protected]

    Changhua, Taiwan Hsin-Hung Wu is a Professor at National Changhua University of Education (NCUE), Changhua, Taiwan since August 2006. Currently, he is Dean of College of Management at NCUE since September 2020. His research interests mainly focus on patient safety culture, dementia care and patient safety culture. He has published 220 journal papers since 1999

    Professor Chih-Hsuan Huang, Business School, Hubei University of Economics

    [email protected]

    Chih-Hsuan Huang received his PhD from the Business School in Brisbane, Australia. He is Associate Professor with the Business School at Hubei University of Economics. His research interests include patient safety, medical quality, and sustainable management. His research in these areas has appeared in a journal such as Asia Pacific Journal of Marketing and Logistics, Journal of Environmental Planning and Management, and Journal of Pediatric Nursing etc.

    Professor Yii-Ching Lee, Department of Health Business Administration, Hung Kuang University

    [email protected]

    Yii-Ching Lee is Assistant Professor at the Department of Health Business Administration at Hung Kuang University. His main areas of research interests are in medical quality, patient safety, rational bond, rational marketing, and hospital management.

    View all papers in this article collection

    Global South's Unmet Needs - Risk to Sustainable Use of Pharmaceuticals and Medical Devices

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Global South's Unmet Needs - Risk to Sustainable Use of Pharmaceuticals and Medical Devices", organized by Guest Advisors Professor Mihajlo Jakovljevic and Professor Maria José Muñoz Torrecillas in Risk Management and Healthcare Policy.

    Global South consists of a large diversity of healthcare and pharmaceutical markets belonging mostly to the Low-and-Middle-Income countries scattered across Latin America, Africa, Asia and the Pacific islands. These nations, and in particular the rapidly developing Emerging BRICS / EM7 / MIST markets among them, will continue to lead real GDP growth worldwide in the upcoming decades.

    Consequently, the Global South countries also lead the global demand for pharmaceuticals (in terms of volume based / subscription drugs turn over) and medical services. This fact is becoming more prominent as the vast majority of global burden of noncommunicable diseases (NCDs) and Population Aging is also moving from the historical dominant trend in the Global North nations towards the South. With low fertility, there is ongoing extinction of traditional family caregiving across these vast regions. This makes the need to secure long terms care provision urgent, a necessity which is hard to finance.

    There remains a strong and increasing gap in sustainability of financing of hospital and home-based long-term care for patients suffering from NCDs in these countries. This is witnessed with a huge gap between the ability to publicly finance universal health coverage, even with rather shallow insurance premiums consisting only of basic services and medical goods.

    Last but not least, high out-of-pocket expenditure leads to catastrophic household expenditure in many families which is also a remarkable feature of social vulnerability of poor citizens in these nations. Poor sustainability of fiscal streams intended to secure provision of such medical goods and services is well documented in the seminal literature. The most typical manifestations are frequent drug shortages of essential medicines and lengthy hospital waiting times for rather sensitive therapies such as oncology, orthopedic surgery and invasive radiology. This Article Collection is intended to welcome a wide diversity of submissions, capable of covering any of the aforementioned unmet needs and challenges.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code DMOXB to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Rethinking Public Health Approaches to Crisis Response: Putting People First

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Rethinking Public Health Approaches to Crisis Response: Putting People First", organized by Guest Advisors Prof. Susannah Mayhew, Dr. Luise Enria, and Dr. Alhaji N’jai in Risk Management and Healthcare Policy

    Recent decades have seen increasingly unpredictable outbreaks of zoonotic and emerging infectious diseases (such as SARS, Zika, Ebola, Covid), changing climate, widespread economic crises and regular outbreaks of violent conflict. The uncertainty of these crises makes it difficult to plan and meet the health needs of the populations facing them. Moreover, indigenous knowledge and the experiences and views of affected populations are rarely considered part of preparedness planning or crisis-response, despite being critical to it. Research on responses to epidemics highlights how a lack of community trust and involvement in formal response strategies undermines efforts to stop the spread of the disease and puts people in life-threatening positions. Experiences from agriculture show the importance of local engagement in decision-making when planning for climate-resilient livelihoods. These experiences provide critical learning to redefine our thinking on emergency responses and global health security. 

    Research has called for greater commitment to involving a variety of local first responders in public health crises as a key step to establishing the inclusive, trust-based decision-making critical for effective crisis response. However, there is little robust evidence from the health sector of “what works” or “why it works” for community engagement and involvement, the role of local knowledge, or how formal health sector and humanitarian crisis-response structures can support and sustain local action to safeguard health. Although guidelines exist on “risk communication and community engagement” they seldom detail genuinely participatory approaches or meaningful community-led action in shaping crisis-response and preparedness planning. Valuable local knowledge is therefore too often ignored. 

    This Collection welcomes submissions that detail actions, experiences, models, or mechanisms of the involvement of community members and local knowledge in responses to any clearly defined public health crisis. We welcome empirical data studies of any relevant study design, particularly those using participatory methods and those seeking to put local knowledge first. We especially welcome contributions led by authors from the global-South. 

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 31 March 2024.

    Please submit your manuscript on our website, quoting the promo code EBOSK to indicate that your submission is for consideration in this Article Collection.

    Guest advisers

    Professor Susannah Mayhew, London School of Hygiene & Tropical Medicine

    [email protected]

    Susannah Mayhew is Professor of Health Policy, Systems and Reproductive Health at the London School of Hygiene & Tropical Medicine. Her research specialisations are in policy analysis, policy implementation, governance and accountability research – including community engagement; health systems and systems integration research (including in epidemic-response); and reproductive health and rights. She has led multi-partner research projects in numerous countries across sub-Saharan Africa and South East Asia. At present she works primarily in West and East Africa on cross-sectoral responses to climate and health challenges, including reproductive health and zoonotic outbreaks, with a focus on community involvement.

    Dr. Luisa Enria, London School of Hygiene & Tropical Medicine

    [email protected]

    Luisa Enria is Assistant Professor in Anthropology at the London School of Hygiene & Tropical Medicine. Her work applies approaches from medical and political anthropology to study how communities engage with, imagine and at times resist development and humanitarian interventions, with a particular focus on health emergencies. She worked as a social scientist on the Ebola vaccine trials in Sierra Leone as well as several projects on the political economy of emergency vaccine deployment, rumors in epidemics, assessing community engagement for vaccine campaigns in humanitarian settings and she has developed a training on citizen ethnography for Community Health Workers. She currently holds a UKRI Future Leaders Fellowship on the politics of knowledge in epidemic preparedness.

    Dr. Alhaji U. N’jai

    [email protected]

    Alhaji U. N’jai is Associate Professor in Immunology, Infectious Disease, Toxicology, environmental science, and Public Health at University of Sierra Leone with dual appointment at California University of Science and Medicine. He is also director of University of Wisconsin-Madison Global Health Institute’s One Health Center, West Africa. Dr. N’jai has a broad multidisciplinary research interest at the intersection of biomedical science (infectious disease, toxicology, immunology, genomics, systems biology), environmental science, epidemiology, One Health, anthropology, and indigenous African Knowledge systems. Since December 2014, he has led the Ebola control and infectious disease emerging in Africa (IDEA) research initiative in Sierra Leone resulting in international collaborative projects on Ebola and infectious diseases between University of Sierra Leone, University of Wisconsin-Madison, and University of Tokyo. Dr. N’jai is a principal investigator for Abbott Pandemic Defense Coalition (APDC) Acute Febrile Illness Surveillance in Sierra Leone. He is also the founder and chief strategist for Project 1808 and Koinadugu College. Dr. N’jai was deputy incident manager for Ebola in 2021 and currently serves as a senior technical advisor for the Directorate of Health Securities and Emergencies (DHSE) at Sierra Leone Ministry of Health as well as the chairman of the One Health Technical Working Group in Sierra Leone.

    View all papers in this article collection

    Stem Cells and Cloning: Advances and Applications

    Tissue Stem Cells

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Tissue Stem Cells" in Stem Cells and Cloning: Advances and Applications.

    Tissue stem cells, also known as somatic or adult stem cells, are usually multipotent and can differentiate into a limited number of adult and specialized cell types. They are found in low numbers in adult tissues and are considered as a rare population of cells present throughout the postnatal life. These cells produce mature cell types that facilitate generating the tissue in which they reside. They also maintain tissue homeostasis by replacing cells lost due to continuous tissue turnover or injury. Tissue stem cells can be isolated from wide variety of sources such as bone marrow, umbilical cord and cord blood, adipose tissue, and dental pulp. 

    The aim of this Article Collection is to highlight hematopoietic stem cells and mesenchymal stromal cells, which have shown great promise in regenerative medicine and dentistry. These cells have the potential to advance cellular therapeutics for a wide range of diseases. As we can isolate tissue stem cells from a variety of sources, examining the self-renewal and differentiation potential of these stem cells in various tissue types is at the forefront of stem cell research. 

    In this Article Collection, we will explore research highlighting the numerous types of tissue stem cells and their translational capacity for regenerative purposes. We welcome original research, reviews, hypothesis formation, technology reviews, and short reports related to the isolation, characterization, and/or functionality of stem cells isolated from (but not limited to):

    • Bone marrow
    • Umbilical cord, cord blood. amniotic fluid, placentae, and Wharton’s jelly
    • Dental pulp and gingival tissue
    • Adipose tissue
    • Skeletal muscle and tendon
    • Perivascular fraction of cells from various tissues

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 June 2024.

    Please submit your manuscript on our website, quoting the promo code CAAEI to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Mohsin Wahid, Tenure Track Associate Professor of Pathology, Dow University of Health Sciences

    [email protected]

    View all papers in this article collection

    Substance Abuse and Rehabilitation

    Last laugh: dangers of nitrous oxide misuse

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “Last laugh: dangers of nitrous oxide misuse”, edited by Editor-in-Chief Dr. Rajendra D. Badgaiyan in Substance Abuse and Rehabilitation.

    Upon submission, please use the promo code IOBXB for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of “Last laugh: dangers of Nitrous Oxide misuse”. The deadline for manuscripts is the 31 May 2024.

    For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

    About the Thematic Series

    Typical clinical use of nitrous oxide, otherwise known as laughing gas, is for sedation during painful procedures. However, in recent years the misuse of nitrous oxide as a recreational drug has become prominent, known for its instantaneous and pleasant effects. Less than pleasant, though, are the psychological and physical consequences of nitrous oxide misuse. Users may experience euphoria related to nitrous oxide use, but drug-induced psychosis, mood disorders, and traumatic brain injuries are equally as likely.

    Outcomes of misuse are not limited to the brain, as embolisms, neuropathy, myelopathy, esophagus damage and more are linked to nitrous oxide misuse. Moreover, constant inhalation of the substance may lead to vitamin deficiencies, leading to the body attempting to futilely compensate. The psychological “high” from nitrous oxide leaves individuals vulnerable to physical harm, as risk assessment falters, meaning injuries whilst intoxicated are common.

    How do we treat these psychological and physiological outcomes? Treatment can include counteracting the imbalances nitrous oxide leads to, successfully reducing side effects. For the behavior itself, research may branch out into other substances and apply effective treatments to nitrous oxide misuse. Moreover, psychological support may uncover the underlying reasons for misuse. This Thematic Series also seeks to investigate how to prevent nitrous oxide misuse as it rises in popularity as a substance, including risk factors leading to misuse, social factors affecting use, improving knowledge and more.

    The journal is seeking original submissions and review articles on the following topics related to nitrous oxide misuse and related issues:

    • Incidence of drug-induced psychosis
    • Relationship to later psychotic and mood disorders
    • Traumatic Brain Injury (TBIs) related to nitrous oxide misuse
    • Damage to the nervous system through myelopathy, neuropathy and more
    • Cardiovascular and respiratory side effects including embolisms, emphysema and more
    • Vitamin deficiencies and subsequent consequences
    • Self-injury through substance misuse
    • Treatment by countering physiological abnormalities
    • Tapering the addiction cravings and behavior using cobalamin injections
    • Efficacy of treatments for other substance misuse disorders to treat nitrous oxide misuse
    • Detection of risk factors for nitrous oxide misuse
    • Prevention through harm-reduction campaigns and information sharing

    Submit your manuscript

    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Therapeutics and Clinical Risk Management

    Lymphoproliferation at the crossroad between hematology and immunology: molecular and clinical implications

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Lymphoproliferation at the crossroad between hematology and immunology: molecular and clinical implications" in Therapeutics and Clinical Risk Management.

    Lymphoproliferation, clinically expressed with lymphadenopathies, hepato-splenomegaly, or lymphoid organ infiltration, is a common feature of different diseases, ranging from infections to hematologic malignancies. In the recent years, there has also been an increasing interest in the impact of lymphoproliferative features in patients with inborn errors of immunity (IEI), as benign polyclonal lymphoproliferation is one of the leading signs in different IEIs, including the autoimmune lymphoproliferative syndrome and other immune dysregulation disorders. Moreover, the knowledge on lymphoproliferative malignancies israpidly progressing, with the increasing availability of new therapeutic regimens.

    Therefore, a deeper understanding of the diseases featured by lymphoproliferation is warranted, in order to improve the recognition and treatment of the main causes of lymphoproliferation, including IEIs and malignancies.

    This aim of this Article Collection is to offer an overview of lymphoproliferative diseases, considering the diagnostic aspect (with a specific focus on the new diseases associated with lymphoproliferation) and the therapeutic options in the setting of both polyclonal and malignant lymphoproliferation. Specifically, the possibility to have the contribution from both an immunological and onco-hematological point of view could significantly increase the impact of this Collection. This Article Collection will consider review papers and original research papers.

    Keywords

    • Lymphadenopathy
    • Inborn errors of immunity
    • Immune dysregulation
    • Lymphomas
    • Splenomegaly

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 November 2024.

    Please submit your manuscript on our website, quoting the promo code IHLGQ to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Giorgio Costagliola, Azienda Ospedaliero Universitaria Pisana (AOUP)

    [email protected]

    Medical doctor and researcher at the Pediatric Hematology and Oncology Department of the Azienda Ospedaliero Unviersitaria Pisana (AOUP), with a special focus on inborn errors of immunity. Junior member of the European Society for Immunodeficiencies and member of the Associazione Italiana Oncologia ed Ematologia Pediatrica (AIEOP) and Italian Primary Immunodeficiency network (IPINET).

    Rita Consolini, University of Pisa

    [email protected]

    Professor of Pediatrics at the University of Pisa, involved in teaching pediatric and immunology. Medical Doctor 1976 University of Pisa, Italy (pass with distinction). Expertise in Pediatrics (1979), Immunology (1982) and Haematology (1986). Member European Society for Immunodeficiencies (ESID), Associazione Italiana Oncologia ed Ematologia Pediatrica (AIEOP) and Italian Primary Immunodeficiency network (IPINET).

    View all papers in this article collection

    Unlocking the Secrets of the Nervous System: Unveiling the Biomarkers of Neurological Diseases

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Unlocking the Secrets of the Nervous System: Unveiling the Biomarkers of Neurological Diseases" in Therapeutics and Clinical Risk Management.

    This Collection aims to compile groundbreaking research and insights into the biomarkers associated with neurological diseases. Biomarkers play a crucial role in understanding the pathophysiology of neurological disorders, aiding in early diagnosis, prognosis prediction, and monitoring the efficacy of therapeutic interventions. The gathered articles will explore the diverse range of biomarkers, from genetic and protein markers to imaging and clinical biomarkers, that are instrumental in unravelling the complexities of neurological diseases.

    The importance of identifying and understanding biomarkers in neurological diseases cannot be overstated. These markers provide valuable information about the disease process, ultimately facilitating personalized medicine approaches and more effective treatments. By elucidating the intricate relationship between biomarkers and neurological diseases, we can unlock new avenues for research and intervention, thereby improving patient outcomes and contributing to the global fight against these debilitating conditions.

    We invite authors to submit original research articles, comprehensive reviews, and perspective pieces that delve into the various aspects of biomarkers in neurological diseases. Submissions should focus on topics such as the identification and validation of new biomarkers, the role of biomarkers in disease progression and treatment response, and the challenges and opportunities in translating biomarker research into clinical practice. Through this article collection, we aim to create a valuable resource for researchers, clinicians, and anyone with an interest in the dynamic field of neurological diseases and their associated biomarkers.

    Keywords

    • Neurological Diseases
    • Biomarkers
    • Prognosis
    • Disease Monitoring
    • Clinical Applications

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 July 2024.

    Please submit your manuscript on our website, quoting the promo code RFPYX to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Xiaoqiao Dong, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine

    [email protected]

    Dr. Xiaoqiao Dong holds a doctoral degree and is a chief physician and master's degree supervisor. He specializes in clinical work related to traumatic brain injuries, spontaneous cerebral hemorrhage, and subarachnoid hemorrhage, and conducts basic and clinical research on acute brain injuries. Dr. Dong has participated in more than 30 projects, published over 70 SCI articles, received 9 awards for scientific and technological progress, and obtained 3 invention patents.

    View all papers in this article collection

    Veterinary Medicine: Research and Reports

    Nutritional insights into pet diets

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Nutritional insights into pet diets" in Veterinary Medicine: Research and Reports.

    Over the years, the number of food and dietary trends available for pets has drastically increased, alongside an overall increase in the "humanization" of pet food; owners can now choose between raw, organic, gluten free etc more than ever before. With some of these trends being extreme, there is now a need to investigate these new trends and diets for their nutritional value to pets as well as their safety and effect on the animal. This Collection aims to comprehensively present the nutritional impact of these diets and their impact on the pets' behavior and short- or long-term health outcomes.

    Journal Editors are seeking original research, and review article submissions on the following topics; however this list is not exhaustive, and contributors are welcome to modify or add a title of their interest.

    Nutritional Insights into pet diets:

    • Grain free food trends
    • Vegan/Vegetarian food trends
    • Carnivore diets
    • Nutritional deficiencies in pets
    • Impact of nutrition on pets physical health
    • Impact of nutrition on pets behavior
    • Improving pets oral health with diet
    • Pet weight issues
    • Raw diets
    • Humanization of pet food
    • Personalized pet diets

    Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 31 March 2024.

    Please submit your manuscript on our website, quoting the promo code LXVBL to indicate that your submission is for consideration in this Article Collection. If you have any questions about this Article Collection, please contact Victoria Ship at [email protected].

    View all papers in this article collection